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CHAPTER 1
INTRODUCTION

Significance

In the US every year, over 50,000 people die following traumatic injury. It
is estimated that 30-40% of these deaths are directly due to extensive blood loss
and shock (Centers for Disease Control and Prevention, 2012; Kauvar and
Wade, 2005). Current treatment for hemorrhagic shock includes volume
resuscitation, the goal of which is to restore perfusion of the vital organs (Perel et
al., 2013). However, fluid volume restitution alone is often insufficient to regain
perfusion pressure, in which case catecholamines or other vasoconstrictors are
given (Hollenberg, 2011). Therefore, such treatment is only administered after
sufficient volume resuscitation in order to avoid exacerbation of ischemia and
reperfusion injury. During hypoperfusion, the peripheral tissues become hypoxic
and undergo anaerobic metabolism. The byproducts of this process can form
reactive oxygen species (ROS) upon the reintroduction of blood flow to cause
further damage to the microvasculature and induce endothelial injury (Verma et
al., 2002). While significant treatment advances have been made in recent
years, morbidity and mortality remain high, especially when resuscitation is
delayed. Novel methods of resuscitation that can be employed rapidly and easily
are required to improve patient survival from traumatic blood loss.
1

2
Progressive blood loss produces a complex multiphasic response of the
autonomic nervous system. During the initial stage of hemorrhage, arterial
pressure is maintained primarily through the unloading of the arterial
baroreceptors, which activate sympathetic drive causing vasoconstriction and
increased heart rate (Korner et al., 1990; Schadt and Ludbrook, 1991). Once a
significant amount of blood has been lost (20-30% total volume in humans and
15% total volume in unanesthetized rats), a reversible decompensatory response
is initiated during which there is a decrease in sympathetic outflow and rapid fall
in blood pressure (Hasser and Schadt, 1992; Ludbrook and Ventura, 1996).
This transient response is hemodynamically similar to vasovagal syncope. This
response may be beneficial in that it increases ventricular filling time and cardiac
output (Barcroft and Edholm, 1945). The syncopal phase persists until a second
set of compensatory responses develop that help regain perfusion pressure to
peripheral organs. The second compensatory response is characterized by a
slow restoration of sympathetic drive (Haljamae, 1984). Without therapeutic
intervention, this secondary compensatory stage eventually plateaus. If blood
loss continues beyond this stage, vascular permeability increases, and vascular
reactivity declines (Liu et al., 2003). This last stage is known as decompensation
and is extremely difficult to treat. Emergency interventions that prolong the
secondary compensatory phase and delay decompensation are crucial for
patient survival from traumatic blood loss.
Our lab has found that 5-HT1A receptor agonists, including the full agonist,
8-OH-DPAT, accelerate sympathetic recovery and stimulate sympathetic-
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dependent increases in venous tone without increasing total peripheral
resistance when given after the onset of hypotensive hemorrhage or hemorrhagic
shock (Osei-Owusu and Scrogin, 2004; Scrogin, 2003; Scrogin et al., 2000;
Tiniakov et al., 2007; Tiniakov and Scrogin, 2006). These effects are prevented
by ganglionic blockade or sympathetic denervation of the splanchnic vasculature.
Thus, 8-OH-DPAT administration increases perfusion pressure by mobilizing
blood from the venous pool in the splanchnic vasculature (Tiniakov et al., 2012;
Tiniakov and Scrogin, 2009). This effect persists beyond the duration of drug
action, suggesting that an initial increase in sympathetic activation mobilizes
blood stores that remain in the effective circulation even after the direct effects of
the drug have worn off. Low dose drug injection in the cisterna magna, directly
above the floor of the 4th ventricle was found to produce the most robust and
rapid rise in sympathetic activity in hemorrhaged rats compared to other routes of
administration (Scrogin, 2003). Attempts to better define the site of action of
5HT1A receptor agonists have been hampered by an inability to observe the
sympathoexcitatory effects of 5-HT1A receptor agonists in anesthetized animals.
In the course of the studies described above, it was found that selective
lesion of caudal serotonin neurons attenuated normal ventilatory responses and
recovery of sympathetic activity following hypotensive hemorrhage. Destruction
of serotonin neurons also exacerbated metabolic acidosis, indicating that
lesioned animals had exaggerated peripheral tissue hypoxia (Kung et al., 2010).
Excessive tissue hypoxia developed despite high arterial blood O2 levels.
Evidence that tissue hypoxia after hemorrhage is more severe in lesioned
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animals despite elevated arterial blood O2 indicates that loss of serotonin cells in
the caudal brainstem impairs delivery of blood to peripheral tissue. Nevertheless,
blood pressure compensation following hemorrhage was similar in lesioned and
sham-lesioned animals, which led us to speculate that lesioned animals
maintained blood pressure by increasing peripheral resistance. These data
further suggest that serotonin neurons are important for maintenance of cardiac
output and peripheral oxygenation during low volume states, a phenomenon that
may be dependent upon sympathetic activation. Thus, 8-OH-DPAT and
serotonin neurons have similar effects during hemorrhage. Specifically, both
increase sympathetic recovery following hypotensive hemorrhage and improve
tissue oxygenation, most likely by increasing cardiac output. Thus, we propose
that endogenous serotonin may be released during hemorrhage and act on 5HT1A receptors expressed on non-serotonergic neurons to mediate sympatheticdependent increases in perfusion. Therefore, 8-OH-DPAT may act by
accelerating and further augmenting the normal serotonin-dependent mechanism
activated by stimuli associated with hemorrhage.
5-HT1A receptors normally couple to inhibitory Gαi proteins (Fargin et al.,
1989). Activation of 5-HT1A receptors leads to membrane hyperpolarization
(Innis et al., 1988; Penington and Kelly, 1990). Indeed, in euvolemic animals, 8OH-DPAT produces profound sympathoinhibition, most likely through activation
of 5-HT1A receptors expressed on tonically active RVLM cells that excite preganglionic sympathetic nerves (Kubo et al., 1995; Lewis and Coote, 1993).
Therefore, the sympathoexcitatory effect of 8-OH-DPAT observed in
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hemorrhaged animals may be due to disinhibition of a reflex response that is
activated by some stimulus associated with blood loss, but is not active when
blood volume is normal. In accord, the sympathoexcitatory effect of 8-OH-DPAT
in hemorrhaged animals is attenuated by disruption of afferent input to the CNS
from peripheral chemoreceptors and arterial baroreceptors (Osei-Owusu and
Scrogin, 2006). These data are consistent with the possibility that chemo and/or
baroreceptor afferents convey information that somehow attenuates the full
sympathoexcitatory reflex that develops during hemorrhage; and that 5-HT1A
receptor activation reverses this effect to enable full expression of compensatory
responses.
Afferent nerves that emanate from the carotid body transmit information
on arterial blood gases and pH to the central nervous system through the IXth
cranial nerve (Berger, 1979). Chemosensory afferents terminate primarily in the
commissural subnucleus of the nucleus tractus solitarius (NTS) (Sapru, 1996).
Excitation of chemosensory afferents by acute hypoxia promotes increased
ventilation, increased sympathetic activity and bradycardia. Injection of excitatory
amino acid neurotransmitters into the commissural NTS promotes similar reflex
responses (Almado and Machado, 2005).
Blood pressure is sensed by arterial baroreceptor afferents which arise
from stretch receptors in the wall of the carotid vessels and the aortic arch. They
are activated by vessel stretch, which leads to sympathoinhibition, bradycardia
and hypotension. Arterial baroreceptor afferents travel along with the
chemosensory afferents in the sinus and IXth cranial nerve in rats (Ciriello,
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1983). However, nerve terminals of baroreceptor afferents terminate primarily in
more rostral regions of the NTS in the medial and dorsomedial subnuclei.
Injection of excitatory amino acids in this region produces responses similar to
activation of the arterial baroreflex (Viard and Sapru, 2002).
Disruption of afferent input from both the carotid chemoreceptors and
arterial baroreceptors by sinoarotic denervation prevents the increase in
sympathetic drive and heart rate that characterizes the initial normotensive phase
of hemorrhage (Korner et al., 1990). This leads to a slight acceleration in the
onset of the syncopal response to hemorrhage. Sinoaortic denervation also
slows the recovery of sympathetic activity, much like serotonin cell lesion (OseiOwusu and Scrogin, 2006). While it is well known that arterial baroreceptor
unloading contributes to the compensatory response to hemorrhage, the role of
peripheral chemoreceptors in the sympathetic response to hemorrhage remains
controversial. Oxygen pressure within the carotid body declines as blood
pressure falls during blood withdrawal in the anesthetized cat (Buerk et al.,
1989). The decline parallels increases in sinus nerve discharge, suggesting that
the peripheral chemoreceptors are involved in reflex responses to hemorrhage .
However, during hemorrhage, arterial blood O2 levels rise due to an initial
increase in ventilation. Rising acidosis also results in bronchodilation which
helps to oxygenate blood. Therefore, it is thought that the decline in perfusion of
the carotid body is the primary stimulus that increases chemoreflex activation.
Nevertheless, studies indicate that the blood pressure and heart rate changes
that develop during blood loss and subsequent compensation are not affected by
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carotid body artery ligation in the unanesthetized rat, suggesting that
chemoreceptors may have little effect on compensation from hemorrhage
(Silveira et al., 2005). However, our results have also shown that lesion of
caudal raphe serotonin neurons has no effect on blood pressure and heart rate
responses to blood loss but does have a significant influence on sympathetic and
ventilatory drive during hemorrhage; these factors also have a significant effect
on tissue oxygenation. It remains to be determined whether peripheral
chemoreceptors contribute to ventilatory and sympathetic responses to recovery
from blood loss and whether they modulate the hemodynamic response to
compensation.
During hypotensive hemorrhage, loss of tissue perfusion and low pH in the
carotid body should activate chemoreceptors, while simultaneous hypotension
should unload arterial baroreceptors. Both stimuli normally promote reflex
sympathoexcitation and increased ventilation (Brunner et al., 1982; Kara et al.,
2003). However, the ventilatory response to hypoxia declines with continued
hypoxic exposure (Morrill et al., 1975; Tabata et al., 2001). Sympathetic activity
also declines, though the response is somewhat delayed (Hunt et al., 2008).
This effect, known as hypoxic ventilatory decline, is dependent upon the integrity
of the carotid body; and is associated with increased GABA release in the
commissural NTS where chemoreceptor afferents terminate (Tabata et al., 2001).
It is not known whether ventilatory decline contributes to the sympathoinhibitory
response to severe hemorrhage. However, we have noted that rats subjected to
lesion of hindbrain serotonin cells show a significant decline in ventilation that
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begins to develop at the onset of blood loss, while intact animals show an initial
increase in ventilation that returns to baseline. Thus, it is plausible that
endogenous serotonin release normally counteracts hypoxic ventilatory decline
during hemorrhage in order to maintain ventilatory drive, which in turn may
contribute to increased sympathetic drive through central coupling mechanisms.
Cardiovascular afferents enter the NTS near the dorsal surface of the
brainstem at the floor of the 4th ventricle in the region where the
sympathoexcitatory effects of 8-OH-DPAT administration were found to be most
robust. The NTS also receives extensive innervation from caudal raphe neurons
(Schaffar et al., 1988). Selective lesion of serotonin nerve terminals in the NTS
produces similar decreases in sympathetic and ventilatory responses during
hemorrhage as seen with the more widespread caudal raphe serotonin cell lesion
(Kung and Scrogin, 2011). Rats subjected to lesion of serotonin nerve terminals
in the NTS also show a profound reduction in ventilatory and sympathetic
responses to chemical hypoxia. In contrast, the same animals show an increase
in arterial baroreflex gain. These data suggest that serotonin released in the
NTS may contribute to compensation after blood loss by facilitating peripheral
chemoreflex responses.
The mechanism by which serotonin is released in the NTS to augment
recovery from hemorrhage remains unknown. Studies in our lab and by others
suggest that serotonin neurons in the caudal raphe mediate central
chemoreception and react to changes in CO2/H+ to promote ventilation (Kung et
al., 2010; Teran et al., 2014). Serotonin neurons in the caudal raphe are
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activated during hypercapnia, and metabolites of serotonin have been shown to
accumulate in the caudal NTS following hypovolemia (Curtis et al., 2013; Haxhiu
et al., 2001; Johnson et al., 2005). Immunohistochemical analysis has shown
these same serotonin neurons physically wrap around the main blood vessels
that perfuse the brainstem and have an ideal location to directly sense changes
in CO2/H+ in the arterial blood supply to the brain (Bradley et al., 2002). When
isolated and cultured, these neurons show sensitivity to elevated CO2 and H+
(Wang et al., 2001). Moreover, depletion of serotonin in vivo attenuates the
ventilatory responses to hypercapnia and peripheral chemoreceptor activation
(Hodges et al., 2008; Kung et al., 2010; Kung and Scrogin, 2011). Thus, it is
possible that during hemorrhage, as blood flow is reduced, peripheral
chemoreceptors become activated to facilitate sympathetic and ventilatory drive,
but after prolonged activation these compensatory responses wane (hypoxic
ventilatory decline). With sustained blood loss, animals experience metabolic
acidosis (hypoventilatory hypercapnia), which may stimulate serotonin neurons in
the caudal raphe to release serotonin in the NTS and thereby activate 5-HT1A
receptors, which may disrupt the attenuated ventilatory response that develops
during sustained peripheral chemoreceptor activation. Studies performed in this
dissertation investigated whether endogenous serotonin and exogenous
administration of 8-OH-DPAT activate 5-HT1A receptors in the caudal NTS to
promote sympathetic compensation from hemorrhage. In addition, studies were
performed to determine if this same receptor population is critical for the
ventilatory response to hypoxic hypercapnia. A hypoxic hypercapnic stimulus
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was used here to mimic the hypoxic acidosis that occurs with hemorrhage. A
better understanding of the central mechanisms involved in recovery form blood
loss could contribute to the identification of novel therapeutic targets for treating
patients with traumatic blood loss.
Main Hypothesis
In the current project, studies were performed to examine the OVERALL
HYPOTHESIS: 5-HT1A receptor activation in the caudal nucleus tractus solitarius
(NTS) augments recovery from hypotensive hemorrhage by facilitating peripheral
chemoreceptor activation. This hypothesis was examined by utilizing the
following aims.
Specific Aim 1: To determine if endogenous serotonin activates 5-HT1A
receptors in the caudal NTS to facilitate sympathetic drive during compensation
from hypotensive hemorrhage in unanesthetized rats.
Rationale
Current treatments for hemorrhagic shock can cause reperfusion injury
and organ damage, making novel treatments critical for improved survival.
Lesion of caudal serotonin neurons attenuates sympathetic recovery following
hemorrhage and exacerbates metabolic acidosis and tissue hypoxia (Kung et
al., 2010). These data suggest that during severe blood loss, serotonin
neurons may be critical to the maintenance of peripheral tissue oxygenation
during hypovolemia. Selective and discrete lesion of serotonin nerve terminals

11
within the portion of the NTS that receives afferent input from the cardiovascular
system produces virtually the same disruption of ventilatory and sympathetic
recovery as the more global caudal raphe lesion (Kung and Scrogin, 2011).
However, serotonin neurons release multiple neurotransmitters in addition to
serotonin, and multiple serotonin receptor subtypes are expressed in the NTS.
It is not known which receptor subtype mediates the ability of endogenous
serotonin to facilitate compensatory responses to blood loss. Parallel studies
performed in the lab found that the selective 5-HT1A receptor agonist, 8-OHDPAT, produced the most rapid and robust increase in sympathetic drive and
blood pressure when administered into the 4th ventricle near NTS subnuclei that
regulate cardiovascular control. Evidence that serotonergic innervation of this
region is necessary for normal sympathetic and ventilatory responses to
hemorrhage led us to investigate the possibility that endogenous serotonin acts
on 5-HT1A receptors in the NTS to modulate sympathetic recovery following
hemorrhage. Therefore, we utilized a short hairpin RNA (shRNA) targeting the
rat 5-HT1A receptor to enable discrete and selective down regulation of the rat
5-HT1A receptor. This methodology enabled us to determine whether
endogenous activation of 5-HT1A receptors in the NTS was critical for normal
compensation from blood loss in the unanesthetized rat.
Experiments
A) It was determined if decreased 5-HT1A receptor mRNA levels in the
caudal NTS attenuated sympathetic drive during recovery from
hypotensive hemorrhage.
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B) It was determined if decreased 5-HT1A receptor mRNA levels in the
caudal NTS augmented metabolic acidosis following hypotensive
hemorrhage.
Specific Aim 2: To determine if the pressor and sympatho-excitatory effects of
8-OH-DPAT observed in unanesthetized, hemorrhaged-rats is dependent upon
5-HT1A receptors in the caudal NTS.
Rationale
8-OH-DPAT accelerates sympathetic recovery, increases in venous tone
and attenuates metabolic acidosis when given to rats subjected to hypotensive
hemorrhage or hemorrhagic shock. The sympathoexcitatory effect of 8-OHDPAT in hemorrhaged animals is severely attenuated after sinoaortic
denervation, suggesting that sensory afferents of the sinoaortic nerve transmit
information that attenuates the full extent of reflex responses to hypovolemia,
and that 8-OH-DPAT unmasks and accelerates the complete reflex response.
The effects of 8-OH-DPAT are most robust when drug is administered into the 4th
ventricle, near the NTS, where the arterial baroreceptor and chemoreceptor
afferents project. However, 8-OH-DPAT has affinity for other receptors
expressed in the NTS (e.g. 5-HT7 receptors) so the exact location and receptor
population which mediates the effects of 8-OH-DPAT are not known. Therefore,
we determined if the compensatory responses that are accelerated by 8-OHDPAT administration were dependent on 5-HT1A receptors located within the
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caudal NTS. We used the same AAV vector described in Specific Aim 1 to
selectively decrease 5-HT1A receptor expression in the caudal NTS to determine
the role of these receptors in the sympathetic or pressor response to 8-OH-DPAT
administration
Experiments
A) It was determined if decreased 5-HT1A receptor mRNA in the caudal
NTS reduced the sympathoexcitatory and pressor effects of 8-OHDPAT systemic administration during hypotensive hemorrhage.
Specific Aim 3: To determine if acidosis facilitates peripheral chemoreflex
responses and whether this effect is dependent on 5-HT1A receptors in the
caudal NTS.
Rationale
The ability of 8-OH-DPAT to accelerate the compensatory responses to
hemorrhage is dependent on the integrity of the sinoaortic nerves that carry
baroreceptor and chemoreceptor input to the NTS. Loss of endogenous
serotonin input in the NTS increases arterial baroreflex gain during hypotension
but impairs peripheral chemoreceptor activation in response to chemical hypoxia.
This led us to speculate that the ability of 8-OH-DPAT and endogenous serotonin
to improve sympathetic recovery from hemorrhage likely depends on peripheral
chemoreceptor activation rather than arterial baroreflex unloading. 5-HT1A
receptors typically induce neuronal hyperpolarization. Thus, 8-OH-DPAT (and
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endogenous serotonin) may disinhibit full expression of chemoreflex responses
during hemorrhage by acting on 5-HT1A receptors in the NTS. We predicted that
acidosis would promote serotonin release, which in turn, would facilitate
peripheral chemoreflex response to hypoxia. Therefore, we examined the role of
NTS 5-HT1A receptors on ventilatory responses to the simultaneous activation of
central and peripheral chemoreceptors that is believed to occur during severe
hemorrhage. In these studies, chemoreflex activation was induced by altering
blood gases to simulate the hypoxia and acidosis that develops during
hemorrhage, without altering blood volume. We utilized the same AAV vector as
described in Aim 1 to determine if 5-HT1A receptors in the caudal NTS are
necessary for augmentation of ventilatory responses to hypoxic hypercapnic gas
exposure. In addition, we determined which serotonin cell populations of the
caudal raphe were activated by the same hypoxic hypercapnic conditions.
Experiments
A) It was determined if decreased 5-HT1A receptor mRNA levels in the
caudal NTS inhibits the ability of acidosis to augment the ventilatory
response to hypoxia.

B) It was determined if immunoreactive serotonin neurons in the caudal
raphe are activated by acidosis.

CHAPTER II
REVIEW OF RELATED LITERATURE
Current treatment for hemorrhagic shock
Severe trauma is the leading cause of death in children and young adults
(1-44 years of age) in the United States as well as many other developed
countries (Centers for Disease Control and Prevention, 2012). In the United
States alone, this accounts for an average of 50,000 deaths per year and
costs the government over 400 billion dollars annually (Corso et al., 2006).
This monetary figure also accounts for the cost of lost productivity since
traumatic injury results in 30% of all life years lost, more than cancer and
heart disease combined (Centers for Disease Control and Prevention, 2012).
Of those traumatic deaths, 30-56% are due directly to blood loss (Kauvar and
Wade, 2005). Hemorrhage also is the most common cause of preventable
death during combat and accounts for 50% of all combat casualties (Clifford,
2004). Severely injured trauma patients usually require the resources of a
designated trauma center within an hour after injury in order to improve their
chance of survival. However, nearly 45 million Americans still do not have
immediate access to a trauma center, and morbidity and mortality remain high
(Centers for Disease Control and Prevention, 2012).
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The current treatment for hemorrhagic shock is primarily directed at
resuscitation with fluid volume to maintain perfusion pressure of the vital organs.
This consists of an immediate administration of volume expanders that are either
crystalloids (saline, Ringer’s lactate, etc) or colloids (blood, blood substitutes,
etc.) (Perel et al., 2013). While necessary to avoid hypoperfusion, aggressive
fluid resuscitation can also lead to detrimental complications including
hemodilution, endothelial damage, and coagulopathy (Cripps et al., 2013).
When volume resuscitation is unable to maintain proper organ perfusion
pressure; patients may require the additional administration of vasoconstrictive
agents such as catecholamines, including norepinephrine, dopamine,
epinephrine, or non-catecholaminergic vasoactive drugs such as phenylephrine,
and vasopressin (Hollenberg, 2011). Although these therapeutic interventions
can increase vasoconstriction to maintain blood pressure (BP), they can also
exacerbate ischemic reperfusion (IR) injury. During hypoperfusion, the
peripheral tissues become hypoxic and subsequently undergo anaerobic
metabolism. Byproducts of this process can form reactive oxygen species (ROS)
upon the reintroduction of blood flow and oxygen. Reactive oxygen species can
promote damage of the microvasculature and induce endothelial injury. The
endothelium is important for maintaining the integrity of the vasculature, and with
disruption of the endothelial layer, introduction of leukocytes and platelets into
the vessels can promote inflammation leading to organ failure and death (Verma
et al., 2002).
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The inflammatory response to hemorrhage and resuscitation also leads to
complications during recovery. Within 3 days post-hemorrhage, enhanced gene
expression of the proinflammatory cytokines, IL-1β, TGF-β, TNF-α, IL-10, IL-6,
and INF-γ develops (Shenkar et al., 1994). The increase of cytokine production
correlates directly with acute lung injury following recovery from blood loss. The
production of proinflammatory cytokines also promotes disseminated
intravascular coagulopathy (DIC), a pathological condition of dysregulated
coagulation cascade that can occur during hemorrhage. With administration of
resuscitation fluids, coagulation factors become diluted and can lead to
hypocoagulation, which is associated with improper clot and fibrin formation that
can lead to mortality 24 hours after traumatic injury (Palmer and Martin, 2014).
Thus, even with restoration of perfusion pressure, inflammation, endothelial
damage, and coagulopathy can eventually lead to death several days after the
initial traumatic injury. While advancements in treatment have been made,
morbidity and mortality associated with blood loss remain high.

Autonomic responses to hemorrhage
Progressive blood loss elicits a complex, multiphasic response from the
autonomic nervous system (Figure 1). During the initial stages of blood loss, BP
is maintained primarily through the arterial baroreflex (Korner et al., 1990; Schadt
and Ludbrook, 1991). Decreased BP reduces activation of stretch-sensitive
mechanoreceptors which promotes sympathetically-mediated increases in
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Figure 1. Progressive blood loss elicits four distinct phases of autonomic
nervous system response. Arterial pressure (AP, top), heart rate, (HR,
middle), and renal sympathetic nerve activity (RSNA, bottom) of an
unanaesthetized rat subjected to continued blood withdrawal. From left to right,
normotensive phase (white box; I), hypotensive phase (light gray-shaded box; II),
secondary compensatory phase (medium gray-shaded box; III) and
decompensation phase (dark gray-shaded box; IV).
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vasoconstriction and reflex tachycardia that help to maintain organ perfusion with
oxygenated blood.
After a significant amount of blood is lost (20-30% of total blood volume in
humans or 15% total blood volume of a conscious rat), these compensatory
responses suddenly abate, resulting in a dramatic decline in BP paralleled by a
rapid fall in sympathetic drive (Hasser and Schadt, 1992; Ludbrook and Ventura,
1996; Schadt and Ludbrook, 1991). This drop in BP is reminiscent of a
vasovagal syncopal or “fainting” and is thought to be evolutionarily beneficial due
to a resulting increase in ventricular filling time and increased cardiac output
(CO).
This transient loss of BP is reversed as a secondary sympathetic
compensatory phase ensues, characterized by a slow, but even greater increase
in sympathetic drive than observed in the initial sympathoexcitatory phase
(Haljamae, 1984). During the syncopal-like phase of hemorrhage, when
sympathetic drive is at its nadir, blood pools in the highly compliant venous
vasculature. This ultimately “traps” the blood within the veins and limits return of
venous blood flow back to the heart further decreasing CO. Therefore, when
sympathetic drive is re-established, an increase in sympathetically-mediated
venoconstriction remobilizes blood back to the heart where it can be redistributed
to the arterial vasculature. The second sympathoexcitatory phase is
accompanied by the simultaneous release of vasoconstrictive hormones that
primarily constrict the arterial side of the vasculature because the majority of their
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receptors reside in the arterial vasculature (Liu et al., 2003). Arterial
vasoconstriction is less hemodynamically favorable since the majority of the
blood is within the venous vasculature and further constriction of the arterial
vasculature may actually exacerbate ischemia at the capillary beds (Mellander
and Lewis, 1963).
If blood loss progresses, the secondary increase in sympathetic drive
eventually wanes, and the subsequent decrease in blood flow to the brain further
attenuates sympathetic drive. Also at this time, the vasculature becomes more
permeable and less responsive to catecholamines (Liu et al., 2003). Increased
permeability of the vasculature disrupts the osmotic gradient and allows fluid and
plasma proteins to leak out from the interstitium and augments inflammation by
promoting the release of lymphatic molecules like macrophages and leukocytes.
If left untreated, this forth stage eventually progresses to end organ failure and
death. Patients that arrive to trauma centers during this final stage are very
difficult to treat. Therefore, research efforts have focused on prolonging the
previous stages of hemorrhage in order to prevent patients from advancing to
decompensation.

Overview of baro-, chemo- and cardiopulmonary reflexes during
hypotensive hemorrhage
The autonomic nervous system is responsible for insuring proper tissue
oxygenation and organ perfusion pressure and does so utilizing a myriad of
physiological reflexes. One such negative feedback system, termed the arterial
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baroreflex, utilizes stretch-sensitive receptors (baroreceptors) to detect changes
in pressure to modulate BP. When there is a rise in mean arterial pressure
(MAP), detected as increased stretch, baroreceptors are activated and reduce
sympathetic outflow to the peripheral vasculature and heart, thereby facilitating a
subsequent fall in BP. Conversely, when BP is low, these receptors fire less
frequently and subsequent increases in sympathetic drive and reflex tachycardia
permit perfusion pressure to rise. The arterial baroreceptors are most sensitive
in the physiological range of BP (70 – 150 mmHg) and possess a firing threshold
of 60 mmHg. Thus, when BP is less than 60 mmHg, arterial baroreceptors are
unable to further modulate perfusion pressure because the arterial vessels are
fully dilated (Seagard et al., 1990). In addition to the arterial baroreceptors, lowpressure stretch receptors, termed cardiopulmonary baroreceptors, also respond
to changes in pressure. Cardiopulmonary baroreceptors are located in large
systemic veins, pulmonary vessels, and the atrium of the heart and are primarily
responsible for regulating blood volume through hormone release (Mancia et al.,
1986). Because the venous side of the vasculature is highly compliant,
increases in stretch of the cardiopulmonary receptors are indicative of changes in
blood volume since the majority of the blood is contained within the large veins.
Elevations in blood volume are detected as an increase in stretch of the large
veins. The subsequent activation of the cardiopulmonary baroreceptors causes
cardiopulmonary afferents that project to the brain through the vagus nerve to
initiate a reflex reduction in sympathetic nerve activity.
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Chemoreceptors include both peripheral chemoreceptors and central
chemoreceptors which modulate sympathetic activity and control ventilation.
Both receptors groups are sensitive to changes in pCO2 and pH, but only the
peripheral chemoreceptors can detect changes in oxygen content in the
peripheral circulation. Central chemoreceptors and peripheral chemoreceptors,
which alter sympathetic drive and ventilation, are necessary to help maintain
MAP and metabolic homeostasis.

Anatomy of arterial baroreflex
The primary arterial baroreceptors are specialized stretch receptors
located on the aortic arch and the carotid sinuses near the bifurcation of the
internal and external carotid arteries. As BP rises, the blood vessels passively
expand and activate the arterial baroreceptors to generate an action potential.
The action potentials are carried by afferent fibers from the aortic arch and
carotid sinus to the caudal NTS by the vagus and glossopharyngeal nerves
respectively (Berger, 1979; Ciriello, 1983). The release of excitatory amino
acids, presumably glutamate, coincides with the activation of baro-sensitive
second order neurons within the NTS to activate excitatory glutatmatergic fibers
that project to the caudal ventrolateral medulla (CVLM) (Lawrence and Jarrott,
1994; Talman et al., 1984).
The second order neurons in the NTS project to the CVLM and release
glutamate to activate inhibitory neurons that release γ-aminobutyric acid (GABA)
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to inhibit the rostroventrolateral medulla (RVLM) and suppress tonic sympathetic
drive. It is important to note that these inhibitory neurons within the CVLM are
tonically active and continuously suppress sympathetic drive without
baroreceptor input.
The GABAergic afferents from the CVLM extend short axons bilaterally
just rostral to the RVLM to suppress activity of bulbospinal presympathetic
excitatory neurons that primarily control tonic sympathetic activity. The
bulbospinal neurons have glutamatergic projections to sympathetic preganglionic
neurons located in the intermediolateral nucleus (IML) of the spinal cord
(Pilowsky and Goodchild, 2002). Therefore, when BP increases, the aortic arch
and carotid sinuses distend to increase action potential generation by the arterial
baroreceptors. This in turn, activates second order neurons in the caudal NTS
which activate the CVLM to increase inhibition of the RVLM. Decreased activity
in the RVLM results in decreased sympathetic drive, reduces HR, and ultimately
decreases BP (Figure 2). The NTS also contains excitatory projections to the
nucleus ambiguous (NA) which regulates parasympathetic outflow to the heart.
Activation of the NA promotes vagal stimulation to the heart to reduce HR.
Conversely, when BP decreases, the baroreceptors become less active and the
RVLM becomes disinhibited, which augments sympathetic drive and tachycardia
to increase BP.
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Figure 2. Neural pathways of the arterial baroreflex. Sagittal view of a rat
brain illustrating projections involved in the arterial baroreflex (Dampney et al.,
2002). Arterial baroreceptors generate action potentials in response to increases
in BP and activate second order neurons within the NTS. Glutamatergic input to
the GABAergic neurons in the CVLM facilitates inhibition of the bulbospinal
neurons in the RVLM. This ultimately reduces activation of the sympathetic
preganglionic fibers in the IML and suppresses sympathetic outflow. Therefore,
activation of the arterial baroreflex attenuates tonic sympathetic activity to reduce
vasoconstriction and HR.
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Physiological role of the arterial baroreflex and hypotensive
hemorrhage
Arterial blood pressure is tightly regulated and maintained (between 85100 mmHg in humans) to ensure proper oxygenation and nutrient delivery to the
vital organs as well as provide waste removal. Arterial baroreceptors are key
players in maintaining MAP within this narrow range. The carotid sinus
baroreceptors are more sensitive than the baroreceptors located in the aortic
arch, due to the larger pressure within the aortic vessel compared to the carotid
arteries. Therefore, maximal carotid sinus sensitivity occurs between 70-150
mmHg. Thus, minute to minute variations in pressure effectively alter the firing
rate of the baroreceptors which, in turn, maintains BP within a physiological
range. In contrast, aortic baroreceptors detect changes in BP at a higher
pressure range (100-200 mmHg). It is important to note that the point at which
BP is maintained or, “set point,” changes during exercise, chronic hypertension,
and heart failure. In addition to changes in pressure, arterial baroreceptors can
also detect changes in pulse pressure.
During hemorrhage, the baroreceptors are unloaded as blood is lost and
pressure wanes. This results in less activation of the baro-sensitive neurons in
the NTS that facilitate inhibition of tonic sympathetic activity. Therefore,
excitatory bulbospinal neurons within the RVLM are disinhibited and promote a
robust increase in sympathetic drive and tachycardia to maintain BP.
Additionally, during blood loss, there is a decrease in pulse pressure. The
combination of reduced BP and pulse pressure in hemorrhagic shock results in
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an even greater response from the baroreceptors. Vagal activity is also reduced
to alleviate parasympathetic activation and increase BP (Wehrwein and Joyner,
2013).

Anatomy of the peripheral chemoreflex
Peripheral chemoreceptors are composed of specialized cells strategically
located in carotid bodies in the carotid sinus and the aortic bodies within the
aortic arch. Carotid bodies are composed of two main cell types, type I or
glomus cells are the excitable cells that can directly detect changes in pH, CO 2,
and especially O2 and generate action potentials. Additionally, the carotid bodies
contain type II cells (15-20% of the total cell population), which have long
processes that physically wrap around the glomus cells and play a more
supportive role, similar to glial cells (Lopez-Barneo et al., 2008). Although the
exact mechanism by which glomus cells detect changes in oxygen remains to be
fully elucidated, the leading hypotheses include the metabolic hypothesis and the
membrane hypothesis. First, the metabolic hypothesis suggests that the glomus
cells respond to even slight changes in O2 content because oxygen-sensing
proteins within the cytoplasm or mitochondria of the cells become activated
during decreases in cellular O2. During hypoxia, heme-containing proteins, such
as cytochrome oxidase, prevent potassium (K+) channels from opening. The
subsequent reduction of K+ influx promotes membrane depolarization, activation
of voltage gated calcium (Ca2+) channels and ultimately, neurotransmitter
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release. Alternatively, the membrane hypothesis proposes that certain K +
channels, such as high conductance Ca2+ activated channels and low
conductance Ca2+ insensitive channels, are able to directly detect changes in O2
content to activate influx of extracellular Ca2+ through voltage-dependent Ca2+
channels (Lopez-Barneo et al., 1988; Peers, 1990). Whether indirectly or directly
activated, the influx of Ca2+ promotes membrane depolarization to facilitate the
final step in oxygen sensing, and neurotransmitter release.
While numerous neurotransmitters have been associated with peripheral
chemoreceptor activation, the most prevalent active neurotransmitters released
in the synapse are acetylcholine and adenosine triphosphate (ATP). Upon Ca2+
influx, neurotransmitters are released from the glomus cell into the synapse and
activate the afferent nerve fibers that project to the medulla. Additionally, the
carotid body is a highly dopaminergic structure, and it is thought that dopamine
(DA) is released in an autocrine fashion to reduce activation of the carotid body
in a negative feedback loop (Lopez-Barneo et al., 2008).
Chemoreceptor afferent fibers then relay this information through the
carotid sinus and glossopharyngeal nerves that synapse in a more caudal portion
of the NTS, separate from where baroreceptor afferents project in the
commissural NTS (Figure 3). These sensory afferents release excitatory amino
acid neurotransmitters, such as glutamate, to facilitate direct activation of the
RVLM to increase sympathetic drive. Additionally, the NTS promotes increases
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Figure 3. Neural pathways of the peripheral chemoreceptors. Sagittal
image of a rat brain illustrating projections involved in the peripheral
chemoreceptor activation (Dampney et al., 2002). Peripheral chemoreceptors in
the carotid and aortic bodies are activated by pH, CO2 and decreased O2
(hypoxia). Activation of the peripheral chemoreceptors stimulate second order
neurons in the caudal NTS. Excitatory chemo-sensitive neurons in the NTS
directly activate excitatory input into the RVLM to stimulate sympathetic drive.
Additionally, activation of the peripheral chemoreceptors increases activity in the
rVRG to enhance ventilation by downstream stimulation of the phrenic motor
nucleus (PMN). Therefore, activation of the peripheral chemoreflex augments
tonic sympathetic activity and facilitates ventilation.
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in ventilation through direct projects to the rostal ventrolateral respiratory group
(rVRG) of nerves which facilitate phrenic nerve activity (Mifflin, 1992). Lastly,
second order neurons in the NTS that receive afferent input from peripheral
chemoreceptor afferents also project to the NA to promote parasympathetic
outflow to the heart.

Physiological role of the peripheral chemoreflex and hypotensive
hemorrhage
Although peripheral chemoreceptors become activated by increases in
CO2 and decreases in pH; they are primarily activated by hypoxia. Glomus cells
within the carotid body can be activated either indirectly by O 2-sensitive proteins
or directly by K+ channels to promote membrane depolarization. Depolarization
causes Ca2+ influx through voltage dependent Ca2+ channels, which facilitate the
release of excitatory amino acid neurotransmitters that excite the sensory
afferents that project to second order neurons in the NTS. Upon activation of the
NTS, direct projections from the NTS to the RVLM augment sympathetically
mediated increases in vasoconstriction. Additionally, ventilation is increased by
activation of neurons of the phrenic motor nucleus in the cervical spinal cord.
Furthermore, peripheral chemoreceptor activation facilitates coronary
vasodilation and bradycardia through vagal activation of the parasympathetic
system. Thus, the traditional peripheral chemoreflex response is associated with
increased sympathetically mediated vasoconstriction, increased ventilation, and
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bradycardia. The carotid bodies are a highly vascularized structure that receive
an enormous amount of blood flow (10 times the flow per unit mass compared to
the rest of the cerebral circulation), but have a relatively low metabolic demand
(1-2 ml/100g/min O2 consumption) (Barnett et al., 1988; De Burgh Daly et al.,
1954; Obeso et al., 1989). Therefore, during hemorrhage, the reduced blood
flow past the carotid bodies is sensed as reduced blood oxygen content and
promotes the peripheral chemoreflex to boost sympathetic drive and increase
ventilation to ameliorate reductions in BP. During hemorrhage, bradycardia is
masked by input from the arterial baroreceptors that suppress vagal input to the
heart.

Peripheral chemoreceptor and baroreceptor interactions
Peripheral chemoreceptor activation results in increased ventilation,
exaggerated vasoconstriction, and varying effects on HR. In contrast, activation
of the arterial baroreflex elicits vasodilation, bradycardia, and reduced BP. Since
baroreceptors and chemoreceptors have opposing effects on ventilation and
sympathetic nerve discharge, it is plausible that these reflexes antagonize each
other. Specifically, there is evidence that elevated BP associated with arterial
baroreceptor activation attenuates the sympathetic and ventilatory responses
that result during peripheral chemoreceptor activation. Conversely, peripheral
chemoreceptor activation is potentiated by hypotension (Heistad et al., 1974;
Mifflin, 1993).
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Central chemoreceptors
In contrast to peripheral chemoreceptors, central chemoreceptors are cells
located in the brainstem that are exclusively sensitive to changes in CO 2 and H+
ion content. Activation of central chemoreceptors facilitates sympathoexcitation
and augments ventilation during respiratory or metabolic acidosis via projections
to the neural circuitry in the brainstem and spinal cord involved in sympathetic
and ventilatory drive.
The partial pressure of arterial blood CO2 content (PaCO2) is tightly
controlled and maintained near 40 mmHg in humans. The pH of the arterial
blood is closely regulated and typically ranges between 7.35-7.45. Even slight
disturbances in the cellular environment produce dramatic alterations in
ventilation in order to maintain homeostasis. In humans, ventilation can increase
by as much as 50% in response to slight increases in PaCO2 (1.5 mmHg) or
decreases in pH (0.01) (Smith et al., 1988). Increases in CO2 and H+ ions
promote a robust increase in ventilation, which buffers the blood by causing the
release of CO2 in the lungs. This occurs because bicarbonate (HCO3) and H+
ions are quickly converted by carbonic anhydrase (CA) into water and CO 2.
Moreover, CO2 is easily able to permeate lipid membranes, unlike H+ ions, which
are unable to diffuse across the blood-brain barrier (BBB). Thus, H+ ions require
a transport mechanism, such as the Na+/H+ exchanger to relay plasma pH
information to the brain, but this process takes significantly longer than CO 2
diffusion (Adler et al., 1990). Alternatively, CO2 can readily cross the BBB and be
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converted back into H+ ions to acidify brain tissues and activate the central
chemoreceptors (Figure 4).
Besides possessing the intrinsic ability to detect changes in CO2/H+ ions,
the central chemoreceptors also must possess a direct connection to the
respiratory central pattern generator (CPG) to induce increased ventilation in
response to increased demand for buffer. The central pattern generator refers to
the semi-autonomous neural network within the pons and medulla that drives
ventilatory function. The CPG contains the ventral respiratory group (VRG)
composed of a bilateral group of inspiratory and expiratory neurons that have
been divided into the rostral ventral respiratory group (rVRG), caudal ventral
respiratory group (cVRG), Pre- Bötzinger complex (PreBötC) and Bötzinger
complex (BötC). Activity of the VRG is regulated by afferent input from the NTS
and pontine nuclei (Kölliker-Fuse nucleus and parabrachial nucleus) that regulate
phase transitions between inspiration and expiration (Abdala et al., 2009; Alheid
and McCrimmon, 2008; Smith et al., 2009; Smith et al., 2013). Behavioral
responses also influence the CPG through input from the cortex, cerebellum,
basal ganglia, and hypothalamus (Pattinson et al., 2009a; Pattinson et al.,
2009b). The VRG contains projections to motor neurons that control the upper
airway muscle and innervate the diaphragm and thoracic respiratory muscles.
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Figure 4. Schematic representation of how CO2 and H+ ions in
plasma activate central chemoreceptors. CO2 is able to readily cross the
blood brain barrier (BBB). Conversely, H+ ions require the aid of a transporter,
such as the Na+/H+ exchanger to cross the BBB more slowly. During
hemorrhage, when peripheral tissue becomes hypoxic and undergoes anaerobic
metabolism, H+ ions can be converted in the blood by carbonic anhydrase to
CO2, which can quickly cross the BBB and be converted back into H+ ions to
acidify brain tissue and activate the central chemoreceptors. Simultaneously,
ventilatory drive increases such that most of the H+ is blown off in the lungs as
CO2. The remaining H+ accumulates in the blood which eventually perfuses the
brain. Thus, during blood loss, central chemoreceptors would presumably be
activated more so by the local metabolic production of H+ and H+ transport, rather
than PaCO2 which remains low during the hyperventilatory response to
hemorrhage.
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During homeostasis, inspiratory drive is initiated in the PreBötC and
facilitated by the rVRG. Inhibitory GABAergic and glycinergic interneurons from
PreBötC suppress expiratory drive from the BötC and cVRG. The PreBötC also
provides excitatory glutamatergic input to the rVRG. The rVRG contains the main
cluster of bulbospinal premotor neurons that relay inspiratory drive to the phrenic
motor neurons that innervate the diaphragm to control and initiate inspiration
(Smith et al., 1991). Bulbospinal neurons in the rVRG are also inhibited by
interneurons in the cVRG and BötC regions. Conversely, expiration is driven by
BötC through the inhibition of PreBötC and rVRG. The BötC activates cVRG,
which contains bulbospinal expiratory neurons that excite thoracic and lumbar
motor neurons to facilitate expiration by engaging the abdominal muscles.
Although the rhythmic drive to motor neurons can persist without sensory
feedback; these respiratory networks are heavily influenced by central
chemoreceptors.
The exact location of the central chemoreceptors is not entirely clear and
remains a topic of debate. Central chemoreceptors were thought to be confined
to the ventrolateral surface of the medulla because direct application of acidic
solutions to the CVLM and RVLM augmented ventilation while selective blockade
of neurotransmission in these regions via lesion, cooling, or chemicals reduced
the ventilatory and sympathetic responses to hypercapnia (Hanna et al., 1979).
More recently, additional sites of central chemosensation within the brainstem
have been identified. These include the NTS (Dean et al., 1990), locus
coeruleus (Pineda and Aghajanian, 1997), serotonin neurons within the
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medullary raphe (Wang et al., 1998), glutamatergic neurons in the retrotrapezoid
nucleus (RTN) (Mulkey et al., 2004), and orexinergic neurons in the
hypothalamus (Williams et al., 2007). Although several potential central
chemoreceptor sites have been investigated, attention has been primarily
focused on the serotonergic neurons in the medullary raphe and glutamatergic
neurons of the RTN. The evidence supporting the involvement of serotoninergic
neurons of the medullary raphe in the central chemoreflex will be explored further
in the section entitled “serotonin and central chemoreception,” located on page
64.
The RTN is a nucleus located near the ventral surface of the rostral
medulla and is known to mediate tonic ventilatory drive, but is also thought to
modulate ventilation in response to changes in CO2 (Mulkey et al., 2004). Within
the RTN exists a bilateral cluster of glutamatergic, non-purinergic neurons
(~1000 neurons total) that can be identified by their unique expression of the
transcription factor, paired-like homobox2b (Phox2b). This transcription factor is
known to regulate neuron formation and differentiation in brain regions important
to cardiorespiratory function (Dauger et al., 2003; Tiveron et al., 2003).
Subsequently, mutations within the Phox2b transcription factor gene result in
autonomic dysfunction and are linked to congenital central hypoventilation
syndrome. Moreover, mice that lack Phox2b neurons within the RTN experience
pronounced hypoventilation and reduced chemoreflex responses (Dubreuil et al.,
2008).
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The small subset of neurons proposed to be central chemoreceptors in the
RTN have been extensively studied in vitro and in vivo over the last decade.
Brainstem slice recordings have shown that these particular neurons are
stimulated by acidification and inactivate when pH is increased (Lazarenko et al.,
2009; Mulkey et al., 2004; Stornetta et al., 2006). Additionally, focal acidification
of the RTN via microdialysis produced a 25% increase in ventilation in awake
rats (Li et al., 1999). Moreover, rats exposed to increasing concentrations of CO2
gas were found to have increased c-Fos expression in the RTN indicating that
these neurons are activated during hypercapnia (Sato et al., 1992). Recently, a
more selective activation of these neurons was found to promote increases in
ventilation in vivo. Studies by Abbott et al. utilized a lentiviral delivery system to
express light-activated cation channel, Channel Rhodopsin 2 (ChR2) in RTN
neurons in rats. Channel expression was driven by a Phox2-responsive
promoter enabling the use of photostimulation to selectively activate only the
neurons within the RTN that expressed Phox2b. Results of these experiments
concluded that direct excitation of these neurons augments breathing frequency
and amplitude in vivo (Abbott et al., 2009).
The RTN also projects to the VRG to facilitate ventilation directly. Tract
tracing methods have elucidated connections of the RTN to the ventrolateral
medulla, caudal and lateral portions of the NTS, and the dorsolateral pons.
Specifically, the RTN has direct projections to regions associated with the CPG
including the PreBötC (Rosin et al., 2006). If glutamatergic neurons within the
RTN are intrinsically sensitive to changes in CO2/H+, then they are also able to
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initiate alterations in ventilation directly through these connections to maintain
PaCO2 within a normal physiological range. Interestingly, the RTN receives
synaptic input from other putative chemoreceptors located in the medullary raphe
and NTS (Takakura et al., 2006). Therefore, it is possible that
additional/alternative central chemoreceptors, such as the serotonergic neurons
in the medullary raphe, and/or input from cells in the NTS that are responsive to
peripheral chemoreceptor activation facilitate RTN central chemosensitivity in
vivo.

Nucleus tractus solitarius
The nucleus tractus solitarius (NTS) is an important sensory integration
center located in the dorsal medulla within the brainstem. The NTS is the initial
site to which a multitude of sensory afferents, including the arterial baroreceptors,
project. The NTS is involved in a vast range of autonomic functions from
sensations of tastes and intestinal mobility to cardiovascular and ventilatory
function. In general, the NTS contains important second order neurons that
receive sensory inputs critical in initiating the autonomic responses that maintain
cardiorespiratory homeostasis in the face of pathological or environmental
changes.
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Anatomical features of the NTS
The NTS is composed of multiple subnuclei that are orientated rostrocaudally along the solitary tract. The solitary tract is the bundle of cranial nerves
(facial, glossopharyngeal, and vagus) that carry visceral sensory information to
the CNS (Berger, 1979; Ciriello, 1983; Mifflin, 1992). Therefore, sensory
information is organized in this rostro-cadual orientation such that the more
rostral regions convey information from gustatory and somatic processes, while
the more caudal region receives input from cardiovascular, renal, digestive and
respiratory organs. The more caudal portion of the NTS is known to be involved
in compensation from hypotensive hemorrhage and will be the primary focus of
this section.
As previously mentioned, the NTS receives afferent projections from the
arterial baroreceptors and peripheral chemoreceptors. The arterial baroreceptors
project to the more medial portion of the NTS to modulate sympathoexcitation via
projections to the CVLM. Additionally, the peripheral chemoreceptors project to
the more caudal regions of the NTS to modulate cardiorespiratory parameters in
response to changes in O2 through direct projections to the RVLM and VRG (see
section, overview of baro-, chemo- and cardiopulmonary reflexes during
hypotensive hemorrhage on page 20).
Additionally, the NTS can modulate cardiac function through
glutamatergic projections to cardiac vagal pre-ganglionic neurons (CVPN)
located in the dorsal motor nucleus of the vagus (DMN) and NA. Activation of
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CVPNs initiate negative chronotropic, ionotropic, and dromotropic effects
depending on their origin. Specifically, CVPNs located in the DMN have negative
dromotropic, ionotropic and chronotropic effects on the heart (Nosaka et al.,
1982; Stuesse, 1982; Takanaga et al., 2003). Interestingly, DMN CVPNs do not
appear to be modulated by arterial baroreceptor input, unlike CVPNs located in
the NA. The CVPNs of the NA facilitate bradycardia in response to arterial pulse
pressure changes and are reduced during the inspiratory phase of ventilation.
The NTS also projects to the paraventricular nucleus of the hypothalamus
(PVN). The PVN is an integration center for autonomic and endocrine function
that is particularly important in maintaining cardiovascular homeostasis. The
PVN is known to regulate BP in response to stress, primarily through activation of
the hypothalamic-pituitary-adrenal (HPA) axis (Badoer and Merolli, 1998;
Herman et al., 1996). The PVN also has direct projections to regions important
for cardiorespiratory responses to hemorrhage, including the RVLM, spinal cord,
phrenic motor nucleus, PreBötC, and the dorsomedial, medial, and commissural
portions of the NTS (Affleck et al., 2012; Kc et al., 2002a; Saper et al., 1976).
Interestingly, exposure to hypoxia enhances c-Fos expression in NTS
neurons that project to the PVN, and these projections were found to be mostly
catecholaminergic (King et al., 2012). Hypotensive hemorrhage and hypercapnia
have also been shown to increase activation of the PVN (Badoer and Merolli,
1998; Kc et al., 2002b). Moreover, lesion of the PVN has been shown to block
the pressor response to chemical hypoxia in the unanesthetized rat (Olivan et al.,
2001). Based on these findings, it appears that the PVN plays a pivotal role in
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peripheral and/or central chemoreceptor activation, possibly through the input
received from the NTS.
Additionally, NTS provides direct catecholaminergic and peptidergic
projections to the central nucleus of the amygdala (CeA), a subnucleus of the
amygdala found to be important in the modulation of BP during exposure to
fearful stimuli (Zardetto-Smith and Gray, 1990). In turn, the CeA provides
inhibitory GABAergic projections that synapse onto second order baroreceptor
neurons within the NTS. Thus, CeA activation in response to fear/anxiety can
attenuate arterial baroreceptor activation to promote increases in BP (Saha,
2005). The CeA also modulates BP during stress via direct projections to C1
adrenergic regions in the RVLM that promote sympathoexcitation (Saha et al.,
2005).
As mentioned previously, the NTS can augment ventilation through direct
projections to the VRG. Additionally, the NTS projects to pontine nuclei to
modulate ventilation. The pontine ventilator nuclei are located in the parabrachial
area at the junction between the midbrain and the pons and are composed of
three regions: the Kölliker-Fuse nucleus (KFN), lateral parabrachial nucleus
(LPBN) and the medial parabrachial nucleus (MPBN). Both the KFN and the
LPBN receive projections from the caudal NTS and are involved in
cardiorespiratory functions (Herbert et al., 1990). Lesion of either the KFN or
LPBN has no effect on normal breathing in room air, but elicits an impaired
ventilatory response to hypoxia and hypercapnia in the unanesthetized rat.
Interestingly, KFN and LPBN lesions also produce altered behavior of the rats
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during hypercapnic gas exposure. Specifically, control animals were observed to
spend more time sniffing, moving, gasping, and generally were more active than
animals subjected to KFN and LPBN lesion (Mizusawa et al., 1995). Since the
ventilatory response in either region has been shown to be heavily impaired by
anesthetics, it appears as though consciousness and higher brain function is
important in the ventilatory response to changes in CO2. Moreover,
consciousness may be necessary for behavioral responses to sensory
information generated by changes in blood gases that are integrated within the
NTS.

Neurotransmission in the NTS
As mentioned previously, the more caudal portion of the NTS receives
input from the arterial baroreceptor and the peripheral chemoreceptor afferents
carried by the solitary tract. Neurotransmitter release from these afferent
projections modulate sympathetic drive and ventilation. Although it is known that
an excitatory amino acid neurotransmitter is released from these afferents,
numerous additional neurotransmitters, gases, and peptides are also thought to
be involved in modulating the arterial baroreflex and peripheral chemoreflex
responses.
Many investigators have found evidence that glutamate acts as the
primary excitatory amino acid neurotransmitter released from the baroreceptor
afferents to activate second order neurons within the NTS. Microinjection of the
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NMDA glutamate receptor antagonist, (2R)-amino-5-phosphonovaleric acid (AP5) into the NTS of conscious rats did not change baseline BP but did reduce
baroreflex gain in response to phenylephrine-induced hypertension (Machado,
2001; Machado and Bonagamba, 1992). The utilization of alternative glutamate
receptor antagonists that were specific for metabotropic glutamate receptors or
non-NMDA glutamate receptors (AMPA or Kainate receptors) ultimately revealed
that glutamate had varying effects on BP depending on the specific glutamate
receptor population that was manipulated and whether the animal was
anesthetized. In general, glutamate neurotransmission modulates beat-to-beat
BP control through a non-NMDA glutamate receptor population, whereas
activation of the arterial baroreceptors by larger changes in BP facilitate
glutamate binding of the NMDA glutamate receptors.
Similarly, Substance P (SP) has been identified as one of the main
neurotransmitters released in the NTS in response to baroreceptor activation
(Helke et al., 1980). Aortic nerve afferent fibers release SP in the NTS in
response to increased BP (Potts and Fuchs, 2001). Moreover, NTS
microinjections of exogenous SP or SP antagonist were found to enhance and
blunt the arterial baroreflex respectively, but only in response to loading
(activation) of the baroreceptors (Seagard et al., 2000). Selective destruction of
cells in the NTS that express the primary SP receptor, neurokinin-1 (NK-1), using
a SP-conjugated saponin toxin, impaired baroreflex sensitivity (Riley et al., 2002).
Thus, SP also appears to contribute to arterial baroreceptor activation through
NK-1 receptors in the NTS.
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Retrograde tracing studies have also identified a population of inhibitory
interneurons in the NTS that are activated by the arterial baroreflex and project to
the CVLM to modulate RVLM activity. These neurons are located more rostrally
and are distinct from the interneurons in the NTS that are tonically active. At
least a portion of these baro-sensitive interneurons are GABAergic (Izzo et al.,
1992). Several investigators have studied the role of these GABAergic neurons
in the NTS and found that their selective activation facilitates the pressor effect
associated with inhibition of the arterial baroreflex (Sved and Sved, 1990).
Similarly, this response was reversed with direct injection of an antagonist to the
GABAA receptors, gabazine (Zubcevic and Potts, 2010). Therefore, GABA
appears to be the primary neurotransmitter involved in baroreflex inhibition.
Glutamate is also thought to be the primary excitatory amino acid released
in the NTS to facilitate ventilatory and BP effects during peripheral
chemoreceptor activation. Peripheral chemoreceptors are also activated by
systemic KCN injection that elicits a transient hypoxic state in the carotid body
cells. Consequently, increased ventilation and BP, as well as bradycardia, result
in response to simultaneous activation of sympathetic and parasympathetic
systems. Similar responses in conscious rats have been observed following
microinjections of L-Glutamate directly into the NTS (Colombari et al., 1998). It
appears that glutamate modulation of HR develops through NMDA glutamate
receptor activation since direct microinjection the NMDA receptor glutamate
antagonist, AP-5, eliminates the bradycardia associated with peripheral
chemoreceptor activation (Accorsi-Mendonca et al., 2009).
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The pressor effect of peripheral chemoreceptor activation is also
dependent on glutamate neurotransmission, but this process is thought to be
mediated through a non-NMDA ionotropic glutamate receptor population in the
NTS. When Machado et al. microinjected the non-selective AMPA and Kainate
antagonist, 6,7-dinitroquinoxaline-2,3-dione (DNQX), in the NTS and
administered KCN to activate the peripheral chemoreceptors, there was only a
partial attenuation of the pressor effect associated with peripheral chemoreceptor
activation. This suggests that an alternative glutamate receptor subtype or
another excitatory neurotransmitter besides glutamate is also involved in the
pressor response to peripheral chemoreceptor activation (Machado and
Bonagamba, 1992).
Interestingly, separate studies found that NTS microinjections of ATP
mimicked peripheral chemoreceptor activation, similar to results seen with direct
injection of L-Glutamate (de Paula et al., 2004). Moreover, when the nonselective purinergic receptor antagonist, suramin, was administered, a significant
attenuation of the bradycardiac response to chemical hypoxia was observed
(Paton et al., 2002). More recent studies microinjected both a non-selective
ionotropic glutamate receptor antagonist, kynurenic acid, and purinergic receptor
P2X2 antagonist, pyridoxalphophate-6-azophrenyl-2’,4’-disulfonic acid (PPADS),
during chemical hypoxia. The result was significantly impaired sympathoxcitatory
and pressor responses to peripheral chemoreceptor activation. In summary,
NTS microinjection studies suggest that ATP and glutamate may be cotransmitters involved in peripheral chemoreceptor activation in the NTS. It
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appears that glutamate, and possibly ATP, facilitate the pressor effect of
peripheral chemoreflex activation through increases in sympathetic drive via nonNMDA and purinergic receptors. Additionally, it is likely that glutamate binds
NMDA receptors in the NTS to mediate the bradycardic component of peripheral
chemoreceptor activation through subsequent cardiac vagal activation.
Increased sympathetic and ventilatory drive during peripheral
chemoreceptor activation can be modulated by a myriad of neurotransmitters.
Noradrenergic structures in the brain, including the A1 and A2 regions of the
medulla, show increased c-Fos expression in response to chemical hypoxia and
activation of the carotid sinus nerve (Buller et al., 1999; Erickson and Millhorn,
1994; Smith et al., 1995; Teppema et al., 1997). The role of norepinephrine (NE)
in peripheral chemoreceptor activation was further supported by in vivo studies
that found excitation or inhibition of these same regions could modulate
cardiorespiratory responses to peripheral chemoreceptor activation (Hayward,
2001; Perez et al., 1998). Anatomically, the caudal NTS projects to other central
noradrenergic structures, and noradrenergic cells identified in the NTS make up
the A2 nucleus (Dahlstrom and Fuxe, 1964; Jacobowitz and Palkovits, 1974).
Microinjection of NE into the caudal NTS produces a dose-dependent decrease
in the pressor response to KCN injection in awake rats, suggesting that NE
exerts an inhibitory effect on the pressor/sympathoexcitatory response to
peripheral chemoreceptor activation (Silva de Oliveira et al., 2007). Both α1 and
α2 adrenergic receptors are expressed in the NTS, but the expression of α 1
adrenergic receptors is more prevalent in the medial NTS, while α2 adrenergic
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receptors are expressed primarily in the more caudal portions of the caudal NTS
(Young 1985). Microinjection of the selective α1AR agonists, phenylephrine or
methoxamine, near the medial NTS elicits a dose-dependent increase in BP and
HR. In contrast, dose-dependent decreases in BP and HR are produced by
microinjection of α2AR agonist, clonidine, in the same region (Kubo et al., 1987;
Tsukamoto et al., 2002; Zandberg et al., 1979). Similar results are seen with
microinjection of clonidine in the commissural NTS of rats. Moreover, the effects
of clonidine can be reversed by microinjection of α2AR antagonist yohimbine
(Bhuiyan et al., 2009). In general, α1- and α2-adrenergic receptors are thought to
have an inhibitory/modulatory role on both the arterial baroreflex and peripheral
chemoreflex.
It is also important to note that the physiological response to hypoxiainduced peripheral chemoreceptor activation is biphasic. The initial
augmentation of ventilation is followed by a decline or “roll off” in ventilation
termed hypoxic ventilatory decline (HVD). It is likely that glutamate contributes to
the immediate increase in ventilation during hypoxia exposure, but the
mechanism by which HVD occurs remains to be fully elucidated. One
neurotransmitter thought to be involved in HVD is GABA. The NTS receives
GABAergic innervation from other brain regions, such as the PVN; but the major
source of GABA in the NTS is from interneurons. Most GABAergic interneurons
are excited by second order neurons that become activated by afferent fibers
from the solitary tract. Consequently, GABA’s role in the inhibition of the NTS is,
to some degree, regulated by excitatory drive. It has been proposed that with
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prolonged peripheral chemoreceptor activation, and thus increased glutamate
accumulation, GABA synthesis increases to facilitate HVD. Data from
microdialysis studies of Tabata et al. showed that rats exposed to sustained
hypoxia had significantly elevated GABA concentrations in the NTS 15 minutes
after the start of gas exposure. Animals in which the carotid bodies have been
denervated do not accumulate GABA upon exposure to hypoxia. Therefore, it is
plausible that with prolonged peripheral chemoreceptor activation GABA levels
increase, and, as a consequence, ventilatory drive becomes suppressed.
Separate studies have found that increased GABA concentrations in the
commissural NTS correlates with impaired peripheral chemoreceptor activation.
Specifically, microinjection of the GABA reuptake inhibitor, nipecotic acid,
reduces the ventilatory, BP, and sympathetic responses to peripheral
chemoreceptor activation. Furthermore, this effect is reversed by GABAA
receptor antagonist, bicuculline. Similar to the results seen with blockade of
GABA reuptake, microinjection of GABAA receptor agonist, muscimol, attenuates
the autonomic responses to peripheral chemoreceptor activation. Together,
these studies provide significant evidence that GABA neurotransmission is
facilitated by excitatory second order neurons in the NTS to reduce the peripheral
chemoreflex response during sustained hypoxia.
Another neurotransmitter that may contribute to HVD, is DA. It has been
well established that glomus cells of the carotid bodies are highly dopaminergic
structures that utilize DA release to inhibit peripheral chemoreceptor activation in
an autocrine fashion (Gonzalez et al., 1994; Prabhakar, 1994). Additionally, DA
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is found in peripheral chemoreceptor afferent fibers that terminate in the NTS.
Like GABA, DA has also been shown to accumulate in the NTS during sustained
hypoxia, and its accumulation is dependent on intact carotid sinus nerves (Goiny
1991). Dopamine is thought to activate D2-like receptors in the caudal NTS (Qian
et al., 1997; Yokoyama et al., 1994). The D2 receptors are inhibitory and have
been co-localized within the NTS with synaptophysin, a presynaptic vesicle
protein. Thus, DA release in the NTS can attenuate excitatory glutamatergic
synaptic transmission via the activation of presynaptic D2 receptors located in the
caudal NTS. Furthermore, DA release during sustained hypoxia may enhance or
coincide with HVD.
Previous studies from our laboratory and others have found that serotonin
also plays a critical role in the physiological responses to peripheral
chemoreceptor activation. The NTS receives extensive serotonin innervation
from the nodose ganglion as well as the caudal raphe nuclei (Nosjean et al.,
1990; Thor and Helke, 1987a). Earlier studies found that serotonin turnover was
increased in the NTS of rats that received systemic injection of phenylephrine,
and that this effect was abolished by sinoaortic denervation (Bhaskaran and
Freed, 1988). It was also previously shown that low dose microinjection of
serotonin in mediocaudal and commissural NTS produced cardiovascular
responses typically associated with baroreceptor activation, specifically
decreased HR and BP. In a study from Orer et al., the selective serotonin
neurotoxin, 5,7-DHT, was utilized to lesion serotonin nerve terminals in the NTS.
They showed a moderate, but significant increase in BP in unanesthetized, freely
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moving rats (Orer et al., 1991). Previous studies from our laboratory utilized the
same neurotoxin to selectively destroy the serotonergic nerve terminals in the
dorsomedial medulla (including the NTS) in rats. Loss of serotonin innervation in
the NTS enhanced arterial baroreceptor reflex gain but reduced the sympathetic
and ventilatory response to peripheral chemoreceptor activation by systemic
KCN injection (Kung and Scrogin, 2011). Although several serotonin receptor
subtypes have been identified in the NTS, 5-HT1A, 5-HT2, and 5-HT3 receptors
have been the most extensively studied to date. In general, that 5-HT2 and 5HT1A receptors in the NTS are thought to mediate the depressor effect of arterial
baroreflex activation, while 5-HT3 receptors located on vagal afferent fibers
facilitate hypertensive responses during baroreflex activation induced by
systemic phenylephrine (Itoh et al., 1992; Itoh and Bunag, 1991; Merahi et al.,
1992). Interestingly, partial and full 5-HT1A receptor agonists have been shown
to increase ventilation in rats following spinal cord injury and in intact cats and
rats, although the location of these effects remains obscure (Garner et al., 1989;
Mendelson et al., 1990; Teng et al., 2003).

Overview of central serotonergic system
Serotonin, or 5-Hydroxytryptamine, is a monoamine neurotransmitter
biochemically synthesized from tryptophan via tryptophan hydroxylase (TPH).
The majority of serotonin (approximately 90%) is produced and stored in
enterochromaffin cells located in the lining of the gut, while the remaining
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serotonin is synthesized in the CNS. Serotonin modulates numerous
physiological and behavioral functions, such as mood, sleep, appetite,
vasoconstriction, and pain processing. Serotonin has the capacity to regulate so
many biological functions owing to the widespread distribution of its molecularly
diverse receptor subtypes throughout the CNS.

Anatomy of serotonergic system
The majority of serotonin innervation in the CNS originates from a group of
neurons termed the raphe nuclei. This cluster of nuclei is located medially
throughout the rostrocaudal extent of the brainstem. Although the raphe nuclei
are made up of a heterogeneous population of neurons, the main constituents of
the region are serotonergic.
There are two major divisions of raphe nuclei (Figure 5). The more rostral
group of raphe nuclei (B5-B8) are located in the midbrain and rostral pons and
project almost exclusively to the forebrain to modulate pathways involved in
mood, appetite, and sleep. The caudal raphe nuclei (B1-3) are located within the
caudal pons and medulla oblongata and project within the brainstem as well as to
regions within the spinal cord to regulate cardiorespiratory function and pain
processing. In 1964, Dalhstrom and Fuxe identified and divided serotonin nuclei
within the raphe into 9 groups (B1-9) (Dahlstrom and Fuxe, 1964).
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Figure 5. Sagittal view of a rat brain depicting serotonin innervation
throughout the CNS. The more rostral serotonin nuclei, B5 (pontine median
raphe), B6 (pontine dorsal raphe), B7 (midbrain dorsal raphe), and B8 (midbrain
median raphe) project rostrally towards the forebrain to mediate functions related
to mood, sleep, and appetite. The more caudal raphe, B1 (raphe pallidus), B2
(raphe obscurus), and B3 (raphe magnus have projections within the medulla
and spinal cord which modulate cardiorespiratory function and pain processing
(Cooper JR, 2003).
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The rostral group is composed of three nuclei and is responsible for 85%
of all serotonin innervation within the brain. The caudal linear nucleus (CLi) is the
most rostral of the raphe nuclei, but contains relatively few serotonin neurons
compared to the other raphe nuclei. The dorsal raphe (DR-B7) is the next most
rostral of the nuclei. The DR contains the largest number of serotonin neurons,
the majority of which are located in the rostral portion of the DR and also utlize
SP as a co-transmitter with serotonin (Hornung, 2003). The most caudal nucleus
of the rostral group is the median raphe (MR-B8). The majority of serotonin
synthesizing neurons are located in the midline (>80%), while the lateral
extensions of the MR rarely express serotonin. Caudal extensions of the DR and
MR located in the pons are termed B6 and B5 respectively. Both the DR and MR
receive glutamatergic afferent projections from the limbic system in the forebrain
including the cingulate cortex, ventral tegmental area, and several nuclei of the
hypothalamus (Behzadi et al., 1990; Peyron et al., 1998). While the rostral raphe
nuclei project to a myriad of regions in the forebrain, there is very little overlap of
projections from the DR and MR. The DR projections provide afferent input to
the amygdala, hypothalamus, olfactory bulb, cortex, and basal ganglia (Van de
Kar 1979). In contrast, the MR project to more midline structures which include
the hippocampus, caudal raphe nuclei, laterodorsal tegmental nucleus, dorsal
raphe nucleus, interpeduncular nucleus, medial mammillary body, and other
medial sites (Vertes 1999). In general, the rostral raphe project throughout the
forebrain to mediate many behavioral functions, such as arousal, aggression,
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and anxiety (Monti, 2011; Pucilowski and Kostowski, 1983; Zangrossi and Graeff,
2014).
The caudal raphe are composed of the raphe magnus (RM-B3), which is
the largest serotonergic group of the caudal raphe, the raphe obscurus (RO-B2),
and the raphe pallidus (RP-B1, smallest group of serotonergic neurons). The
caudal raphe project to other regions within the brainstem and to the spinal cord
to regulate a variety of autonomic functions. The RM is mainly involved in pain
processing as it has projections (most of which are serotonergic) to the dorsal
horn of the spinal cord. Studies have identified an excitatory projection from the
periaqueductal gray (PAG) region to the RM which promotes the release of
opioid neurotransmitters in the spinal cord to cause analgesia (Mason, 2001).
The RO has been shown to augment ventilation and has reciprocal projections
with the PreBötC and hypoglossal motorneurons. Glutamate injections into the
RO or direct activation of the RO by optogenetic means both result in a dramatic
increase in ventilation (Depuy et al., 2011; Ptak et al., 2009). The RP has been
shown to be involved in regulating tachycardia and increased BP in response to
emotional stressors and provides excitatory input to the sympathetic neurons that
innervate brown adipose tissue to stimulate thermogenesis (Morrison et al.,
2012; Pham-Le et al., 2011).
The NTS receives extensive serotonin innervation from all three of the
caudal raphe, the DR, and peripherally from the nodose ganglia, in which the cell
bodies of the vagal sensory afferent nerves are located (Gaudin-Chazal et al.,
1982; Nosjean et al., 1990; Schaffar et al., 1988; Thor and Helke, 1987b). The
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highest density of serotonin innervation is located in the commissural and
dorsomedial band of the parvocellular subdivision of the NTS and to a lesser
degree in the remaining portion of commissural NTS and lateral and medial
subdivisions of the NTS. Only sporadic serotonin immunoreactive fibers are
observed in the ventrolateral subnucleus and remainder of the parovocellular
portions of the NTS (Maley and Elde, 1982). It is also important to note that
projections from the caudal raphe also release SP as a co-transmitter with
serotonin in the NTS, dorsal motor nucleus of the vagus (DMX), area postrema,
hypoglossal nucleus and the ventral horn of the cervical spinal cord (Thor and
Helke, 1987a; Thor et al., 1988). There are considerably fewer serotonin and SP
double-labeled varicosities from the nodes and petrosal ganglia in the NTS
compared to the spinal cord or hypoglossal nucleus. Instead, serotonin and SP
are more likely to be co-localized in varicosities arising from the RM, RO, and RP
(Thor and Helke, 1989).

Serotonin receptors
To date, 7 classes of serotonin receptors have been identified, each with
multiple receptor subtypes (14 total). The majority of serotonin receptors are Gprotein coupled receptors (GPCRs), with the exception of the ionotropic 5-HT3
receptor. The first group of serotonin receptors are the 5-HT1 family, comprised
of 5 receptor subtypes (5-HT1A, 5-HT1B, 5-HT1D, 5-HT1E, and 5-HT1F), which are
typically inhibitory in nature. Specifically, these receptors preferentially couple to
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Gαi/o to inhibit adenylyl cyclase (AC) as well as to activate K+ channels that
promote hyperpolarization. The 5-HT1A receptor is the most extensively studied
receptor of this family due to its wide CNS distribution and prominent role in
various mood disorders. Both, the 5-HT1A and 5-HT1B receptors have been
localized to the NTS, but the exact role of these receptors within the NTS
remains unknown (Manaker and Verderame, 1990).
The 5-HT2 receptor family is composed of 3 receptor subtypes (5-HT2A, 5HT2B, and 5-HT2C) and promotes depolarization by preferentially coupling to
Gαq/11 to activate phospholipase C (PLC) and increase inositol phosphatase 3
(IP3) levels. This leads to increased Ca2+ to promote vascular constriction and
neurotransmission. Cells of the NTS express both 5-HT2A and 5-HT2C receptors.
The 5-HT2A receptors have been shown to be involved in the depressor and
bradycardic responses of arterial baroreflex function (Comet et al., 2007;
Pompeiano et al., 1994).
The ionotropic 5-HT3 receptor is composed of 5 subunits (5-HT3A/B/C/D/E),
but must contain at least one 5-HT3A subunit to be functional. Upon ligand
binding, the channels are permeable to cations such as, Na+, Ca2+, and K+ and
typically promote depolarization and facilitate neurotransmission. The 5-HT3
receptor is highly expressed within the NTS on vagal afferent terminals (Leslie et
al., 1990; Pratt and Bowery, 1989). Activation of these receptors promotes
release of glutamate within the NTS to facilitate vagal excitatory input to the NTS
(Jeggo et al., 2005).
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The remaining receptors, 5-HT4, 5-ht5, 5-ht6, and 5-HT7 are less well
characterized, but it is recognized that 5-ht5 receptors couple to Gαi, while the
rest couple to Gαs and activate AC, and thus protein kinase A (PKA) to facilitate
depolarization. The NTS also expresses 5-HT4 and 5-HT7 receptors. Although
these receptors have not been as extensively studied, some laboratories have
found that activation of the 5-HT4 receptor in the NTS results in an attenuated
bradycardic response to cardiopulmonary reflex activation in anesthetized rats
(Edwards and Paton, 1999). Additionally, 5-HT7 receptors located in the NTS
have been shown to increase cardiac vagal drive in anesthetized rats (Kellett et
al., 2005).

Major function of serotonin
Serotonin has been investigated over many decades and has been
identified as a key neurotransmitter in a variety of physiological functions
including appetite, mood, arousal, thermoregulation, and autonomic functions.
Although the role of serotonin in cognitive and emotional functions has been well
documented, its role in cardiovascular function has not been as well
characterized. Injection of serotonin directly into the NTS results in a dosedependent increase in BP that can be blocked by local and systemic injection of
serotonin antagonists. Additionally, administration of a selective serotonin
reuptake inhibitor (SSRI) augments the serotonin-dependent increase in BP
(Wolf et al., 1981). Similar results were reproduced in unanaesthetized rats
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(Callera et al., 1997). More recently, a study by Curtis et al., found increased
serotonin metabolite accumulation in the caudal NTS of rats exposed to
polyethylene glycol (PEG) induced hypovolemia (Curtis et al., 2013).

Serotonin and 5-HT1A receptors in hemorrhage
General functions of serotonin in hemorrhage
Several laboratories have provided evidence that central release of
serotonin is involved in the sympatholytic phase of hemorrhage resulting in a
dramatic fall in BP. Studies performed in anesthetized cats and rats found that
depletion of serotonin resulted in a delayed hypotensive response to
hypovolemic shock. Furthermore, central administration of a non–selective
serotonin receptor antagonist, methysergide, produced similar effects (Blum and
Spath, 1986; Elam et al., 1985; Morgan et al., 1988). Direct injections of the 5HT1A receptor antagonist, WAY-100635, in the RVLM resulted in a delayed
hypotensive and sympathoinhibitory responses to blood loss in anaesthetized
rats. Thus, central serotonin release was thought to contribute to syncopal-like
responses to blood loss through activation of 5-HT1A receptors located in the
RVLM (Dean and Bago, 2002). However, additional studies have provided
conflicting evidence for the role of central serotonin to sympathoinhibitory
responses that follow blood loss. Unanesthetized animals subjected to prior
depletion of serotonin demonstrated normal phasic responses to blood loss,
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suggesting that anesthesia likely contributed to previous observations that
implicated serotonin release in sympathoinhibition (Evans et al., 1992).
More recent studies from our laboratory have investigated the role of the
serotonin neurons of the caudal raphe in hypotensive hemorrhage. Utilizing the
immediate early gene, c-Fos, as a marker for neuronal activation, serotonin
neuronal activation was assessed during hemorrhage in unanesthetized, freely
moving rats. Serotonin neurons within the caudal raphe, including the RO and
RM, were activated during hypotensive hemorrhage but not during hydralazineinduced hypotension (Kung et al., 2010). Studies from our laboratory also found
that selective destruction of the caudal hindbrain serotonin neurons resulted in an
attenuation of sympathetic and ventilatory recovery from hypotensive
hemorrhage rather than attenuated sympathoinhibition to blood loss as had been
observed in previous studies. In addition, rats subjected to serotonin depletion
showed greater metabolic acidosis as a result of hypotensive hemorrhage
despite normal BP and HR responses. Metabolic acidosis is indicative of
peripheral tissue hypoxia. Thus, oxygen delivery to peripheral tissue was
reduced by serotonin depletion. Oxygen delivery is dependent upon CO and
arterial blood oxygenation. Interestingly, the partial pressure of O2 in arterial
blood (PaO2) was significantly higher in serotonin depleted animals. These data
suggest that the rats depleted of serotonin had impaired oxygen delivery to the
peripheral tissues, possibly due to reduced CO. Since BP is determined by CO
and TPR, the data further suggest that after serotonin lesion normal BP
responses to blood loss are maintained by detrimental increases in peripheral
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resistance rather than more hemodynamically favorable increases in CO.
Together, these studies suggested that endogenous serotonin release from the
caudal raphe contributes to sympathoexcitation and increased ventilation during
compensation from hypotensive hemorrhage, and that in the absence of
serotonin BP may be maintained by a potentially more dangerous increase in
TPR that further reduces tissue perfusion.
The mechanism by which serotonin neurons in the caudal raphe become
activated during blood loss remains unknown. The recovery of sympathetic and
ventilation following blood withdrawal was found to rise in parallel with the
PaCO2, suggesting that central chemoreceptor activation may contribute to
compensation from blood loss. Moreover, rats subjected to serotonin depletion
were found to have reduced sympathetic and ventilatory responses to hyperoxichypercapnic gas exposure. Hyperoxia prevents activation of peripheral
chemoreceptors. Therefore, these data suggest an important role for serotonin
neurons in central chemoreceptor responses to acidosis in unanesthetized
animals.
Following the initial study by Kung et al., evidence supported the view that
serotonin neurons in the caudal hindbrain facilitated chemosensory input in the
brainstem to modulate sympathetic and ventilatory drive. But it was unclear
where serotonin was acting to mediate these effects. The NTS is an important
sensory integration center in the brainstem and receives extensive serotonin
innervation from the caudal raphe neurons. Therefore, additional studies were
conducted to selectively destroy serotonin nerve terminals in the dorsomedial
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medulla, including regions of the NTS. Serotonin nerve terminal lesion in the
dorsal midline brainstem also reduced sympathetic and ventilatory responses to
compensation from hypotensive hemorrhage in unanesthetized, freely moving
rats (Kung and Scrogin, 2011). Additionally, the lesion reduced the sympathetic
and ventilatory responses to peripheral chemoreceptor activation by systemic
KCN injections but enhanced arterial baroreflex gain during pharmacologically
induced hypotension. Results from the serotonin nerve terminal lesion study
were consistent with the previous studies, and further supported the view that
serotonin facilitates sympathetic and ventilatory recovery during blood loss by
facilitating chemoreflexes within the NTS.

5-HT1A receptor activation in hemorrhage
Although previous studies have identified a sympathoexcitatory role for
central serotonin release in the NTS during hypotensive hemorrhage, the
receptor population mediating these effects remains unknown. The previously
mentioned studies found that administration of the non-selective serotonin
receptor antagonist, methysergide, delayed the hypotensive phase of
hemorrhage (Elam et al., 1985; Morgan et al., 1988). However, methysergide
also acts as an agonist at 5-HT1A/B/D receptors (Hoyer et al., 1994). Studies from
our laboratory found that injection of methysergide into the lateral
cerebroventricle delayed the hypotension, bradycardia, and sympathoinhibition
associated with progressive blood loss in unanesthetized rats (Scrogin et al.,
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2000). It was also found that the partial 5-HT1A receptor agonist, buspirone, and
the more selective 5-HT1A receptor agonist, 8-OH-DPAT mimicked the effects of
methysergide in a dose-dependent manner (Osei-Owusu and Scrogin, 2004).
Systemic injection of the potent 5-HT1A receptor antagonist, WAY-100635, dosedependently blocked the ability of methysergide to delay the sympathoinhibitory
effect of hemorrhage, whereas a selective 5-HT2 receptor antagonist had virtually
no effect.
To better localize the 5-HT1A receptor population that mediated these
effects, 8-OH-DPAT was injected in various rostro-caudal locations along the
ventricular system of rats subjected to hypotensive hemorrhage. Injections into
the 4th ventricle produced the most robust responses with the shortest latency.
The results suggested that 5-HT1A receptors located in the hindbrain contributed
to compensation from blood loss (Scrogin, 2003). The portion of the NTS that
receives cardiovascular and chemoreceptor afferents forms the ventral floor of
the 4th ventricle. This area also expresses 5-HT1A receptors. Denervation of the
baroreceptor and chemoreceptor afferents that innervate the NTS was found to
attenuate the sympathoexcitatory and pressor effects of 8-OH-DPAT compared
to intact controls (Osei-Owusu and Scrogin, 2006). This implies that
baroreceptor, and/or peripheral chemoreceptor input into the NTS is necessary
for sympathoexcitatory and pressor responses elicited by 5-HT1A receptor
activation in a hypovolemic rat. This is intriguing because the
sympathoexcitatory and pressor effects of 8-OH-DPAT are only observed in a
hypovolemic rat. Activation of 5-HT1A receptors actually induces
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sympathoinhibition in euvolemic rats. Therefore, it is plausible that 5-HT1A
receptors modulate a pathway that is quiescent in the euvolemic rats but is
activated during severe blood loss.
Subsequent studies utilizing a more severe shock model (~50% estimated
blood volume withdrawn) showed that 8-OH-DPAT administration increased
mean circulatory filling pressure (MCFP) in hemorrhaged rats (Tiniakov and
Scrogin, 2006). Mean circulatory filling pressure is the mean pressure that exists
when CO stops and the blood redistributes throughout the vasculature. Thus,
MCFP is a measure of how full the circulatory system is and is determined by
blood volume and venous tone, since the veins are more compliant than the
arterial vasculature. Given that the amount of blood withdrawn during
hemorrhage was not different between 8-OH-DPAT and saline-control treated
rats, it was assumed that 8-OH-DPAT increased MCFP through increased
venous tone. An increase in venous tone should cause an increase in venous
return and BP if right arterial pressure is maintained. In fact, systemic
administration of 8-OH-DPAT to hypovolemic animals was also found to improve
metabolic acidosis following severe blood, indicating that 5-HT1A receptor
activation improves oxygen delivery to peripheral tissue in the hemorrhaged
animal. Indeed, it was determined that 8-OH-DPAT administration in
hemorrhaged rats increased BP exclusively by increasing CO. Neither HR nor
TPR were affected by 8-OH-DPAT administration. Thus, 8-OH-DPAT may
selectively promote venoconstriction to ultimately increase venous return and CO
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and ameliorate the progression of metabolic acidosis in hypovolemic rats
(Tiniakov et al., 2007).
It is also plausible that 8-OH-DPAT may mobilize blood stores within the
venous vasculature to increase MCFP. The splanchnic vasculature holds 33% of
blood volume in euvolemic animals (Greenway and Lister, 1974). Due to the
high compliance of the splanchnic venous vasculature, a relatively large portion
of this blood remains unstressed and contributes very little to central venous
pressure. Sympathetic-mediated constriction of the splanchnic veins can result
in up to 60% of blood re-mobilization back into the circulation to increase
perfusion pressure (Reilly et al., 2001). Our laboratory also showed that bilateral
denervation of the splanchnic sympathetic nerves in the rat did not alter the initial
pressor effect of 8-OH-DPAT but did abolish the ability of 8-OH-DPAT to
increase MCFP and improve acid-base balance. Interestingly, denervation
greatly shortened the pressor effect of 8-OH-DPAT, as did ganglionic blockade.
Together, the data indicate that 8-OH-DPAT, when given following hemorrhagic
shock, promotes a sympathetic-dependent increase in the splanchnic venous
tone that increases CO and thereby reduces metabolic acidosis (Tiniakov et al.,
2012). Endogenous serotonin released from the caudal hindbrain raphe
produces very similar effects to administration of the 5-HT1A receptor agonist, 8OH-DPAT in hypovolemic animals. These findings suggest that 8-OH-DPAT and
endogenous serotonin release may both facilitate sympathetic and ventilatory
compensation through activation of 5-HT1A receptors located within the NTS.
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Serotonin and central chemoreceptors
As discussed previously, the serotonergic neuronal population within the
mid-line medullary raphe are considered putative central chemoreceptors.
Central chemoreceptors are defined by their intrinsic sensitivity to PaCO2/H+ and
direct connection to a respiratory network that mediates ventilation. Over the
years, there have been various (often conflicting) results from studies
investigating whether serotonin neurons of the caudal raphe are central
chemoreceptors or modulate chemosensitivity.
In general, serotonin has not been shown to be necessary for homeostatic
ventilatory rhythmogenesis in adults, but it does increase the frequency and
amplitude of phrenic nerve bursts during hypercapnia (Corcoran et al., 2013).
Hypercapnia has also been shown to induce c-Fos expression in raphe serotonin
neurons (Haxhiu et al., 2001; Johnson et al., 2005), and to augment serotonin
release within the dorsomedial medulla (Kanamaru et al., 2013). Hypercapnia
was shown to increase the firing rate of serotonin neurons in the raphe of freely
moving cats (Veasey et al., 1995). Moreover, numerous laboratories have
shown that rodents display reduced chemosensitivity when serotonin neurons
have been genetically altered (Barrett et al., 2012; Buchanan and Richerson,
2010; Hodges et al., 2011; Hodges et al., 2008; Penatti et al., 2011a),
pharmacologically lesioned (Nattie et al., 2004), or selectively silenced (Ray et
al., 2011). Dietary restriction of tryptophan also reduces central chemosensitivity
(Penatti et al., 2011b). Together, these studies indicate that serotonin modulates
or facilitates central chemoreflex activation.

65
One compelling piece of evidence that serotonin neurons are central
chemoreceptors is their ideal location for the direct assessment of how efficiently
the lungs oxygenate the blood supply. The PaCO2 is an excellent reflection of
the aveolar ventilation, and immunohistochemical analysis has shown that
serotonin immunoreactive caudal raphe neuronal dendrites physically wrap
around the major arterial blood vessels in the brain (Bradley et al., 2002).
Therefore, it is plausible that these neurons are able to penetrate the blood
vessels to directly and accurately assess PaCO2 and H+ in the arterial blood
supply to the brain. This idyllic location of serotonin neurons is comparable to
the peripheral chemoreceptors located in carotid and aortic bodies, which enable
them to directly measure the oxygen content of the blood immediately after
departing the heart.
Furthermore, when the same serotonin neurons are removed and
cultured, they are found to be directly sensitive to changes in CO 2 and H+ (Wang
et al., 1998; Wang et al., 2001). Specifically, they are more active when CO2 is
elevated and pH is decreased. Conversely, when pH increases or CO2
decreases, these neurons become quiet. This intrinsic ability to be activated by
changes in CO2 and pH strongly suggest that these neurons are chemosensitive.
Caudal raphe serotonin neurons not only provide afferent projections to
numerous components of the respiratory network including, PreBötC and
hypoglossal motorneurons, but they have also been shown to directly stimulate
respiratory motor output. Patch clamp recording studies by Ptak et al., found that
focal administration of a glutamate receptor agonist in the RO caused an
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increase in firing rate of the serotonin neurons that was proportionate to an
increase in firing of the hypoglossal nerve (Ptak et al., 2009). And for the first
time, a study has recently shown that specific activation of serotonin neurons via
optogenetic-mediated activation in vivo caused an increase in phrenic nerve
bursting frequency and amplitude (Depuy et al., 2011).
Serotonin receptor subtypes involved in this central chemoreceptor
response have been linked to 5-HT2A/C, 5-HT4A, and 5-HT1A receptor activation.
When 5-HT2 receptor agonists are administered via the cerebroventricles, a
subsequent increase in ventilation occurs which can be reversed by 5-HT2
receptor antagonist administration (Ray et al., 2011). Similarly, a 5-HT4A receptor
agonist has been shown to increase respiratory motor output. Systemic
administration of 8-OH-DPAT also restores ventilation after fentanyl-induced
apnea (Manzke et al., 2003; Zhuang et al., 2012). As mentioned, 5-HT1A
receptors are inhibitory, and their ability to promote ventilation suggests a
potential role for 5-HT1A receptor-mediated disinhibition of respiratory centers
through suppression of GABAergic or glycinergic interneurons (Corcoran et al.,
2014).
Despite evidence from the aforementioned studies, some investigators do
not believe that serotonin neurons play a role in central chemoreception in vivo
because serotonin neurons in the RO were unresponsive to hyperoxic
hypercapnia in anaesthetized rats (Depuy et al., 2011). Similarly, other studies
have found that intact medullary serotonin neurons are not chemosensitive by in
vivo recordings in anaesthetized rats (Mulkey et al., 2004; Takakura and Moreira,
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2013). However, it has been well documented that the hypercapnic ventilatory
response (HCVR) is significantly impaired by isoflurane and other anesthetics. In
fact, studies from Depuy et al., found that 8% CO2 only increased ventilation by
35% in anesthetized rats. In contrast, studies performed in unanaesthetized rats
found 7% CO2 produce a dramatic 250% increase in ventilation (Davis et al.,
2006; Hodges et al., 2008).
Similarly, arguments have been made against serotonin neurons as
central chemoreceptors because they are less sensitive to CO2 during sleep.
Therefore, some have suggested that the responses of serotonin activation are
due to arousal rather than central chemosensitivity. However, it has long been
known that HCVR is reduced during slow wave sleep and further reduced during
REM, but the mechanism is unknown (Bulow, 1963). Additionally, the firing of
serotonin neurons is highest during wakefulness, and virtually absent during
REM sleep. Combined with the fact that serotonin neurons are important for
arousal from sleep during elevated CO2, it plausible that consciousness is
necessary for serotonin neurons to be fully active and augment the HCVR.
Another argument against the medullary raphe as central chemoreceptors
includes a study by Mulkey et al.,that utilized TASK knockout mice. It had been
previously determined that TASK1/3 channels are the acid sensitive ion channels
directly linked to chemosensitivity of the medullary raphe in vitro. Therefore,
when TASK channel knockout mice were found to have a normal HCVR, it was
presumed that serotonin neurons in the medullary raphe were not central
chemoreceptors. However, there are several plausible explanations for why
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these results do not exclude serotonin neurons as central chemoreceptors.
Specifically, brain slice recordings were performed in P7-P12 mice despite the
fact serotonin neurons are not fully developed until P21 (Wang and Richerson,
1999). It is well known that age affects chemosensitivity and that in earlier
stages of development chemosensation is mediated more by central
chemoreceptors in the LC and NTS (Conrad et al., 2009; Stunden et al., 2001).
More importantly, TASK channels become inactive with most anesthetics, and
thus serotonin neurons may not be chemosensitive when studied in an
anesthetized animal model (Conway and Cotten, 2012; Patel et al., 1999; Talley
and Bayliss, 2002).
In light of the most recent studies, there is a compelling amount of
evidence suggesting that medullary serotonin neurons may act as central
chemoreceptors or at least contribute to part of the ventilatory response to
hypercapnia. Additionally, serotonin neurons are most active during
wakefulness, and silenced during sleep. Therefore, studies examining the
contribution of serotonin neurons to the central chemoreflex in awake animals
are necessary for a better understanding of the ventilatory response to
hypercapnia.

CHAPTER III
5-HT1A RECEPTORS IN THE NUCLEUS TRACTUS SOLITARIUS FACILITATE
SYMPATHETIC RECOVERY FOLLOWING HYPOTENSIVE HEMORRHAGE

Abstract
Serotonin neurons in the caudal raphe are activated in response to
hypotensive hemorrhage. Moreover, selective destruction of the same neuronal
population results in attenuated sympathetic and ventilatory responses to blood
loss. The caudal raphe provide extensive serotonin innervation of the nucleus
tractus solitarius (NTS), the lesion of which also attenuates ventilatory and
sympathetic responses to hemorrhage and peripheral chemoreceptor stimulation.
Multiple serotonin receptor subtypes are expressed in the NTS, but it is not
known which receptor subtype mediates compensatory responses during blood
loss. However, our prior studies found that systemic administration of the 5-HT1A
receptor agonist, 8-OH-DPAT, improves recovery from hypotensive hemorrhage
by stimulating sympathetically-mediated venoconstriction and CO. Thus, we
hypothesize that serotonin released in the NTS during hemorrhage activates 5HT1A receptors that facilitate sympathetic recovery. We utilized viral mediated
knockdown of the rat 5-HT1A receptor in the caudal NTS to examine the role of 5HT1A receptors on compensation following hemorrhage. Genes encoding a
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5-HT1A shRNA or scrambled version of the same sequence were incorporated
into adeno-associated viral (AAV) vectors and injected into the caudal NTS of
rats. Five weeks after viral injection, rats treated with the vector encoding the 5HT1A shRNA showed decreased recovery of renal sympathetic nerve activity
following hemorrhage compared to controls (-6.4 ± 12.9 vs. +42.6 ± 15.6% of
baseline, 30 min after start of hemorrhage, P<0.05). They also showed greater
lactate levels 60 min after the start of hemorrhage (2.77 ± 0.5 vs 1.34 ± 0.2
mmol/L, P<0.05). The 5-HT1A mRNA expression in the commissural NTS was
directly correlated with renal sympathetic nerve activity and inversely correlated
with lactate 50 minutes after hemorrhage termination (P< 0.01, P< 0.05
respectively). These data indicate that serotonin released in the caudal NTS
during hemorrhage activates 5-HT1A receptors to facilitate sympathetic-mediated
compensation and tissue perfusion following severe blood loss.

Introduction
Progressive blood loss elicits a complex, multiphasic response of the
autonomic nervous system, but the mechanisms that regulate these responses
remain ambiguous. Initially, blood pressure is maintained primarily through
sympathetically-mediated increases in vasoconstriction and tachycardia (Korner
et al., 1990; Schadt and Ludbrook, 1991). After significant blood loss, these
compensatory responses suddenly abate, resulting in a rapid and dramatic
decline in BP (Hasser and Schadt, 1992; Ludbrook and Ventura, 1996). As
blood loss continues, a secondary, sympathoexcitatory phase ensues, in which
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venoconstriction mobilizes blood pooled in the highly compliant venous
vasculature. The resulting increase in venous return increases CO and
maintains BP (Haljamae, 1984). This phase can only be temporarily sustained in
the absence of volume resuscitation and with continued blood loss, eventually
gives way to decompensation, characterized by a decline of sympathetic drive
and a more permeable and less responsive vasculature (Liu et al., 2003).
Elucidating the pathways that contribute to the secondary sympathoexcitatory
response to blood loss could lead to novel methods of therapy to manipulate and
prolong the sympathetically-mediated venoconstriction, and thereby slow the
progression to decompensation.
Serotonergic neurons in the caudal raphe of rats become activated during
blood loss (Kung et al., 2010). Selective lesion of those same serotonin neurons
results in attenuated sympathetic and ventilatory recovery following hypotensive
hemorrhage. Rats subjected to lesion of caudal raphe serotonin neurons also
develop greater metabolic acidosis with hemorrhage, despite having elevated
arterial blood oxygen and normal BP recovery (Kung et al., 2010). Together,
these data suggest that serotonin neurons in the caudal raphe are necessary for
normal compensation from blood loss, quite possibly by orchestrating a beneficial
hemodynamic pattern in which perfusion pressure recovers more by
venoconstriction and increased venous return rather than by arterial constriction
which may further exacerbate tissue hypoxia.
Caudal medullary serotonin neurons have numerous projections within the
medulla and brainstem, including the NTS (Schaffar et al., 1988). These
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projections densely innervate the medial and commissural subnuclei of the NTS,
where baroreceptor and peripheral chemoreceptor afferents terminate. We
found that lesion of the serotonin nerve terminals in the dorsomedial brainstem
(including the medial and commissural NTS) significantly impaired sympathetic
and ventilatory recovery from blood loss in conscious rats. The lesion also
attenuated ventilatory and sympathetic responses to peripheral chemoreflex
activation (Kung and Scrogin, 2011). Given the similar effects of caudal
serotonin cell body lesion and discrete lesion of serotonin nerve terminal lesion in
the dorsomedial brainstem in hemorrhaged animals, it is plausible that
endogenous serotonin acts in the NTS during hemorrhage to augment
sympathetic drive and ventilation, possibly by enhancing peripheral
chemoreceptor responsiveness.
It is not known which serotonergic receptor population mediates these
compensatory effects. A myriad of serotonin receptor subtypes are expressed in
the NTS including the 5-HT1A receptor (Edwards and Paton, 1999; Gustafson et
al., 1996; Leslie et al., 1990; Manaker and Verderame, 1990; Pompeiano et al.,
1994). Previous experiments have shown that the selective 5-HT1A receptor
agonist, 8-OH-DPAT, elicits a sympathetically mediated increase in BP when
administered centrally or systemically to conscious, hypovolemic rats (Scrogin,
2003). This pressor effect is due almost exclusively to an increase in venous
tone with virtually no effect on peripheral resistance (Tiniakov et al., 2007).
Furthermore, the sympathoexcitatory effect of 8-OH-DPAT is dependent on intact
sinoaortic nerve afferents which terminate in the medial and commissural
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subnuclei of the NTS (Osei-Owusu and Scrogin, 2006). Since, 8-OH-DPAT
appears to mimic the hemodynamically beneficial effects of endogenous
serotonin release during blood loss, we predicted that 5-HT1A receptor activation
in the NTS would be necessary for normal compensation from hypotensive
hemorrhage.
Therefore, in the current study we tested the hypothesis that 5-HT1A
receptors in the caudal NTS are necessary for normal recovery of sympathetic
activity following severe hemorrhage. Moreover, we determined whether 5-HT1A
receptor activation in the NTS contributes to peripheral tissue oxygenation.
Here we used an AAV vector to selectively reduce gene expression of the 5-HT1A
receptors within the NTS to test these hypotheses.

Methods
Short hairpin RNA sequence screening
Five short hairpin RNA (shRNA) sequences targeting various regions of
rat 5-HT1A receptor mRNA were cloned into a humanized Renilla reniformis
green fluorescent protein (hrGFP) expression vector (courtesy of Dr. Nichole
Dudek). The plasmid contained a mouse RNA polymerase III U6 promoter
upstream of the shRNA sequence, and a hrGFP marker gene driven by a
separate Cytomegalovirus (CMV) promoter. The 5 shRNA sequences and the
control shRNA sequence targeting the rat tryptophan hydroxylase 2 (TPH2) gene
are provided in Table 1.
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Table 1. shRNA sequences screened in HEK 293 cells.
shRNA
5-HT1A shRNA #1

Sequence 5’  3’
GTGAAAGGAAGACGGTGAA

5-HT1A shRNA #2

CCGAGTGGGCAACTCCAAA

5-HT1A shRNA #3

GCTCAATCCGGTTATTTAT

5-HT1A shRNA #4

GAGGTGCACCGAGTGGGCAACTCCAAAGA

5-HT1A shRNA #5

GGCTATCACCGACCCTAT

TPH2 shRNA

CCACCATTGTGACGCTGAA

The sequences for the 5 shRNA sequences targeting various portions of the rat
5-HT1A receptor (5-HT1A shRNA #1-5) and the control shRNA targeting the rat
TPH2 gene (TPH2shRNA).
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The full length rat 5-HT1A receptor gene (gift from Dr. Paul Albert) was cloned
into the mammalian expression vector mCherry-C1-I74T3 (donated by Dr. Roger
Y. Tsien) by Dr. Dudek to produce a rat 5-HT1A receptor mCherry fusion protein
(mCherry-5-HT1AR) that was used to examine efficiency of shRNA-mediated
knockdown.
Human embryonic kidney (HEK) 293 cells were grown at 37°C in
Dulbecco’s Modified Eagle Medium (DMEM; Hyclone™, ThermoScientific) with
high glucose (4.5g/L), L-Glutamine, and Sodium Pyruvate. Medium was
supplemented with 1.2g Sodium Bicarbonate, 1% nonessential amino acids, 10%
fetal bovine serum (FBS; Cellgro), 100 units/mL penicillin (Cellgro) and 100µg/ML
streptomycin (Cellgro) in the presence of 5% CO2. HEK 293 cells were grown in
six-well plates (9.6 cm2) to 80% confluency, then were co-transfected with 0.4µg
mCherry-5-HT1AR and 1.2 µg of the shRNA-hrGFP encoding plasmid using the
transfection reagent, TurboFect (ThermoScientific) according to manufacturer’s
guidelines. Three days post transfection, the efficacy of each shRNA sequence
was determined via fluorescent microscopy by comparing the intensity of red
fluorescence of cells treated with each shRNA sequence to fluorescence of cells
treated with a control shRNA vector. Fluorescence intensity was determined
using Image J software (NIH, USA). Afterwards, cells were lysed and harvested
in Trizol™ (Invitrogen).
5-HT1A receptor protein and mRNA expression were determined by
Western blot and semi-quantitative PCR respectively (methods described below).
The most efficient shRNA sequence and a scrambled version of the same
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sequence without homology to any known sequence in the rat genome were
incorporated into serotype 2/8 adeno-associated viral (AAV) vectors through an
outside vendor (Gene Transfer Vector Core, University of Iowa, USA).
Semi Quantitative Reverse Transcriptase-Polymerase Chain Reaction
Total RNA was isolated from transfected cell lysates (Trizol, Invitrogen)
and reverse transcribed into cDNA (First Strand cDNA Synthesis, Fermentas)
according to the manufacturer’s guidelines. Specific primers for GAPDH and 5HT1A receptor were used to amplify cDNA from extracted RNA (Table 2;
Integrated DNA Technologies). PCR reactions were prepared with PCR buffer,
200µM dNTPS, 1mM MgSO4, 1-4µL cDNA, 20µM forward primer, 20µM reverse
primers, 1U KOD Hot Start Polymerase then up to 50µL with PCR water
(Novagen). PCR cycling conditions for 5-HT1A receptor were as follows: 94°C for
1 min, followed by 30 cycles of 94°C for 15s/45° for 30 s/ 72°C for 45 s and a
final extension period of 10 min at 72°C. Similar PCR cycling conditions were
used for GAPDH: 94°C for 1 min, followed by 32 cycles of 94°C for 15s/58° for 30
s/ 72°C and a final extension at 72°C for 10 min. PCR products were run on a
1% agarose gel at 100 volts along with a 1Kbp DNA molecular weight marker
(GeneScript USA Inc). Images were acquired with a Kodak Image Station
4000mm Pro. Band density was calculated using Image J (NIH, USA) and
individual 5-HT1AR bands were normalized to the GAPDH band.
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Table 2. Reverse transcriptase PCR primers.
Gene
Symbol

T
(°C)

Cycle

Forward Primer (5’3’)
Reverse Primer (5’3’)

Size
(bp)

CAA GGT CAT CCA TGA CAA CTT TG
GAPDH

58

32

500
GTC CAC CAC CCT GTT GCT GTA G
TCC AGA ATG TGG CCA ACT AT

5-HT1A

45

30

510
CCT TCT TTT CCA CCT TCC TG

Forward and reverse primers specific for rat glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) and 5-HT1A receptor. Primer specific temperature
used for annealing phase of RT-PCR (T), number of cycles of PCR performed,
and product length are also shown.
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Immunoblotting
Total protein was extracted from transfected HEK 293 cell lysates
according to manufacturer’s guidelines (Trizol, Invitrogen). Protein concentration
was determined by BCA assay (Pierce) using bovine serum albumin (BSA) as
standard. Protein (10µg) was then separated by electrophoresis on a 10%
sodium dodecyl sulfate (SDS)-polyacrylamide gel for 1.5 hours at 150 volts, then
transferred to a nitrocellulose membrane (BioRad) for 2 hours at 100 volts. The
membrane was blocked in 5% nonfat dry milk and 0.1% Tween-20 in Trisbuffered saline (TBST) for 1 hour, prior to overnight incubation with a custom
rabbit anti-5-HT1A receptor antibody (1:10,000, Pacific Immunogical), or mouse
anti-actin (1:40,000, MP Biomedicals Inc.) in 1% nonfat dry milk at 4˚C.
Membranes were washed with TBST (3 times for 10 minutes) and incubated with
HRP-conjugated anti-mouse and anti-rabbit secondary antibodies (1:2000 and
1:5000 respectively, Pierce) for 1 hour at room temperature. The membrane was
washed a final time with TBST (3 times for 10 minutes) then protein bands were
developed with Super-Signal West Pico substrate (Themo) and exposed on
autoradiographic film. The band density was quantified with Image J (NIH, USA),
and normalized to actin.
Animals
Experiments were performed on 44 Male Sprague-Dawley rats (275 to
300 g; Harlan, Indianapolis, IN), which were acclimated to the institutional animal
facility under standard conditions (22°C ambient temperature, 12:12 hour light
cycle) with food and water available ad libitum for at least 1 week prior to
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surgery. All experimental protocols were approved by the Institutional Animal
Care and Use Committee and conducted in compliance with the Principles of
Laboratory Animal Care, as adopted and promulgated by the United States
National Institutes of Health.
Surgical procedures
AAV Vector injections
Prior to surgery, AAV vectors were diluted in viral storage buffer (400nM
NaCl, 20 mM Tris base) to 1x1012 vg/ml and dialyzed in 0.9% saline (Slide-aLyzer, ThermoScientific) according in manufacturer’s guidelines. Briefly, 10-25
µL of virus was dialyzed for 10-25 min in 500 mL 0.9% saline on ice. After
dialysis, heparin (1000 units/ml) was added in a 1:7 ratio (heparin: virus v/v) to
facilitate the initial internalization step of viral infection (Smith et al., 2004). Rats
were anesthetized with ketamine/xylazine (85/13mg/kg, im) and placed in a
stereotaxic apparatus with the nose bar positioned 11 mm below a flat skull
plane. Throughout the surgery, animals were monitored and supplemental doses
of ketamine (10 mg/supplemental injection, im) were administered as necessary
to maintain a surgical plane of anesthesia. The back of the skull was exposed
and a small portion of the occipital bone was removed in order to visualize the
dorsal surface of the brainstem at the level of calamus scriptorus. A glass
micropipette pulled to an outer diameter of 20-40 µm, was filled with virus
encoding the 5-HT1AR shRNA or scrambled version of the same sequence.
Using an oil pressure injection system, AAV vectors were infused bilaterally (750
nL/site) at a rate of 200 nL/min, 0.5 mm ventral to calamus scriptorus at two
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rostrocaudal planes along the NTS: +0.5 and 0 mm relative to calamus
scriptorus. Injections were made 0.7 mm lateral from the midline for the rostral
set of injections, and 0.25 mm lateral from the midline for the caudal set of
injections for a total of 4 injections targeting the commissural and medial NTS.
Prior to the injection, the glass pipette remained in the tissue for 5 minutes after
insertion to allow the tissue to equilibrate. Similarly, following each injection, the
injector remained in tissue for 5 minutes after infusion to ensure that the virus
had completely exited the injector tip before removal so as to avoid viral spread
to alternative brain regions dorsal to the injection site. Following injection, the
neck muscle and skin were closed in separate layers and rats were given
buprenorphine (50µg/kg, sc) every 8 hours, for 2 days post-surgery along with
ampicillin (150 mg/kg sc) twice per day for 3 days. Animals were then allowed to
recover for four weeks prior to hemorrhage experiments.
Vascular catheter and renal sympathetic recording electrode implantation
The day before hemorrhage experiments, rats were anesthetized with
isoflurane (5% for induction and 1.5-2.5% for maintenance) in 100% O2 (1L/min)
and instrumented with bilateral femoral arterial catheters (PE-50 fused with PE10 tubing) to enable simultaneous blood withdrawal and direct measurement of
arterial pressure. A third catheter was inserted in the femoral vein to enable
blood sampling for venous blood gas determinations and for systemic injections.
All catheters were externalized at the nape of the neck and secured with 3-0 silk
suture. After catheter implantation, a segment of the left renal sympathetic nerve
was isolated through a left flank incision. A fiber bundle was placed on a bipolar
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electrode made from Teflon-coated stainless steel (bare diameter = 0.005 in; A-M
Systems, Everett, WA) and isolated in Kwiksil silicon (World Precision
Instruments). The electrode lead wires were tunneled under the skin to exit at
the nape of the neck. Rats were given ampicillin (150 mg/kg sc) antibiotic and
ketoprofen (5mg/kg sc) for analgesia and allowed to recover overnight.
Experiments were conducted the day after surgery.
Experimental Protocols
Hypotensive hemorrhage
All rats were subjected to hypotensive hemorrhage conducted as
described previously (Kung and Scrogin, 2011). Briefly, arterial lines were
connected to a withdrawal pump and an arterial pressure transducer through an
overhead swivel system while the rats rested, unrestrained in their home cage.
The recording electrode and venous line were connected to appropriate sampling
lines through the same overhead swivel system. Rats were habituated for at
least one hour, after which blood withdrawal commenced at a rate of 3.2
mL/min/kg for 6 minutes, and then 0.52 mL/min/kg for an additional 4 minutes, to
provide a total withdrawal of 21% of estimated blood volume over 10 minutes.
Data acquisition began 20 minutes prior to the start of blood withdrawal and
continued throughout the course of hemorrhage and for an additional 50 minute
recovery period following termination of blood withdrawal. Femoral venous blood
samples (150 µL) were taken 20 minutes prior to hemorrhage, and 10 and 60
minutes after the start of blood withdrawal to measure hematocrit, venous blood
gases and acid-base status with an i-STAT 1 analyzer (i-STAT, East Windsor,
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NJ). Plasma protein concentrations were determined by a handheld clinical
refractometer (ATAGO U.S.A. Inc.). At the end of the experiment, rats were
given hexamethonium chloride (30 mg/kg iv) to block post-ganglionic sympathetic
activity and allow determination of background noise in the renal sympathetic
recording electrode. A subset of the rats were then quickly anesthetized with
sodium pentobarbital (100mg/kg, iv), and decapitated. Brains were quickly
extracted and flash frozen in cold isopentane and stored at -80°C for later qPCR
assessment of receptor gene expression. The remaining rats were anesthetized
with sodium pentobarbital (100mg/kg iv) then quickly perfused transcardially with
90 ml of sodium nitrate (0.1M) in 6.7 mM phosphate buffer followed by 90 ml 4%
paraformaldehyde in 0.1 M phosphate buffer saline (PBS). Brains were then
removed and post-fixed for 1 hour. The brainstem was blocked and post-fixed
overnight. The following day, brains were transferred to 30% sucrose solution
and stored at 4°C until sectioning. Brains were sectioned on a freezing
microtome in 40 µm sections and collected serially into 6 wells filled with
cryoprotectant (30% sucrose and 30% ethylene glycol in 0.1 M PB) and stored at
-20° until immunohistochemical analysis was performed.
Spontaneous baroreflex sensitivity
Five minute segments of baseline BP and HR data were recorded prior to
hemorrhage and analyzed with Nevrokard SA-BRS software version 3.2.4 to
determine spontaneous baroreflex gain using the sequence method (Padley et
al., 2005). Spontaneous baroreflex gain was determined as the average slope of
linear regressions obtained from at least 3 sequences. Sequences included in
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the analysis had to satisfy the following constraints: three or more consecutive
interbeat intervals (IBI) with variation in the same direction, >0.5 ms that
correlated (r2 > 0.85) with systolic, diastolic, or mean arterial BP variations of
>0.5 mmHg, with a three-beat delay. Parameters used to select sequences were
set based on evidence obtained from our prior work that they retrieved the most
sequences (Henze et al., 2008). A 128-point fast-Fourier transformation with a
smoothed Hamming window was used to conduct cross-spectral analysis on IBI
and BP. The relationship between IBI and BP variability was determined as the
square root of the ratio of IBI and BP power spectra, with 50% overlap and zero
padding of eight. Values were reported as the α-index in the low-frequency (LF,
0.06 – 0.6 Hz) and high-frequency (HF, 0.6- 3.0 Hz) domains (Pinna et al., 2002).
BP variability was determined in the time domain as the standard deviation of
systolic, mean, or diastolic BP. Blood pressure variability was also determined in
the LF domain. HR variability in the LF and HF domains was analyzed using the
IBI power spectra criteria described above (Kuwahara et al., 1994). Group
means for each variable were compared by Student’s t-test.
Data acquisition
Arterial pressure, HR, and renal sympathetic nerve activity (RSNA) were
recorded on a Macintosh G4 Powerbook with PowerLab data acquisition
software (Chart version 5.2.1; ADinstruments, Colorado Springs, CO). Arterial
pressure was measured with a disposable pressure transducer (Transpac IV;
Abbott Labs, North Chicago, IL) and a PowerLab bridge Amplifier
(ADinstruments). Heart rate was calculated using peak-to-peak detection of the
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pulse pressure wave. Sympathetic activity was sampled (4,000 Hz) and
amplified (10,000x) with a PowerLab Bioamplifier (ADinstruments). The raw
signal was filtered (1-1,000 Hz), rectified, and integrated over a 20-ms time
constant. Background noise, determined as the signal that remained after
hexmethonium chloride injection, was subtracted from all values. Only data from
recordings with a signal to noise ratio greater than 2:1 were included in the data
analysis.
Tissue Microdissection
Brains were transferred to a Leica CM 3050 S Cryostat (-15 to -17°C).
Five hundred µm thick sections were cut and 0.75 and 1 mm diameter
micropunches were taken from areas of interest determined using the stereotaxic
rat brain atlas of Paxinos and Watson (Watson, 1982). Bilateral punches were
taken from the commissural- and medial NTS (mNTS) as well as the hypoglossal
nucleus -14.3 to -13.8, -13.3 to -12.3, and -14.8 to -13.3 mm relative to Bregma
respectively. Micropunches from RO were obtained by two midline punches from
-13.3 to -11.3 mm from Bregma. Dorsal raphe samples were obtained from a
single punch -9.3mm to -6.8mm from Bregma. The tissue was homogenized
immediately in 1.0 mL TRIzol® Reagent (Invitrogen) using a glass mortar and
pestle on ice. Samples were transferred to microcentrifuge tubes for RNA
extraction.
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Tissue RNA Isolation and cDNA synthesis
Total RNA was extracted according to manufacturers’ protocols
(Invitrogen) with the addition of GlycoBlue™ Coprecipitant (15mg/mL) to facilitate
nucleic acid precipitation (Invitrogen). RNA purity and concentration were
assessed using a NanoDrop 8000 Spectrophotometer (Thermo Scientific).
Samples were treated with DNAse I enzyme (1U/1µg RNA) (Fermentas) to
remove remaining genomic DNA and cDNA was synthesized (First Strand cDNA
Synthesis Kit, Fermentas) according to the manufacturers’ instructions using 200
ng of total RNA from each sample. Each sample was processed in duplicate
except that the reverse transcription enzyme was omitted in one of the duplicates
as a negative control.
Quantitative Real-Time PCR
Messenger RNA levels of the target 5-HT1A receptor were determined
from tissue obtained from the virus injection site, i.e., mNTS and commissural
NTS, as well as the RO, which is the caudal raphe nucleus with the greatest
density of serotonergic projections to the NTS. This latter analysis was
performed in order to rule out the possibility that any observed physiological
effect of treatment was due to retrograde transport of virus and subsequent
knocked down of 5-HT1A autoreceptors. Samples of DR were also assessed as a
positive control for 5-HT1A gene expression. The α-adrenergic2A receptors
(αAR2A) were also assessed in mNTS and commissural NTS to assess potential
off target or compensatory effects of 1ARshRNA expression. Real-time
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quantitative PCR (qPCR) was performed on amplified cDNA using the CFX96
TouchTM Real-Time PCR Detection System (Bio-Rad). Template cDNA (2ng)
corresponding to the transcripts of interest were amplified using primers (500nM)
for both the sense and antisense strands. SsoAdvancedTM SYBR® Green
Supermix (2X) diluted to 1X with DEPC-treated water was added to all samples.
Samples were run in triplicate and in parallel with a negative control in which
water was substituted for template. The following general PCR protocol was
used with various annealing/extension temperatures: 95°C for 30 sec, 40 cycles
of 95°C for 5 sec and 56-63°C for 30 sec. Melt curves from 65°C to 95°C were
included to confirm that only a single product was formed for each primer pair.
CFX Manager Software was used to determine relative mRNA expression levels
using the 2-ΔΔCT method (Livak and Schmittgen, 2001). Results are presented as
relative mRNA expression normalized to relative GAPDH mRNA and compared
with average group values obtained from rats injected with the scrambled shRNA
that were run in the same cohort (defined as 1.0-fold). Forward and reverse
primers were screened and designed using http://bioinfo.ut.ee/primer3-0.4.0/ and
are shown in Table 3. The Basic Local Alignment Search Tool (BLAST) from the
NCBI website: (http://blast.ncbi.nlm.nih.gov/Blast.cgi?PROGRAM=blastn&
BLAST_PROGRAMS=megaBlast&PAGE_TYPE=BlastSearch) was applied to
ensure that all amplified sequences shared no sequence homology with any
other cDNA in the database. Efficiency of each primer pair was determined by
the slope of the standard curve and kept between 90 and 110%.
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Table 3. Primers for qPCR analysis.
T
(°C)

Primer
Efficiency
(%)

GAPDH

56/61

99/96

5-HT1A

56

89

ADR2A

63

98

Gene
Symbol

Forward Primer (5’ 3’)
Reverse Primer (5’ 3’)
GAC ATG CCG CCT GGA GAA AC
AGC CCA GGA TGC CCT TTA GT
AAG AAG AGC CTG AAC GGA
CAG AGG AAG GTG CTC TTT GG
CGG CAA TAG CAG CTG GAA CG
TTG CCA AAC ACG GTG AAC AG

Size
(bp)
94
171
129

Forward and reverse primers are shown for GAPDH, 5-HT1A (5-HT1A), and αadrenergic2A receptor (ARD2A). Annealing temperature (T), primer efficiency,
and product length are also shown.
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Immunohistochemistry
Serotonin immunoreactivity in caudal raphe nuclei was determined in a
subset of rats injected with AAV vectors to rule out an effect of infection of caudal
raphe serotonin cells with virus as a cause of observed physiological effects.
One out of every six 40 µm sections were washed with 0.05 M potassium
phosphate buffered saline (KBPS, 6 times for 10 minutes) then incubated in
rabbit anti-serotonin primary antibody (1:80,000 in 0.4% Triton X-100 in KBPS;
Immunostar) for one hour at room temperature followed by a 48 hour incubation
at 4°C. Sections were then washed with 0.05 M KPBS (10 times for 6 minutes)
then incubated in goat anti-rabbit Dylight-649 (1:500, Jackson ImmunoResearch)
for 3 hours at 37°C. Following secondary antibody incubation, sections were
washed a final time (10 times for 6 minutes), mounted on gelatin-coated slides,
and coverslipped using Fluromount mounting media (Sigma). Once
coverslipped, sections were immediately stored at 4° for 14 days prior to imaging.
Statistical Analysis
Two-way ANOVA with repeated measures were used to determine the
effects of viral injection on cardiovascular and sympathetic measures as well as
blood gas variables over time. Holm-Šidák post-hoc tests were used to
determine group differences at specific time points (i.e. every minute for the first
10 minutes, then every 5 minutes until the end of the recovery period). P values
of <0.05 were considered significant. Effect of viral injections on gene
expression was determined by unpaired Student’s t-tests. When group data
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failed the Shipiro-Wilk normality test, the Mann-Whitney U Rank Sum Test was
used instead. All qPCR results are expressed as the group mean ± SEM.
Results
shRNA screening
Images of mCherry and hrGFP positive HEK293 cells are shown after
transfection with 5 unique sequences targeting various portions of the rat 5-HT1A
receptor gene (1ARshRNA #1-5) or an shRNA sequence targeting the rat
tryptophan hydroxylase 2 gene (TPHshRNA) as a control (Figure 6). Of the 5
sequences screened, only 1ARshRNA #2 significantly decreased expression of
the 5-HT1A mCherry fusion protein as shown by reduced fluorescence intensity
compared to cells transfected with TPHshRNA control (P < 0.01).
Semi-quantitative PCR also showed a decrease in 5-HT1A receptor
message in cells transfected with 1AshRNA #2 (Figure 7A; P < 0.05). Our
custom designed polyclonal rabbit 5-HT1A rabbit antibody identified a ~46 Kd
protein that was present in HEK293 cells transfected with the full length rat 5HT1A receptor, but not in untransfected cells (Figure 7B). This size is consistent
with the expected size of the unmodified rat 5-HT1A receptor. Whole cell lysates
from cells transfected with the full length 5-HT1A receptor and 1AshRNA#2
showed almost no labeled protein of this size, while cells transfected with the
receptor and the shRNA sequence targeting TPH continued to express the
identified protein. 1AshRNA#2 produced a 97% knockdown of 5-HT1A receptor
protein compared to the TPHshRNA (P <0.01). Together, these experiments
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Figure 6. In vitro screening of shRNA sequences targeting the rat 5-HT1A
receptor. HEK-293 cells co-transfected with Cherry-5-HT1AR and one of 5
different 1ARshRNA sequences or a control sequence targeting the tryptophan
hydroxylase gene, TPHshRNA (left). Each sequence was compared to its own
separate control. Average fluorescent intensity (FI) of mCherry determined from
each plate are also shown (right). Independent experiments were repeated 3
times on separate occasions. Values are group means ± SEM. Student’s t-test
was used to analyze FI of ScramshRNA vs 1ARshRNA#1-5. Only 1ARshRNA
#2 had a significant reduction in FI compared to TPHshRNA [df = 4, t = 7.60, **P
<0.01]
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Figure 7. The 5-HT1A receptor shRNA #2 reduces 5-HT1A receptor mRNA
and protein expression in vitro. A) The cell lysates from HEK 293 cells
transfected with 1ARshRNA #2 and TPHshRNA were used to determine relative
5-HT1A R mRNA levels via semi-quantitative RT-PCR (normalized to GAPDH).
Representative blot of protein obtained from cells transfected with TPHshRNA
and 1ARshRNA #2 (left) and mean densitometry data of 5-HT1AR mRNA from 6
independent experiments (right), Student’s t-test was used to compare
TPHshRNA vs 1ARshRNA,*P<0.05. B) Immunoblot illustrating custom 5-HT1AR
antibody specificity in untransfected (UT) and transfected HEK-293 cells. C)
Representative immunoblot of 5-HT1AR protein levels in cells transfected with
1ARshRNA #2 or TPHshRNA transfected cells (top) and mean densitometry data
(bottom) of 5-HT1AR protein from 3 independent experiments which show
reduced 5-HT1AR protein expression in cells treated with 1ARshRNA #2 vs
TPHshRNA. Student’s t-test [df = 4, t = 4.71, **P <0.01].
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identified one shRNA vector (1ARshRNA #2) that was found to efficiently knock
down 5-HT1A receptor expression in cultured cells.
Four weeks after in vivo injection of viruses encoding hrGFP and the
efficient 1ARshRNA sequence or a scrambled version of the sequence, the
hrGFP transgene was highly expressed in the NTS of injected rats (Figures 8
and 9). Evidence of hrGFP expression in the caudal raphe regions was
identified, but was not extensive (Figure 9). However, there was no apparent
hrGFP expression in serotonin-positive cells of the caudal raphe region. Nor was
there hrGFP expression in or around the DR, an area enriched with 5-HT1A
receptor (data not shown). Approximately 50% and 30% reductions in 5HT1A
receptor mRNA levels were found in the commissural NTS and mNTS
respectively in rats injected with 1ARshRNA compared to ScramshRNA (Figure
10A-C, P < 0.01). The αAR2A receptor levels did not differ between groups in
either the commissural NTS or mNTS injection sites (Figure 10D).

Effects of 5-HT1A receptor knockdown on cardiovascular variables
during hypotensive hemorrhage
Treatment had no effect on body weight (358 ± 5 vs. 368 ± 5 g for
ScramshRNA and 1ARshRNA respectively) prior to the start of hemorrhage. All
rats subjected to acute hypovolemic hemorrhage showed a characteristic
multiphasic response to blood withdrawal (Figures 11 and 12). Specifically, both
groups displayed a short normotensive phase characterized by augmented
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Figure 8. AAV injection sites. A) Schematic, modified from from
Mitchell et al. 1975, shows dorsal view of the rat brain stem modified with
numbers to indicate location of injection sites of AAV. B) Location of
injection sites relative to calamus scriptorus (top), and schematic, modified
from Scott et al, 2000, showing coronal brainstem sections and location of
injection in medial NTS (middle panel) and commissural NTS (lower
panel). C) Fluorescent micrographs demonstrating neuronal infection
(hrGFP expression) in rats injected with AAVs encoding either the
scrambled shRNA (left) or an shRNA targeting the rat 5-HT1A receptor
(right). mNTS, medial NTS; cNTS, commissural NTS; AP, area postrema;
DMVX, dorsal motor nucleus of the vagus; XII, hypoglossal nucleus.
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Figure 9. Representative coronal rat brain sections after
immunohistochemical label of serotonin. Green fluorescence indicates
hrGFP expression or AAV infection and red fluorescence represents serotonin
(5-HT) expression. Cells infected with virus encoding the ScramshRNA or the
1ARshRNA were surrounded by 5-HT-positive nerve terminals in the
commissural NTS (left panels). 5-HT immunoreactive cells of the RO (center
panels) and those of the RM (right panels) were not infected with virus.
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Figure 10. 5-HT1A receptor shRNA selectively and discretely reduces
relative 5-HT1A receptor gene expression at the target site in vivo.
Representative qPCR amplification curves for ScramshRNA (blue) and
1ARshRNA (red) samples from RO (A) and commissural NTS (cNTS, B) show
knockdown in cNTS but not RO. C) Relative 5-HT1AR mRNA levels were
normalized to GAPDH and calcuated as fold change from the average 5-HT1AR
expression of the corresponding brain regions in the rats injected with
ScramshRNA. Values are group means ± SEM. Student’s t-test was used to
assess differences in 5-HT1A receptor mRNA levels between ScramshRNA vs
1ARshRNA in different brain regions. 5-HT1A receptor expression was
significantly decreased in the commissural NTS [df = 17, t = 6.66, P < 0.01] and
mNTS [df = 17, t = 4.71, P < 0.01], but not in the hypoglossal nucleus [df = 16, t =
0.60, P = 0.56], RO [df = 15, t = 1.23, P = 0.24] or DR [df = 13, t = 0.29, P =
0.78]. D) Relative mRNA expression of αAR2A receptor in cNTS and mNTS.
Values are group means ± SEM. Mann-Whitney U and Student’s t-test revealed
no significant differences on the relative αAR2A receptor population in the cNTS
[U = 22, t = 62, p = 0.54] and mNTS [df = 13, t = - 1.04, p = 0.32] respectively in
1ARshRNA vs ScramshRNA rats.
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Figure 11. Representative sample recordings during hypotensive
hemorrhage in ScramshRNA- and 1ARshRNA-injected rats. Representative
sample recordings (2.5 seconds) of arterial pressure (AP), raw renal sympathetic
nerve activity (RSNA) and integrated activity (int. RSNA) in individual
ScramshRNA (A) and 1ARshRNA injected rats (B). Data are shown prior to
hemorrhage (baseline), 3 minutes after start of hemorrhage (peak
compensation), and 8, 20 and 60 minutes after start of hemorrhage, and after
injection with the ganglionic blocker hexamethonium chloride (Hex).
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Figure 12. Mean arterial pressure (MAP), heart rate (HR) and renal
sympathetic nerve activity (RSNA) during hemorrhage and subsequent
recovery in ScramshRNA- and 1ARshRNA-injected rats. The MA, HR and
RSNA during hemorrhage (gray shaded area) and subsequent recovery in rats
injected with AAV encoding ScramshRNA or 1ARshRNA. Values are group
means ± SEM. Number of subjects for ScramshRNA were 8 for RSNA and 16
for MAP and HR measurements respectively. Group number for rats treated with
1ARshRNA were 6 for RSNA and 15 for MAP and HR respectively.
Two-way ANOVA with repeated measures that examined the effect of ShRNA
treatment and Time on cardiovascular variables revealed an interaction between
ShRNA treatment and Time [F (1,144) = 3.06, P < 0.001] on RSNA responses.
Post-hoc Holm-Sidak analyses performed at each time point revealed a
significant reduction of RSNA among 1AshRNA-treated rats compared to
ScramshRNA-treated controls throughout recovery, but not during hemorrhage
itself. *P <0.05 and ** P< 0.01 vs. ScramshRNA treated rats.

98
sympathetic activity and reflex tachycardia. After withdrawal of approximately 912 ml/kg of estimated blood volume, a rapid decline in BP, HR, and RSNA
developed in both groups. After termination of blood withdrawal, BP and HR
recovered over the next 10-15 minutes before reaching a plateau. Treatment
with the 1ARshRNA did not affect either baseline BP or HR, or the response to,
and subsequent recovery from blood withdrawal (Figure 11). Among animals
treated with the ScramshRNA, RSNA recovered following termination of blood
withdrawal in parallel with BP and HR. The RSNA of rats treated with
ScramshRNA exceeded baseline levels and stabilized at a plateau approximately
40-50% above baseline. In contrast, RSNA of rats treated with 1ARshRNA did
not fully return to baseline levels and stabilized at levels approximately 20%
below baseline for the remainder of the experiment. Rats treated with the
1ARshRNA had reduced RSNA (relative to their own baseline) compared to rats
treated with the ScramshRNA during recovery (P<0.01).
Spontaneous baroreflex activity did not differ between the two treatment
groups (Table 4). Similarly, hematocrit and protein plasma levels were
comparable between groups throughout the experiment (Table 5). Lactate levels
were significantly elevated in the 1ARshRNA group compared to the
ScramshRNA group 60 minutes after the start of hemorrhage (Figure 13, P
<0.01), but there were no further differences in the acid-base balance or blood
gas variables between groups (Table 6).
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Table 4. Spontaneous baroreflex sensitivity data from baseline recordings in 1ARshRNA and
ScramshRNA injected rats
Up
Sequences
(ms/mmHg)

Down
Sequences
(ms/mmHg)

All
Sequences
(ms/mmHg)

Alpha
(LF)

Alpha
(HF)

LF Power
(mmHg2)

BP SDNN

SBP

1.89 ± 0.32

1.49 ± 0.21

1.76 ± 0.26

0.83 ± 0.10

1.98 ± 0.37

13.95 ± 1.54

4.54 ± 0.47

MBP

2.18 ± 0.32

2.06 ± 0.26

2.13 ± 0.27

0.90 ± 0.11

2.36 ± 0.38

11.88 ± 1.07

4.21 ± 0.43

DBP

2.30 ± 0.28

1.93 ± 0.25

2.13 ± 0.25

0.91 ± 0.12

2.20 ± 0.30

11.29 ± 0.68

4.21 ± 0.40

SBP

2.28 ± 0.18

1.88 ± 0.62

2.55 ± 0.14

0.61 ± 0.04

2.87 ± 0.51

13.55 ± 2.52

4.33 ± 0.48

MBP

2.54 ± 0.13

2.46 ± 0.22

2.20 ± 0.32

0.65 ± 0.06

3.18 ± 0.39

11.84 ± 2.02

4.09 ± 0.42

DBP

2.56 ± 0.15

2.03 ± 0.11

2.25 ± 0.10

0.67 ± 0.06

2.67 ± 0.29

11.29 ± 1.88

4.09 ± 0.40

shRNA
treatment

LF RRI
(nu)

HF RRI
(nu)

LF - to - HF
ratio

43.22 ± 5.42

41.76 ± 4.82

1.35 ± 0.32

27.71 ± 6.50

57.76 ± 7.50

0.65 ± 0.28

Scram (10)

1AR (6)

Spectral analyses were performed in the low frequency (LF) and high frequency (HF) domains. Number of
animals is shown in parentheses. Systolic (SBP), mean (MBP), and diastolic (DBP) blood pressure. Data are
group means ± SEM. Student’s t-test were used to compare group means for ScramshRNA and 1ARshRNA
treated groups. No significant differences were identified.
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Table 5. Hematocrit and plasma protein concentrations before and after
hypotensive hemorrhage in ScramshRNA and 1ARshRNA rats

n
SCRshRNA 11
0 min
10 min
60 min
1ARshRNA 11
0 min
10 min
60 min

Hematocrit
(%)

Plasma Protein
(g/dL)

43 ± 1
33 ± 1**
33 ± 1**

6.3 ± 0.15
4.7 ± 0.1**
4.9 ± 0.1**

41 ± 2
31 ± 2**
30 ± 2**

6.2 ± 0.1
4.6 ± 0.1**
4.9 ± 0.1**

Values are group means ± SEM. Two-way ANOVA with repeated measures
were used to examine the effect of ShRNA treatment and Time on hematocrit
and protein plasma. No interactions were found. The main effect of Time were
followed up by Holm-Šidák post-hoc analysis. Both plasma protein
concentrations [F (2,21) = 246, P<0.001] and hematocrit levels [F (2, 21) = 531,
P < 0.01] fell by 10 minutes after start of hemorrhage and both remained below
baseline by 60 minutes after start of hemorrhage **P < 0.01 vs 0 minutes within
group.
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Table 6. Effects of hemorrhage on venous blood gas variables and acidbase status in ScramshRNA- and 1ArshRNA-injected rats

pH

pCO2
(mmHg)

0 min

7.49 ± 0.01

43.31 ± 0.44

34.85 ± 1.58

10.00 ± 0.66

10 min

7.44 ± 0.01*

42.35 ± 0.82

26.62 ± 1.38*

4.46 ± 0.55*

60 min

7.46 ± 0.01**,†

46.19 ± 0.54**,‡

31.69 ± 1.14*,‡

9.00 ± 0.78**,‡

0 min

7.50 ± 0.01

42.52 ± 0.66

34.85 ± 1.49

10.08 ± 0.70

10 min

7.44 ± 0.01*

41.89 ± 0.96

27.92 ± 1.14*

4.08 ± 1.06*

60 min

7.45 ± 0.01**,†

46.40 ± 0.76**,‡

31.85 ± 1.64*,‡

8.00 ± 1.12**,‡

n
SCRshRNA

1ARshRNA

pO2

(mmHg)

BE
(mmol/L)

13

13

Values are group means ± SEM. Two-way ANOVA with repeated measures
were used to compare ShRNA Treatment and Time on blood gas variables and
acid-base status. There were no group differences observed at any time point.
Main effects of Time only on pH [F (2, 25) = 57.91, P< 0.001], pCO2 [F (2,25) =
36.33, P < 0.001], pO2 [F (2,25) = 19.88, P < 0.001] and BE [F (2,25) = 121.82, P
< 0.001] were all due to reductions in all variables with hemorrhage and/or
subsequent recovery by 60 min. The main effects of Time were followed up by
post-hoc analysis using Holm-Šidák, * P < 0.05 vs 0 min within group, ** P < 0.01
vs 0 min within group, † P < 0.05 vs 10 min, and ‡ P < 0.01 vs 10 min within
group.
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Figure 13. Lactate levels at baseline, after hemorrhage termination and
recovery. Data were analyzed by 2-way ANOVA with ShRNA treatment and
repeated measures of Time as factors. There were significant effects of shRNA
treatment [F (1,25) = 5.16, P< 0.05] due to higher lactate levels overall in
1ARshRNA treated rats. A main effect of Time [F (2,25) = 62.1, P < 0.01] was
due to the rise in lactate with hemorrhage, and the subsequent fall with recovery.
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5-HT1A receptor knockdown correlates with sympathetic recovery
and acid-base status following hypotensive hemorrhage
5-HT1A mRNA expression in 1ARshRNA-treated rats ranged from 20-80%
of levels found in rats treated with ScramshRNA. To determine if the degree of
5-HT1A receptor knockdown was related to sympathetic compensation from
hemorrhage, RSNA and lactate levels determined 60 min after the start of
hemorrhage were correlated with 5-HT1A mRNA gene expression. Significant
positive correlations between 5-HT1A receptor mRNA and RSNA in both
commissural NTS and mNTS injection sites were observed (Figure 14A;
Spearman coefficient = 0.90 and 0.79, r2 = 0.82 and 0.63, P < 0.01). Lactate was
negatively correlated with 5-HT1A receptor mRNA in the commissural NTS, but
not in the mNTS (Figure 14B; Spearman coefficient -0.82 vs -0.23, r2 = 0.67 vs
0.05, P= 0.01 vs P= 0.42).

Discussion
In the present study, we investigated the role of 5-HT1A receptor
expression in the commissural NTS and mNTS on compensation from
hypotensive hemorrhage in unanesthetized rats. We found that rats with 30-50%
knockdown of 5-HT1A receptors in the commissural NTS and mNTS showed an
attenuated recovery of sympathetic activity following a moderate level and rate of
blood loss (~21% of estimated blood volume over 10 minutes), but showed no
differences in BP or HR responses to hemorrhage. The extent of 5-HT1A
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Figure 14. Relationship of 5-HT1A receptor mRNA levels in the
commissural NTS to sympathetic recovery and and lactate levels. 5-HT1A
receptor gene expression in the commissural NTS is directly related to
sympathetic recovery and inversely related to lactate levels. A) A Spearman
correlation between relative 5-HT1A receptor mRNA expression and RSNA 60
min after the start of hemorrhage in commissural NTS (cNTS; left) and mNTS
(right). B) Spearman correlation data between the relative mRNA levels of 5HT1AR and lactate production 60 minutes after the start of hemorrhage in the
cNTS (left) and mNTS (right).
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receptor knockdown was also related to the level of lactic acidosis and RSNA
activity 50 minutes after termination of hemorrhage. This relationship was most
robust when receptor expression in the more caudal commissural subnucleus of
the NTS was examined. Together, the data indicate that sufficient expression of
5-HT1A receptors in the commissural NTS is necessary for normal sympathetic
compensation following moderate blood loss, and that this receptor population
contributes to oxygen delivery to peripheral tissue during compensation from
hypotensive hemorrhage.
These results extend our previous findings that selective destruction of the
serotonin neurons in the caudal raphe attenuates sympathetic recovery following
hypotensive hemorrhage and exaggerates metabolic acidosis. Such lesions
reduced serotonin innervation of the caudal NTS by 50% and the RVLM by
almost 90%. Despite the use of the same protocol for hemorrhage, the caudal
raphe lesioned animals from the prior study showed more severe lactic acidosis
as well as reduced arterial blood pH. In contrast, animals subjected to 5-HT1A
receptor knockdown in the current study did not show significant deficits in pH
buffering. Clinical evidence indicates that pH does not correlate with lactate until
lactate values exceed 5.0 mM, as was seen in the caudal raphe lesion study
(Mizock and Falk, 1992). It is not known why the animals in this experiment
experienced less severe tissue hypoxia than in our prior study given that the
blood withdrawal protocols were the same. However, in the prior study, animals
were also implanted with diaphragmatic EMG electrodes, which required a more
invasive surgical procedure that could have potentially affected ventilation,
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possibly resulting in an impaired buffering through expiration of CO 2.
Nevertheless, lactate is the first and best indication of deficits in tissue perfusion,
and the present data indicate that 5-HT1A receptors in the NTS contribute to
neural responses that facilitate tissue perfusion following hemorrhage.
Alternatively, the greater metabolic acidosis seen with caudal raphe
serotonin cell lesion may indicate that serotonin acting on additional receptor
populations beyond the 5-HT1A receptors of the NTS may also contribute to
sympathetic-dependent changes in tissue perfusion. A more recent study from
our laboratory would suggest that this is not likely the case since discrete lesion
of serotonin nerve terminals in the caudal NTS also attenuates sympathetic
recovery to the same extent found in the present study. However, blood gases
and acid base balance were not examined in the NTS lesion study.
Rats injected with 1ARshRNA displayed the normal, multi-phasic
response to blood loss, suggesting that 5-HT1A receptors in the NTS are probably
not involved in the initial sympathoexcitatory response or in the sympatholytic
phase of hypotensive hemorrhage. Rather, 5-HT1A receptor activation in the NTS
appears to be necessary for normal secondary sympathoexcitatory
compensation from blood loss. The presence of exaggerated lactic acidosis
during this secondary sympathoexcitatory phase in 1ARshRNA-treated rats
indicates that a deficit in oxygen delivery to peripheral tissue developed following
termination of blood withdrawal in these animals. Furthermore, the correlation of
lactic acid as well as sympathetic recovery with the extent of 5-HT1A receptor
knockdown suggests that sympathetic drive aids in peripheral tissue
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oxygenation. Reduced oxygen delivery results from reduced oxygen in arterial
blood and/or deficits in perfusion of peripheral tissue. In this study, we did not
measure arterial blood gases. However, in the caudal serotonin cell lesion study
PaO2 was actually increased in lesioned animals, indicating that peripheral tissue
hypoxia observed in this prior study was due to reduced perfusion rather than to
a deficit in blood oxygenation. Here, we focused on blood gases measured in
venous blood since they better reflect peripheral metabolic acidosis. No group
differences were found in either PvO2 or PvCO2 at any point, suggesting that
arterial blood oxygen may have been similar between groups during and after
hemorrhage. While we cannot rule out the possibility that tissue O2 extraction
differed between groups and thus that PaO2 differed between groups, given our
prior results that extensive caudal serotonin cell lesion did not impair blood
oxygenation, it seems more likely that the greater tissue hypoxia observed in
1ARshRNA-treated rats was due to reduced perfusion of peripheral tissue.
Our findings that BP responses were not different between groups despite
evidence of perfusion deficits suggests that serotonin acts on 5-HT1A receptors in
the NTS to maintain CO. In the absence of these mechanisms, other potentially
more damaging mechanisms of vasoconstriction may contribute to the
maintenance of the BP. Toung et al, performed elegant studies that examined
the degree to which circulating vasoconstrictor hormones and sympathetic
activity contribute to arterial and venous constriction during blood loss. They
noted that sympathetic activity contributes substantially more to venous
constriction, while increases in angiotensin II and vasopressin contribute to BP

108
maintenance primarily by increasing arterial vasoconstriction (Toung et al.,
2000). Together, these data suggest that endogenous serotonin released during
hemorrhage acts on 5-HT1A receptors in the NTS to maintain CO through
increased venoconstriction; this hypothesis remains to be tested. Nevertheless,
this hypothesis is further supported by our prior studies which showed that
administration of the 5-HT1A receptor agonist, 8-OH-DPAT, into the 4th
cerebroventricle of unanesthetized rats increased venous tone, CO and indices
of tissue oxygenation. Moreover, these effects were found to be dependent upon
sympathetic activity.
It is unclear how 5-HT1A receptors in the caudal NTS contribute to
sympathoexcitation following hemorrhage. The decrease in 5-HT1A receptor
mRNA levels had no effect on any index of spontaneous arterial baroreflex
sensitivity. Therefore, it is unlikely that deficits in baroreflex sensitivity
contributed to the attenuated sympathetic response in 1ARshRNA-treated rats
during hemorrhage. Indeed, our prior study showed that serotonin nerve terminal
lesion actually improved baroreflex sensitivity. The current study further extends
these earlier findings by demonstrating that the enhanced baroreflex sensitivity
that accompanies deficits in serotonin innervation of the dorsomedial portion of
the caudal brainstem are likely not due to deficits in 5-HT1A receptor activation.
Of interest were findings that the 5-HT1A receptor gene expression in the
commissural NTS correlated better with lactate levels or sympathetic recovery 50
minutes after termination of hemorrhage than did receptor expression in the
mNTS. The commissural NTS receives a far greater density of nerve terminals
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from peripheral chemoreceptors than the medial NTS, which itself receives more
arterial baroreceptor terminals than the commissural NTS (Finley and Katz, 1992;
Housley et al., 1987; Mifflin, 1992). Our prior work showed that the
sympathoexcitatory effect of 5-HT1A receptor agonist administration in
hemorrhaged animals was severely attenuated following sinoaortic denervation,
indicating that 5-HT1A receptor-mediated increases in sympathetic activity after
hemorrhage are dependent on arterial baroreceptors and/or peripheral
chemoreceptor input (Osei-Owusu and Scrogin, 2006). Together, these findings
are highly suggestive of the possibility that 5-HT1A receptors facilitate peripheral
chemoreceptor afferent activation of sympathetic drive during hemorrhage.
A limitation of this study is the possibility that our results are due to
unintentional effects of viral injection due either to down regulation of 5-HT1A
receptor populations remote from the site of injection or by altering gene
expression of entirely different receptors that could influence sympathetic drive
during hemorrhage. Post-mortem assessments of 5-HT1A receptor gene
expression confirmed that knockdown of the receptor was localized to the
injection sites. We did not observe significant reductions in gene expression
ventral to the injection site in the hypoglossal nucleus. Nor did we observe
decreases in 5-HT1A receptor gene expression in sites remote from the injection
that are enriched in 5-HT1A receptor such as the DR. We also assessed the
possibility that retrograde transport of the virus and subsequent expression of the
shRNA in serotonin cells that project to the NTS from the RO and RM might have
contributed to deficits in compensation during hemorrhage by reducing
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expression of 5-HT1A autoreceptors. While we noted some hrGFP expression
around the serotoninergic cells of the RO and RM, we did not see co-localization
of hrGFP and serotonin label in either of these regions. Furthermore, 5-HT1A
receptor gene expression in the RO, which provides the densest serotonergic
projections to the caudal NTS, was not affected by 1ARshRNA treatment.
We also explored the possibility that the attenuated sympathetic recovery
exhibited by rats injected with virus encoding the 1ARshRNA was due to
compensatory gene expression of other receptors within the NTS. Previous
investigations have found that αAR2A receptors in the caudal NTS facilitate
central integration of the peripheral chemoreflex (Hayward, 2001). Therefore, we
examined gene expression of the rat αAR2A in the NTS and found no effect of
treatment.
Results from this first study were incorporated into a working model that
illustrates the major findings of Aim 1 (Figure 15). In summary, results from the
current study identified a role for 5-HT1A receptor activation in the sympathetic
recovery that follows hypotensive hemorrhage. Additionally, we found that 5HT1A receptor activation in the caudal NTS facilitates peripheral tissue perfusion.
Although the mechanism by which 5-HT1A receptor activation promotes recovery
from blood loss remains unknown, it is recognized that activation of 5-HT1A
receptors hyperpolarizes neurons. Thus 5-HT1A receptor activation may disinhibit
neurons that normally suppress recovery of sympathetic drive during
compensation from hypotensive hemorrhage. We speculate that as blood loss
progresses, serotonin is released in the NTS where it activates 5-HT1A receptors,
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which in turn, disinhibit inhibitory interneurons that suppress sympathetic drive to
the venous vasculature that mobilizes blood stores. The precise mechanism(s)
that stimulate serotonin release in the NTS remain unknown.
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Figure 15. Diagram of 5-HT1A receptor activation during hypotensive
hemorrhage. Results from Aim 1 identified a role for 5-HT1A receptor activation
in the sympathetic recovery from hemorrhage and facilitates peripheral tissue
oxygenation. Since activation of 5-HT1A receptors produces hyperpolarization of
neurons, it is plausible that 5-HT1A receptor activation may disinhibit GABA
neurons that normally suppress recovery of sympathetic drive during
compensation from hypotensive hemorrhage. Therefore, during blood loss
serotonin is released in the NTS where it activates 5-HT1A receptors, which in
turn, disinhibit GABA interneurons that suppress sympathetic. The precise
mechanism(s) that stimulate serotonin release in the NTS remain unknown.

CHAPTER IV
5-HT1A RECEPTORS IN THE NUCLEUS TRACTUS SOLITARIUS ARE
RESPONSIBLE, IN PART, FOR THE SYMPATHOEXCITATORY AND
PRESSOR EFFECTS OF 8-OH-DPAT ADMINISTRATION DURING
HYPOTENSIVE HEMORRHAGE

Abstract
In prior work outside of this dissertation, we demonstrated that
administration of the full 5-HT1A receptor agonist, 8-OH-DPAT, promotes a
sympathetically-mediated increase in BP in rats subjected to hypotensive
hemorrhage or more severe hemorrhagic shock. The sympathoexcitatory effect
of 8-OH-DPAT was found to be more pronounced when the drug was
administered centrally into the 4th cerebroventricle and was dependent upon
intact sinoaortic nerve innervation. Arterial baroreceptors and peripheral
chemoreceptor afferents of the sinoaortic nerves innervate the dorsomedial
brainstem in the caudal NTS near the site where 8-OH-DPAT was found to have
the most pronounced hemodynamic effects. These findings led us to
hypothesize that 8-OH-DPAT activates 5-HT1A receptors located in the caudal
NTS to mediate its BP and sympathoexcitatory effects in hypovolemic rats. In
this study, we injected the 5-HT1A shRNA AAV or the scrambled AAV control
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virus into the caudal NTS of male Sprague Dawley rats to test this hypothesis.
After 4 weeks, rats treated with the 1ARshRNA-encoding AAV showed a slowed
pressor response to 8-OH-DPAT compared to rats injected with virus encoding
the scrambled shRNA (68 ± 4 vs 87 ± 3 mmHg, 10 min after start of hemorrhage,
P<0.01). 5-HT1A receptor gene expression in the commissural NTS, but not the
medial NTS or underlying hypoglossal nucleus, was inversely correlated with the
latency of BP to recover to 75% of baseline after 8-OH-DPAT injection.
Successful knockdown of the 5HT1A receptor also attenuated the
sympathoexcitatory effect of 8-OH-DPAT (-41.6 ± 13.6 vs 77.1 ± 22.0 % of
baseline, 1 minute after 8-OH-DPAT administration, P < 0.05). The
sympathoexcitatory response to 8-OH-DPAT was directly correlated with 5-HT1A
receptor expression in the NTS (P < 0.05). Together, these data indicate that the
pressor and sympathoexcitatory effects of 8-OH-DPAT administration observed
in hypovolemic rats are due, at least in part, to activation of 5-HT1A receptors in
the caudal NTS.

Introduction
Previous studies from our laboratory have identified a role for 5-HT1A
receptor agonists to facilitate compensation from blood loss. As detailed in
Chapter 2, the administration of 5-HT1A receptor agonists, including the full
agonist, 8-OH-DPAT, produces a hemodynamically favorable outcome when
administered to rats during hypotensive hemorrhage. Moreover, the
sympathoexcitatory and pressor effects of 8-OH-DPAT are reversed by
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administration of 5-HT1A receptor antagonist, WAY-100635 (Scrogin, 2003;
Scrogin et al., 2000).
Subsequent studies utilizing a more severe hemorrhagic shock model
(~50% estimated blood volume) showed that 8-OH-DPAT increased venous tone
(as measured by mean circulatory filling pressure [MCFP]) and venous return,
and reversed lactic acidosis in unanesthetized rats (Tiniakov et al., 2007;
Tiniakov and Scrogin, 2006). Increases in BP following 8-OH-DPAT
administration were due almost exclusively to an increase in CO, with virtually no
effect on TPR. From these studies we concluded that 8-OH-DPAT promotes
sympathetic drive to preferentially augment venoconstriction and mobilize venous
blood back to the heart, and thereby improve tissue perfusion. Mobilization of
venous blood stores during hemorrhage is primarily mediated by the vascular
beds of the splanchnic region (Greenway and Lister, 1974; Reilly et al., 2001).
Accordingly, the rise in MCFP mediated by 8-OH-DPAT is abolished by
sympathetic denervation of the splanchnic vasculature, as is the protective effect
of 8-OH-DPAT against lactic acidosis (Tiniakov et al., 2012).
Prior work also suggests that 8-OH-DPAT accelerates recovery from
hemorrhage by an agonist action on 5-HT1A receptors. In these studies, the
selective 5-HT1A receptor antagonist, WAY-100635, given prior to hemorrhage,
dose-dependently inhibited the ability of 8-OH-DPAT to slow the hypotensive and
sympatholytic response to blood loss. However, WAY-100635 and 8-OH-DPAT
have both been shown to possess affinity for other receptor types including
AR2A receptors (Bonaventure et al., 2004; Sprouse et al., 2004). The AR2A
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receptors located in the caudal NTS have been implicated in sympathetic and
ventilatory responses to chemoreflex activation by chemical hypoxia (Hayward,
2001). A more rostral AR2A receptor population located in the RVLM is also
known to inhibit sympathetic activity by suppression of bulbospinal barosensitive
neurons (Allen and Guyenet, 1993; Hayar and Guyenet, 1999). 8-OH-DPAT also
has significant agonist activity on 5-HT7 receptors which are also expressed in
the NTS (Gustafson et al., 1996; Sprouse et al., 2004; To et al., 1995).
Therefore, it is conceivable that 8-OH-DPAT mediates its actions during
hemorrhage through either an agonist or antagonist effect on 5-HT7 or AR2A
receptors.
It is not clear where in the brainstem 8-OH-DPAT mediates its
sympathoexcitatory effects in hemorrhaged animals. Our prior work showed that
8-OH-DPAT produced the most robust compensatory effects when injected into
the cisterna magna, just above the floor of the 4 th ventricle where the dorsal
surface of the caudal NTS is located (Scrogin, 2003). Evidence that the caudal
NTS receives sinoaortic afferent input and that severing these same afferents
attenuates the sympathetic and BP effects of 8-OH-DPAT led us to speculate
that 8-OH-DPAT might act within the NTS to mediate its beneficial effects in
hypovolemic animals. Moreover, our prior work suggests that endogenous
serotonin, released during hemorrhage, also contributes to sympathetic
compensation following hemorrhage in a manner parallel to that of 8-OH-DPAT
(Kung et al., 2010). Our evidence that serotonin nerve terminal lesion in the NTS
had the opposite effect of 8-OH-DPAT (i.e., delayed sympathetic recovery) led us
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to further speculate that both endogenous serotonin and 8-OH-DPAT act on the
same receptor population to mediate their effects (Kung and Scrogin, 2011).
Therefore, we proposed that 8-OH-DPAT acts on 5-HT1A receptors in the caudal
NTS to mediate its pressor and sympathoexcitatory effects during hypotensive
hemorrhage.
In unpublished studies, we noted that 8-OH-DPAT did not affect BP in
hemorrhaged rats under any anesthesia so far tested including: urethane, chloralose, isoflurane, sodium pentobarbital, ketamine, chloral hydrate or
thiobarbital. The mechanisms behind the insensitivity to 8-OH-DPAT in
anesthetized rats is unclear. Nevertheless this anesthetic effect has complicated
efforts to identify the specific brain region where 8-OH-DPAT mediates its action,
particularly since the caudal hindbrain is difficult to access by chronic
cannulation. This complication, together with the evidence that 8-OH-DPAT has
affinity for several different receptor subtypes led us to utilize highly specific
shRNA knockdown technology as an approach to determine the location and
receptor population on which 8-OH-DPAT acts to mediate its effects. Here, we
utilized AAV delivery of the 5-HT1A shRNA to selectively and discretely reduce 5HT1A receptor expression in the caudal NTS in order to determine whether 8-OHDPAT acts on the 5-HT1A receptors to mediate its pressor and sympathetic
effects in unanesthetized hemorrhaged rats.
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Methods
Animals
Experiments were performed on 27 Male Sprague-Dawley rats (275 to
300 g; Harlan, Indianapolis, IN) which were acclimated to the institutional animal
facility under standard conditions (22°C ambient temperature, 12:12 hour light
cycle) with food and water available ad libitum for at least 1 week prior to
surgery. All experimental protocols were approved by the Institutional Animal
Care and Use Committee and conducted in compliance with the Principles of
Laboratory Animal Care, as adopted and promulgated by the United States
National Institutes of Health.
Surgical procedures
AAV injections
Prior to surgery, AAV vectors were diluted in viral storage buffer [400nM
NaCl, 20 mM Tris base, (1x1012 vg/ml)] and dialyzed in 0.9% saline (Slide-aLyzer, ThermoScientific) as described in Chapter 3. Rats were anesthetized with
ketamine/xylazine (85/13mg/kg, im) and placed in a stereotaxic apparatus with
the nose bar positioned 11 mm below a flat skull plane then AAV vectors were
injected as described previously in Chapter 3. Animals were then allowed to
recover for four weeks prior to hemorrhage experiments.
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Vascular catheter and renal sympathetic recording electrode implantation
The day before hemorrhage experiments, rats were anesthetized with
isoflurane (5% for induction and 1.5-2.5% for maintenance) in 100% O2 (1L min-1)
and instrumented with catheters and a renal sympathetic recording electrode as
described in Chapter 3. The electrode lead wires were tunneled under the skin
to exit at the nape of the neck. Rats were given ampicillin (150 mg/kg sc)
antibiotic and ketoprofen (5 mg/kg sc) for analgesia and allowed to recover
overnight. Experiments were conducted the day after surgery.
Experimental Protocols
Hypotensive hemorrhage
All rats were subjected to hypotensive hemorrhage conducted as
described previously (Kung and Scrogin, 2011) and in detail in Chapter 3 with
modifications described below. Briefly, arterial lines (PE-50 tubing fused with
PE-10) were connected to a withdrawal pump and an arterial pressure
transducer through an overhead swivel system while the unrestrained rats rested
in their home cage. The recording electrode and venous line were connected to
appropriate lead wires and tubing through the same overhead swivel system.
Rats were habituated for at least one hour, after which blood withdrawal
commenced at a rate of 3.2 mL/min/kg for 6 minutes, and then 0.52 mL/min/kg
for an additional 4 minutes, to provide a total withdrawal of 21% of estimated
blood volume over 10 minutes. Precisely 7 minutes after the start of
hemorrhage, 8-OH-DPAT was administered (30 nMoles/kg, iv) followed by a 150
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µL bolus of isotonic saline. Data acquisition began 20 minutes prior to the start
of blood withdrawal and continued throughout the course of hemorrhage and for
an additional 50 minute recovery period following termination of blood
withdrawal. In a subset of rats, femoral venous blood samples (150 µL) were
taken 20 minutes prior to hemorrhage, as well as 10 and 60 minutes after the
start of blood withdrawal to measure hematocrit, venous blood gases and acidbase status with an i-STAT 1 Analyzer (i-STAT, East Windsor, NJ). Plasma
protein concentrations were determined by a handheld clinical refractometer
(ATAGO U.S.A. Inc.). At the end of the experiment, rats were given
hexamethonium chloride (30 mg/kg iv) to enable determination of background
noise in the renal sympathetic recording electrode. The majority of animals were
quickly anesthetized with sodium pentobarbital (100 mg/kg, iv), and decapitated.
Their brains were quickly extracted and flash frozen in cold isopentane and
stored at -80°C for qPCR assessment of receptor gene expression. A small
subset of animals were anesthetized with sodium pentobarbital (100 mg/kg iv)
then quickly perfused transcardially with 90 ml of sodium nitrate (0.1M) in 6.7 mM
phosphate buffer followed by 90 ml 4% paraformaldehyde in 0.1 M phosphate
buffer (PB). Brains were then removed and post-fixed for 1 hour. The brainstem
was blocked and post-fixed overnight. The following day, brains were transferred
to 30% sucrose solution and stored at 4°C until sectioning. Brains were
sectioned on a freezing microtome in 40 µm sections and collected serially into 6
wells filled with cryoprotectant (30% sucrose and 30% ethylene glycol in 0.1 M
PB) and stored at -20° prior to histological assessment of the injection sites.
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Spontaneous baroreflex sensitivity
Five minute segments of baseline BP and HR data were recorded prior to
hemorrhage and analyzed with Nevrokard SA-BRS software version 3.2.4 to
determine spontaneous baroreflex gain using the sequence method as described
in Chapter 3.
Data acquisition
Arterial pressure, HR, and renal sympathetic nerve activity (RSNA) were
recorded on a Macintosh G4 Powerbook with PowerLab data acquisition
software (Chart version 5.2.1; ADinstruments, Colorado Springs, CO) and
analyzed as described in Chapter 3.
Tissue Microdissection
Brains were transferred to a Leica CM 3050 S Cryostat (-15 to -17°C).
Five hundred µm thick sections were cut and 0.75 and 1 mm diameter
micropunches were taken from areas of interest (listed below) localized
according to the stereotaxic rat brain atlas of Paxinos and Watson as described
in Chapter 3 (Watson, 1982). The tissue was homogenized immediately in 1.0
mL TRIzol® Reagent (Invitrogen) using a glass mortar and pestle on ice.
Samples were transferred to microcentrifuge tubes for RNA extraction.
Tissue homogenization and immunoblotting
Total protein was extracted from a subset of micropunch samples using a
homogenizing buffer that consisted of 50 mM Tris buffer (pH 7.6) with sodium
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chloride (0.01 M) and the addition of a proteinase inhibitor cocktail (Roche).
Protein concentration from the micropunch samples was determined by BCA
assay (Pierce) as described in Chapter 3. Immunoblotting protocols were also
performed in the same manner as described in Chapter 3. In addition, hrGFP
protein expression was also determined in micropunch samples by incubating the
membranes overnight with a mouse anti-hrGFP antibody (1:500, Assay Designs)
in 1% nonfat dry milk at 4˚C. Membranes were then incubated with HRPconjugated anti-mouse secondary antibody (1:2000, Pierce) for 1 hour at room
temperature. The membrane was washed a final time with TBST (3 times for 10
minutes) then protein bands were developed with Super-Signal West Pico
substrate (Themo) and exposed on autoradiographic film. The band densities of
5-HT1A receptor and hrGFP were quantified with Image J (NIH, USA), and
normalized to actin.
Tissue RNA Isolation and cDNA synthesis
Total RNA was extracted, genomic DNA removed, and then synthesized
into cDNA according to protocols described in Chapter 3.
Quantitative Real-Time PCR
Messenger RNA levels of the 5-HT1A receptor were determined from
tissue obtained from the commissural NTS, mNTS, RO, hypoglossal nucleus,
and DR as described in Chapter 3. The 5-HT7 receptor and αAR2A receptors
were also assessed in mNTS and commissural NTS to rule out off target, or
compensatory effects of shRNA treatment. Real-time qPCR was performed on
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amplified cDNA using the CFX96 TouchTM Real-Time PCR Detection System
(Bio-Rad). The following general PCR protocol was used with various
annealing/extension temperatures: 95°C for 30 sec, 40 cycles of 95°C for 5 sec
and 56-63°C for 30 sec. Melt curves from 65°C to 95°C were included to confirm
that only a single product was formed for each primer pair. Samples were
prepared and analyzed as described in Chapter 3. Primer sequences used for
amplification and annealing temperatures for each gene are listed in Table 7.
Results are presented as relative mRNA expression normalized to relative
GAPDH mRNA.
Statistical Analysis
Two-way ANOVA with repeated measures were used to determine the
effects of viral injection on cardiovascular and sympathetic measures as well as
and on blood gas parameters over time. Holm-Šidák post-hoc tests were used to
determine group differences every minute for the first 10 minutes, then every 5
minutes until the end of the recovery period. P values of < 0.05 were considered
significant. PCR data from rats treated with the 1ARshRNA-encoding virus were
normalized to the group average of rats injected with the ScramshRNA that were
in the same qPCR cohort. Typically, two animals of each shRNA group were run
in the same cohort. Significance was determined by unpaired Student’s t-tests.
When group data failed the Shipiro-Wilk normality test, the Mann-Whitney Rank
Sum Test was used instead. All qPCR results are expressed as the group mean
± SEM.
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Table 7. PCR conditions for 8-OH-DPAT-treated rats

Gene
Symbol

T
(°C)

Primer
Efficiency
(%)

GAPDH

56/61

99/96

5-HT1A

56

89

5-HT7

61

100

ADR2A

63

98

Forward Primer (5’ 3’)
Reverse Primer (5’ 3’)
GAC ATG CCG CCT GGA GAA AC
AGC CCA GGA TGC CCT TTA GT
AAG AAG AGC CTG AAC GGA
CAG AGG AAG GTG CTC TTT GG
GTG GAT CTT CGG CCA CTT CT
CCA AGG TAC CTG TCG ATG
CTG
CGG CAA TAG CAG CTG GAA CG
TTG CCA AAC ACG GTG AAC AG

Size
(bp)
94
171
108
129

Primers for qPCR analysis. Forward and reverse primers are shown for GAPDH,
5-HT1A, 5-HT2A receptor (5-HT2A), 5-HT7 receptor (5-HT7) and α-adrenergic2A
receptor (ARD2A). Annealing temperature (T), primer efficiency, and product
length are also shown
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Results
Prior to the start of hemorrhage experiments, there was no significant
difference in body weights between ScramshRNA and 1ARshRNA injected rats
(Table 8). Similarly, hematocrit and plasma protein values were not significantly
different between groups. Nor did indices of spontaneous baroreflex sensitivity
differ between groups (Table 9). Both groups displayed the typical multiphasic
response to blood loss (Figure 16). Specifically, BP was maintained with the
onset of blood withdrawal while sympathetic drive and HR increased. After 9-12
ml/kg of estimated blood volume had been withdrawn, a syncopal-like phase
ensued, characterized by a dramatic decline in BP, HR, and RSNA. Seven
minutes after the initiation of blood withdrawal, systemic administration of 8-OHDPAT (30 nM/kg, iv) produced a pressor effect in both treatment groups, but the
effect was more pronounced in the ScramshRNA-treated rats compared to rats
treated with the 1ARshRNA-encoding virus (P <0.01). Specifically, the BP
response to 8-OH-DPAT was slower the first 3 minutes after injection in
1ARshRNA-treated rats compared to ScramshRNA animals. However, BP in
both groups eventually plateaued to a level that was no longer different. 8-OHDPAT raised HR in both groups as well. While, the response was attenuated in
rats treated with 1ARshRNA, the difference was not significant (P = 0.09). Renal
sympathetic nerve activity rose dramatically after 8-OH-DPAT in rats treated with
the ScramshRNA. Though the response tended to be less robust in rats treated
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Table 8. Body weight and blood volume indices for 8-OH-DPAT-treated rats
N
SCRshRNA
0 min
10 min
60 min
1ARshRNA
0 min
10 min
60 min

Hemorrhage
BW (g)

Hematocrit
Plasma
(%)
Protein (g/dL)

(3-12)
383 ± 9

45 ± 1
35 ± 2**
34 ± 1**

6.0 ± 0.1
4.8 ± 0.1**
4.8 ± 0.1**

43 ± 1

6.1 ± 0.1

(4-13)
387 ± 7

1**

4.7 ± 0.1**

33± 1**

4.9 ± 0.1**

34 ±

Body weight (BW), hematocrit, and plasma protein levels before (0 min) after
hemorrhage termination and 8-OH-DPAT injection (10 min) and 50 min after
termination of hemorrhage (60 min) in rats treated with the scrambled shRNA
encoding virus (ScramshRNA) or the 1ARshRNA-encoding virus. The number of
ScramshRNA and 1ARshRNA per group are 12 and 13 respectively for BW
measurements and 3 and 4 respectively for hematocrit and protein samples.
Values are group means ± SEM. A 2-way ANOVA with repeated measures was
used to examine the factors of Treatment and Time over the course of
hemorrhage on hematocrit and protein plasma concentrations. No interaction
was found, but a main effect of Time in both groups was followed up by HolmSidak post-hoc analysis. Both plasma protein concentrations [F (1,6) = 108, P <
0.001] and hematocrit levels [F (1,6) = 156, P <0.001] fell by 10 minutes after the
start of hemorrhage and both remained below baseline at the end of the recovery
period, ** P < 0.01 vs 0 minutes within group.
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Table 9. Spontaneous baroreflex indices in 8-OH-DPAT-treated rats
Up
Sequences
(ms/mmHg)

Down
Sequences
(ms/mmHg)

All
Sequences
(ms/mmHg)

Alpha
(LF)

Alpha
(HF)

LF Power
(mmHg2)

BP SDNN

SBP

1.56 ± 0.18

1.44 ± 0.18

1.52 ± 0.17

0.48 ± 0.07

1.83 ± 0.36

21.08 ± 5.36

4.28 ± 0.43

MBP

1.74 ± 0.17

1.69 ± 0.18

1.72 ± 0.17

0.50 ± 0.07

2.31 ± 0.40

22.16 ± 5.84

3.63 ± 0.18

DBP

1.81 ± 0.22

1.70 ± 0.19

1.75 ± 0.21

0.51 ± 0.07

2.08 ± 0.31

22.53 ± 5.90

3.43 ± 0.10

SBP

1.89 ± 0.19

1.73 ± 0.27

1.87 ± 0.23

0.54 ± 0.09

2.21 ± 0.37

22.04 ± 6.90

3.76 ± 0.29

MBP

2.23 ± 0.19

2.31 ± 0.31

2.28 ± 0.26

0.56 ± 0.09

3.12 ± 0.30

22.56 ± 7.43

3.49 ± 0.28

DBP

2.02 ± 0.14

1.88 ± 0.13

1.99 ± 0.11

0.56 ± 0.09

2.73 ± 0.21

22.54 ± 7.46

3.46 ± 0.28

LF RRI
(nu)

HF RRI
(nu)

LF/HF

17.89 ± 2.95

46.61 ± 7.31

0.47 ± 0.11

16.65 ± 3.45

46.82 ± 7.60

0.44 ± 0.10

ScramshRNA
(7)

1ARshRNA
(9)

Spontaneous baroreflex sensitivity (SBS) determined from baseline BP and HR recordings in rats treated with virus
encoding the 1ARshRNA or ScramshRNAs. Spectral analyses were performed in the low frequency (LF) and high
frequency (HF) domains. SDNN, standard deviation of normal beats; RRI, R-R interval (detected as peak to peak BP);
nu, normalized units. Number of animals is shown in parentheses. Systolic (SBP), mean (MBP), and diastolic (DBP)
blood pressure. Data are group means ± SEM. Student’s t-test were used to compare group means for ScramshRNA
and 1ARshRNA treated groups. No significant differences were identified.
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Figure 16. Effect of ScramshRNA and 1ARshRNA expression in the NTS on
cardiovascular responses to 8-OH-DPAT in hemorrhaged rats. Mean arterial
pressure (MAP), heart rate (HR), and renal sympathetic nerve activity (RSNA)
during hemorrhage (shaded in gray), and subsequent recovery following 8-OHDPAT administration (indicated by arrow) of ScramshRNA (black circles) and
1ARshRNA (open circles) injected rats. Values are group means ± SEM.
Number of subjects for ScramshRNA were 5 for RSNA and 11 for BP and HR
recordings. The 1ARshRNA subject number was 6 for RNSA and 13 for BP and
HR measurements. Data were analyzed by 2-way ANOVA with repeated
measures using ShRNA treatment and Time as factors. A significant interaction
between ShRNA treatment and Time on BP during the first 10 minutes of
hemorrhage was revealed [F (1, 207), = 2.44, P < 0.01]. Post-hoc analysis with
Holm-Šidák performed at each time point showed a lower BP in 1ARshRNA
treated rats immediately following 8-OH-DPAT administration.
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with the 1ARshRNA-encoding virus, the group difference was not significant at
any time point when all animals were included in the analysis (P = 0.27).
In the small subset of animals tested (n = 6), there was no effect of shRNA
treatment on acid-base balance or lactic acidosis with hemorrhage (Table 10).
However, a 2-way ANOVA with repeated measures using Treatment and Time
as factors revealed a significant interaction on PvO2. Post-hoc analysis revealed
that 1ARshRNA-treated rats had significantly decreased PvO2 immediately after
8-OH-DPAT administration (10 min time point).
In most subjects, viral transduction was considered successful as
determined by the presence of hrGFP fluorescence in neurons of the caudal NTS
when tissue was saved for histological analysis, or by evidence of hrGFP mRNA
expression in micropunch samples. Since, hrGFP expression was driven by a
different promoter than the shRNA expression, hrGFP expression was not used
for normalization of shRNA expression. Instead, it was used as a qualitative
measure to determine success or failure of viral transduction. In a subset of
animals in which we collected brains for histological examination, we observed
rare occasions of off target hrGFP expression in which the center of the injection
site was not located within the NTS, but instead, was identified more ventrally
within the hypoglossal nucleus (Figure 17A vs. B). On rare occasions we noted a
complete lack of hrGFP expression in neurons (Figure 17C). Instead, significant
gliosis with some hrGFP expression limited almost exclusively to glia was
observed. Also, in one 1ARshRNA-treated rat, we failed to observe any hrGFP
expression in any tissue samples. In some animals, brain tissue was used for
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Table 10. Venous blood gas and acid-base status for 8-OH-DPAT-treated rats
N

ScramshRNA
0 min
10 min
60 min
1ARshRNA
0 min
10 min
60 min

pH

pvCO2
(mmHg)

pvO2
(mmHg)

BE
(mmol/L)

Lactate
(mmol/L)

7.50 ± 0.01
7.48 ± 0.02
7.47 ± 0.02†

43.47 ± 0.99
41.17 ± 1.23
46.87 ± 1.24†,#

36.67 ± 2.19
35.33 ± 0.88
32.33 ± 1.67

11.33 ± 1.86
8.67 ± 2.19‡
9.00 ± 0.58†

0.71 ± 0.14
1.86 ± 0.41‡
1.05 ± 0.18†,§

7.52 ± 0.01
7.48 ± 0.01
7.47 ± 0.01†

43.16 ± 0.46
40.88 ± 1.95
46.84± 1.53†,#

32.60 ± 1.83
30.20 ± 1.63*
33.80± 0.74

11.8 ± 0.74
7.00 ± 0.89‡
10.00± 1.30†

0.56 ± 0.05
2.63 ± 0.41‡
1.62 ± 0.12†,§

(3)

(5)

Effects of hemorrhage and 8-OH-DPAT administration on venous blood gas variables and acid-base status for rats
treated with virus encoding the scrambled shRNA (ScramshRNA) or the 1ARshRNA. Values are group means ± SEM at
baseline (0 minutes), 10 and 60 minutes after the start of hemorrhage. A 2-way ANOVA with repeated measures was
utilized to examine the factors of Treatment and Time on blood gas variables and acid-base status. A significant
interaction was found between Treatment and Time on p vO2 [F (1,2) = 4.03, P < 0.05]. Post-hoc analysis by Holm-Šidák
revealed a significantly reduction in pvO2 among 1ARshRNA injected rats compared to rats treated with the ScramshRNA
10 minutes after the start of hemorrhage, but not at baseline or the end of the recovery period (60 minutes), * P < 0.05 vs
ScramshRNA. There were no other significant interactions, but a main effect of Time was found for all parameters due to
reductions in all variables with hemorrhage and/or subsequent recovery by 60 minutes. †P < 0.05 vs 0 minutes within
group, ‡P < 0.01 vs 0 minutes within group, §P < 0.05 vs 10 minutes within group, and #P < 0.01 vs 10 minutes within
group.
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Figure 17. Coronal rat brain sections demonstrating variations in hrGFP
expression in AAV-treated rats. A) Successful injection centered in the NTS,
B) off target injection centered in the hypoglossal nucleus. C) Absence of
neuronal expression of hrGFP expression with significant gliosis and glial hrGFP
expression (magnified inset).
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Western blot analysis of 5-HT1A receptor expression. However, the lack of
specificity of the 5-HT1A antibody in tissue prevented us from making
determinations of 5-HT1A receptor protein levels. However, hrGFP expression
could be confirmed in these samples by Western blot. In some cases there was
insufficient tissue for gene expression studies after failed attempts at Western
blot determination of 5-HT1A receptor protein. Therefore, confirmation of the
degree of knockdown was not possible in some regions of a subset of animals.
Among those animals for which gene expression data were obtained, 5HT1A receptor mRNA levels were decreased in 1ARshRNA-treated rats by ~50%
in the commissural NTS (Figure 18). Transduction in the mNTS was more
variable and achieved only a modest (~20%) reduction in 5-HT1A receptor gene
expression. Average receptor expression in the hypoglossal nucleus was also
reduced by approximately 20% in 1ARshRNA-treated rats, but overall the
expression was not different from ScramshRNA-treated rats (Figure 18C).
There was no effect of treatment with the 1ARshRNA-encoding virus on 5-HT1A
receptor mRNA levels in the RO or DR.
Latency to recover 75% of baseline BP was inversely correlated with 5HT1A receptor expression in both the commissural NTS and mNTS injection sites
(Figure 18A and B; Spearman coefficient = - 0.81 and - 0.56, r2 = - 0.66 and 0.31, P < 0.01 and P < 0.05 respectively). Despite the tendency for reduced 5HT1A receptor expression in the hypoglossal nucleus of 1ARshRNA-injected rats,
relative 5-HT1A receptor expression in the hypoglossal nucleus did not correlate
with the time to recover 75% of baseline BP (Figure 18D; Spearman coefficient
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Figure 18. Relationship of 5-HT1A receptor mRNA levels and latency to
recover 75% of baseline blood pressure after hypotensive hemorrhage.
Relative 5-HT1A receptor mRNA levels correlations with time to recover 75% of
baseline blood pressure. A) Spearman correlation of 5-HT1A receptor mRNA
levels in commissural (A) and mNTS (B) and time to recover 75% of baseline
blood pressure following 8-OH-DPAT injection. C) Relative 5-HT1A receptor
expression in the cNTS, mNTS, hypoglossal nucleus, RO, and DR of
ScramshRNA and 1ARshRNA- injected rats. D) Correlation between relative 5HT1A receptor expression in hypoglossal nucleus and time to recover 75% of
baseline BP. Values are group means ± SEM. An unpaired Student’s t-test
revealed a significant decrease in 5-HT1A receptor expression in the cNTS of
1ARshRNA injected rats [df = 12, t = 2.52, P < 0.05] but not in the mNTS
injection sites (df = 15, t = 1.50, P = 0.15), hypoglossal nucleus (df = 13, t = 1.94,
P = 0.07), RO (df = 11, t = - 0.23, P = 0.82) or DR (df = 12, t = - 0.41, P = 0.69).
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-0.31, r2 = -0.10, P = 0.317). Though fewer samples were available for rats that
had adequate renal sympathetic recordings, there was a clear direct correlation
between the 8-OH-DPAT-induced rise in RSNA (one minute after injection) and
5-HT1A receptor expression in the mNTS. Likewise, there was a tendency for the
sympathoexcitatory effect of 8-OH-DPAT administration to correlate with 5-HT1A
receptor expression in the commissural NTS (Figure 19; Pearson correlation
coefficient = 0.728, r2 = 0.57, P < 0.05 and 0.74, r2 = 0.55, P = 0.057). Neither
expression of 5-HT7 receptors nor AR2A was affected by 1ARshRNA treatment
(Figure 20).
Given the apparent lack of viral transduction of the NTS in a subset of
animals, cardiovascular parameters were reanalyzed after exclusion of two
1ARshRNA-treated animals that showed no evidence of hrGFP within the NTS.
Among animals that showed significant infection within either the commissural or
mNTS, there still was a clear deficit in 8-OH-DPAT-induced pressor responses (P
< 0.01). When the two 1ARshRNA-injected rats that did not demonstrate viral
infection within the NTS were excluded, a clear group difference emerged in the
sympathoexcitatory effect of 8-OH-DPAT administration (Figure 21; P < 0.05).

Discussion
Transduction with a 1ARshRNA-encoding AAV produced a selective 2050% knockdown of 5-HT1A receptors in the commissural and mNTS and impaired
the sympathoexcitatory and pressor effect of 8-OH-DPAT in unanesthetized rats
subjected to hypotensive hemorrhage. Additionally, the speed at which 8-OH-
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Figure 19. Relative 5-HT7 and αAR2A expression in commissural NTS and
mNTS of rats injected with ScramshRNA or 1ARshRNA. Values are group
means ± SEM. Unpaired Student’s t-test revealed no significant effect of shRNA
treatment on 5-HT7 and αAR2A receptor mRNA levels.
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Figure 20. Relationship of 5-HT1A receptor mRNA levels in the commissural
and mNTS to RSNA one minute after 8-OH-DPAT administration. A Pearson
correlation of 5-HT1A receptor mRNA levels in the commissural (left) and mNTS
(right) and RSNA 1 minute after 8-OH-DPAT administration.
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Figure 21. Effect of ScramshRNA and 1ARshRNA on responses to
hemorrhage after exclusion of unsuccessfully transduced rats. Mean
arterial pressure (MAP), heart rate (HR), and renal sympathetic nerve activity
(RSNA) during hemorrhage (shaded in gray), and subsequent recovery following
8-OH-DPAT administration (indicated by arrow) of ScramshRNA and
1ARshRNA- injected rats when data from 2 rats that showed no sign of viral
infection in the NTS were excluded. Values are group means ± SEM. Number of
subjects for ScramshRNA were 5 for RSNA and 11 for BP and HR recordings.
The 1ARshRNA subject number were 4 for RNSA and 11 for BP and HR
measurements. Data were analyzed by 2-way ANOVA with repeated measures
using Time and ShRNA treatment as factors. Significant interactions were
followed by Holm-Šidák post-hoc analysis. A 2-way ANOVA revealed a
significant interaction between ShRNA treatment and Time due to a reduction in
the initial pressor response to 8-OHDPAT in 1ARshRNA-injected rats [F (1,200)
= 2.88, P < 0.01]. Similarly, a significant interaction between ShRNA treatment
and Time was also seen on RSNA [F (1, 70) = 3.00, P < 0.05] due to the lack of a
sympathoexcitatory effect of 8-OH-DPAT in 1ARshRNA-treated rats. There were
main effects of ShRNA treatment [F (1,20) = 4.60, P < 0.05) and Time [F (10,20)
= 39.24, P < 0.01] on HR. The effect of treatment was due to lower HR in
1ARshRNA-treated rats, but group differences were not significant at any one
time point.
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DPAT promoted BP compensation was inversely correlated with 5-HT1A receptor
mRNA levels in the NTS, particularly in the commissural NTS. Moreover, the
sympathoexcitatory effect of 8-OH-DPAT administration was significantly
correlated with the expression of 5-HT1A receptors in the NTS. Thus, the major
findings of this study are that the sympathoexcitatory and pressor effects of 8OH-DPAT are, at least in part, mediated by 5-HT1A receptors expressed in the
caudal NTS.
These findings extend our previous work by demonstrating that at least part
of the effect of 8-OH-DPAT is due to a specific action of the drug on 5-HT1A
receptors, most likely within the commissural NTS. In prior work we noted that
the pressor effect of 8-OH-DPAT was prevented by prior administration of the α1
adrenergic receptor (αAR1) antagonist, prazosin (25μg/kg, iv) and the ganglionic
blocker, hexamethonium chloride (30mg/kg, iv). Hexamethonium alone only
partially blocked the 8-OH-DPAT-mediated rise in BP (Tiniakov and Scrogin,
2006). Together, these findings indicate that 8-OH-DPAT has dual effects when
administered to hypovolemic rats. Specifically, 8-OH-DPAT has a direct
vasoconstrictor effect on the peripheral vasculature mediated by αAR 1 receptors
as well as a central sympathoexcitatory effect. Our findings that knockdown of 5HT1A receptors in the NTS partially blocked the pressor response but completely
blocked the immediate sympathetic response are consistent with a direct effect of
8-OH-DPAT on the vasculature. Indeed, this direct pressor effect might be
expected to further inhibit sympathetic drive in the absence of a 5-HT1A-mediated
sympathoexciatory effect due to baroreceptor activation.
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Prior efforts to identify the specific receptor population on which 8-OHDPAT acts to mediate its ability to accelerate recovery from hypotensive
hemorrhage have been limited by the lack of highly selective 5-HT1A agonists
and antagonists. The most selective of the 5-HT1A antagonists, WAY-100635,
has approximately 300 nM affinity for αAR2A receptors (Martin et al., 1999).
Moreover, αAR2A receptors are also located in the NTS, and prior work suggests
that 8-OH-DPAT has affinity for these receptors as well (Bonaventure et al.,
2004; Kubo et al., 1990; Kubo et al., 1987). More recent data also suggests that
WAY-100635 has significant affinity for dopamine receptors which are also
thought to mediate BP responses within the NTS (Chemel et al., 2006; Granata,
1982; Hyde et al., 1996; Kline et al., 2002). Thus, our prior work in which WAY100635 was found to block the effects of 8-OH-DPAT did not completely exclude
the possibility that 8-OH-DPAT acted on these alternative receptor populations to
mediate its effects.
Another difficulty in identifying this receptor population lies in the inability to
observe an effect of 8-OH-DPAT during hemorrhage in the anesthetized animal.
Thus, a pharmacological approach for identifying the precise location would
involve insertion of a chronic guide cannula and subsequent injection of drug
during hypotensive hemorrhage in unanesthetized animals. The NTS is located
on the dorsal surface of the brainstem just above the cervical vertebrae (Berger,
1979; Ciriello, 1983; Torvik, 1956). Thus, the precise location of a guide cannula
would require placement in region that is subject to significant movement during
flexion of the neck and increase the potential for lesion of the brainstem.
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Moreover, relatively high concentrations of antagonist are typically used for
localized in vivo brain injection in order to ensure sufficient receptor occupancy
by drug. However, several alternative receptors for which 8-OH-DPAT has
affinity are located within the NTS, making pharmacological methods
problematic.
The use of the shRNA AAV delivery system in the current study solves both
problems by ensuring that the effects of 8-OH-DPAT are mediated specifically by
the 5-HT1A receptor. Moreover, this system induces chronic down regulation of
receptors which enabled us to examine responses to 8-OH-DPAT in
unanesthetized animals. Nevertheless, the limitation of this approach is the
possibility that changes in gene expression of the target gene may interfere with
the expression of other genes that may alter the cardiovascular effects during
hemorrhage. While we cannot rule out the possibility that non-specific effects on
other proteins contributed to our results, we can rule out off-target effects of other
likely candidates. We chose to examine the 5-HT7 and αAR2A receptors. 8-OHDPAT has very high affinity for the 5-HT7 receptor, and expression of the 5-HT7
receptor has been identified in the dorsal midline brainstem (Bonaventure et al.,
2004). Furthermore, the 5-HT7 receptors expressed in the brainstem have been
shown to augment cardiac vagal activity (Kellett et al., 2005). However, a role for
5-HT7 receptors to modulate cardiovascular responses to hemorrhage have not
been investigated. Our data illustrates that reduced 5-HT1A receptor mRNA
levels did not affect 5-HT7 receptor expression in the caudal NTS, suggesting
that the reduced sympathoexcitatory and pressor effects of 8-OH-DPAT during
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recovery from blood loss are not due to off-target effects of 1ARshRNA on 5-HT7
receptors. Likewise, we investigated the effect on αAR2A receptors since
antagonists of these receptors have significant sympathoexcitatory effects when
injected in the RVLM, and are known to facilitate chemoreflex responses in the
NTS (Allen and Guyenet, 1993; Hayar and Guyenet, 1999; Hayward, 2001). But
again, our studies suggest that alterations in expression of these receptors are
likely not responsible for the attenuated pressor and sympathoexcitatory effects
of 8-OH-DPAT seen in 1ARshRNA-injected rats.
Our prior studies also showed that 8-OH-DPAT improved acid-base balance
and reduced lactic acidosis in rats subjected to hypovolemic shock in which
approximately 50% of blood volume was withdrawn (Tiniakov et al., 2007;
Tiniakov et al., 2012; Tiniakov and Scrogin, 2009). However, we did not observe
an effect of 5-HT1A receptor knockdown on the ability of 8-OH-DPAT to reduce
lactic acidosis with the milder, 21% blood volume withdrawal used to induce
hypotensive hemorrhage in this study. However, 10 minutes after the start of
hemorrhage, we did note a qualitatively smaller rise in lactate in both groups
given 8-OH-DPAT (3 minutes before blood sampling) than observed in animals
subjected to the same blood withdrawal, but not given drug, i.e., experiments in
Chapter 3. Thus, it is possible that 8-OH-DPAT was able to facilitate improved
peripheral perfusion within the short time frame between drug injection and blood
sampling. Nevertheless, the lack of difference in lactic acid between treatment
groups observed in this study suggests that 5-HT1A receptors in the caudal NTS
do not mediate this early beneficial effect of 8-OH-DPAT on acid-base status. It
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should be noted that blood gases were only obtained in a small subset of
animals. Unfortunately, many of the brain tissue samples obtained from animals
for which we had blood gas data were used for Western blot, and thus there was
no data confirming knockdown of gene expression in these animals. Therefore, it
is not possible to determine if the lack of effect of 1ARshRNA treatment on lactic
acidosis was due to lack of 5-HT1A receptor knockdown.
As described above, there are 2 distinct mechanisms behind the pressor
effect of 8-OH-DPAT (Tiniakov and Scrogin, 2006): direct vasoconstriction
through peripheral αAR1 receptor activation and increased sympathetic mediated
venoconstriction. It is not clear whether the direct vascular effects of 8-OH-DPAT
contribute to increased venous tone and increased perfusion, but this seems
quite likely given the dependence of venoconstriction on sympathetic drive (Reilly
et al., 2001; Toung et al., 2000). Both αAR1 and αAR2A receptors are expressed
in the venous vasculature and give rise to increased venous tone when
sympathetic drive is elevated (D'Oyley and Pang, 1990; Ito and Hirakawa, 1984;
Pang and Tabrizchi, 1986). Thus, direct vasoconstrictor effects of 8-OH-DPAT
on the venous vasculature may contribute to improved venous return, particularly
when drug is administered early after hypotensive hemorrhage when sympathetic
tone is low and venous pooling of blood is high (Guyton et al., 1954). Early
mobilization of venous blood through these vascular effects of 8-OH-DPAT may
have masked the beneficial effect of sympathetic-mediated vasoconstriction on
lactic acidosis.
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These studies further indicate that the central pressor effects of 8-OH-DPAT
are mediated by activation of 5-HT1A receptors in the commissural NTS. This
conclusion is based on evidence in the present study that the pressor effect of 8OH-DPAT was robustly correlated to 5-HT1A receptor expression in the
commissural NTS, and less so to receptor expression in the mNTS. Recent
findings indicate that the 5-HT1A receptor is co-localized with GAD67 in cells of
the rat commissural NTS (Ostrowski et al., 2014). Typically, 5-HT1A receptor
activation leads to neuronal cell hyperpolarization due to inhibition of Ca2+
conductance and/or increases in K+ conductance (Albert et al., 1996; Jeong et
al., 2001). Thus, hyperpolarization of GABAergic cells of the commissural NTS
by 8-OH-DPAT may contribute to disinhibition of excitatory functions of the region
including direct excitation of pre-motor sympathetic neurons of the RVLM.
In prior studies, others have noted that 8-OH-DPAT typically produces
significant and rapid sympathoinhibition in unanesthetized euvolemic rats (Bago
et al., 1999; Kubo et al., 1995; Nosjean and Guyenet, 1991; Wang and Lovick,
1992). We have also demonstrated that the sympathoexcitatory effect of 8-OHDPAT in hypovolemic animals is dependent upon sinoarotic innervation of the
NTS (Osei-Owusu and Scrogin, 2006). Thus, it is possible that the
sympathoexcitatory effects of 8-OH-DPAT require activation of sinoarotic
afferents during hemorrhage that, in turn, contributes to activation of GABAergic
neurons in the commissural NTS. In fact, peripheral chemoreceptor afferent
activation during prolonged hypoxia has been found to increase extracellular
levels of GABA in the commissural NTS, and elevation of GABA with sustained
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hypoxia is dependent on integrity of the carotid sinus nerve (Tabata et al., 2001).
It remains to be determined if 8-OH-DPAT acts to increase sympathoexcitation
by inhibiting GABA neurotransmission in the commissural NTS. Recent work
suggests that 8-OH-DPAT inhibits both GABAergic and glutamatergic
neurotransmission in the commissural NTS in the rat brain slice (Ostrowski et al.,
2014). In these studies, the predominant effect was a decrease in glutamatergic
responses under basal conditions. Our findings are consistent with the possibility
that prolonged excitatory neurotransmission in the NTS during hemorrhage
contributes to increased GABA cell activation, and that 8-OH-DPAT acts to
reverse this effect. Thus, differences in response to 8-OH-DPAT in the presence
and absence of sinoaortic nerve activation may be due to changes in the
prevailing level of GABAergic tone present in the NTS. Prolonged hypoxia
increases GABA release in the commissural NTS, and the ability of 8-OH-DPAT
to increase blood pressure was more strongly correlated with receptor
expression in the commissural NTS where chemoreceptor afferents terminate in
the highest density. Moreover, we did not observe any effect of 5-HT1A receptor
knockdown on spontaneous arterial baroreflex sensitivity. Together these
findings suggest that 5-HT1A receptors in the commissural NTS may disinhibit
sympathetic drive during prolonged activation of peripheral chemoreceptors.
In summary, our work indicates that 8-OH-DPAT acts through 5-HT1A
receptors in the commissural NTS to produce sympathoexcitation and increased
BP in the unanesthetized rat subjected to hypotensive hemorrhage. These
findings suggest that 5-HT1A receptor agonists that penetrate the blood brain
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barrier may be useful in the treatment of hypotensive hemorrhage or
hemorrhagic shock.

CHAPTER V
5-HT1A RECEPTORS IN THE CAUDAL NUCLEUS TRACTUS SOLITARIUS
MEDIATE THE INDICES OF AROUSAL TO HYPOXIC HYPERCAPNIA

Abstract
Prior studies in our laboratory and within this dissertation have identified a
role for 5-HT1A receptors of the caudal NTS in the sympathoexcitatory response
observed during recovery from hemorrhage. However, the role of serotonin and
5-HT1A receptors in chemoreflex responses, such as those elicited during
hemorrhage, remain to be fully elucidated. In the current study, we tested the
hypothesis that hypercapnia, sufficient to acidify arterial blood to the same extent
seen in hemorrhage, would activate serotonin neurons of the caudal raphe and,
in turn, augment peripheral chemoreflex responses to hypoxia through activation
of 5-HT1A receptors in the NTS.
In contrast to our hypothesis, hypercapnia (in the presence of hyperoxia)
sufficient to lower arterial blood pH to levels observed in hemorrhagic shock (i.e.,
decrease ~0.07 pH units) did not increase c-Fos expression in serotonin neurons
of the caudal raphe. Instead, only hypoxic hypercapnia increased c-Fos
expression in serotonin immunoreactive neurons in the RM and RO. Exposure to
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hyperoxic hypercapnia or hypoxic hypercapnia increased c-Fos expression in the
commissural NTS to the same extent (P<0.01). Treatment with the 1ARshRNAencoding virus did not affect overall ventilatory rate, tidal volume, or cumulative
minute ventilation during hypoxic normocapnia, hyperoxic hypercapnia or hypoxic
hypercapnia. However, rats treated with the ScramshRNA-encoding virus
exhibited intermittent bouts of high frequency ventilation during hypoxic
hypercapnia that was suppressed in rats treated with the 1ARshRNA-encoding
virus. Accordingly, ventilatory rate determined over the entire course of the 45
min exposure to hypoxic hypercapnia, but not that determined during hypoxia or
hypercapnia alone, was attenuated by 5-HT1A knockdown (1,121 ± 99 vs 599 ±
38 bpm over 45 min, P<0.01). Group differences in intermittent high frequency
ventilation were due to decreased percent of time spent sniffing in rats treated
with the 1AshRNA-encoding virus compared to ScramshRNA-injected rats (4.9 ±
1.1 vs 11.2 ± 2.4 % time, P < 0.05). Together, these data support the
hypothesis that the combination of hypoxia and hypercapnia stimulates serotonin
neurons in the caudal raphe to release serotonin in the NTS, which in turn
stimulates arousal by activation of 5-HT1A receptors.

Introduction
Studies performed in our laboratory indicate that serotonin cells of the
caudal raphe and serotonin nerve terminals in the dorsomedial medulla that
include the caudal NTS are necessary for normal ventilatory and sympathetic
responses following compensation from blood loss. Our work further indicates

148
that serotonin release improves peripheral tissue perfusion following hypotensive
hemorrhage. Serotonin cells of the caudal raphe are also necessary for normal
ventilatory responses to hypercapnia in unanesthetized rats (Kung et al., 2010).
Together, these findings led us to hypothesize that serotonin cells of the caudal
raphe are activated by the acidosis that develops during hemorrhage. The
resulting release of serotonin in the NTS is further hypothesized to facilitate
peripheral chemoreflex responses and thereby improve ventilation and
sympathetic activity following blood loss. Our findings that the 5-HT1A agonist 8OH-DPAT acts in a manner that mimics the beneficial effects of serotonin during
hemorrhage led us to further speculate that serotonin acts in the NTS to facilitate
peripheral chemoreflex activation by stimulating 5-HT1A receptors.
Controversial evidence from other laboratories has suggested a role for
serotonin neurons in the caudal raphe as central chemoreceptors. Serotonin
neurons located along the major blood vessels that perfuse the brainstem are
ideally situated to directly assess the acid-base status of blood entering cerebral
circulation (Bradley et al., 2002). Moreover, primary cultures of caudal raphe
serotonin neurons were found to be directly sensitive to changes in CO2 and pH
(Wang et al., 1998; Wang and Richerson, 1999; Wang et al., 2001). Given our
previous evidence that destruction of the same serotonin neurons resulted in
impaired chemosensitivity to respiratory acidosis, we began to question whether
serotonin neurons of the caudal raphe may be activated in response to the
metabolic acidosis that develops during hemorrhage.
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Several serotonin receptor subtypes are expressed in the caudal NTS and
several of these have been implicated in the regulation of ventilatory responses
to various stimuli. A recent study by Zhuang et al., showed that 8-OH-DPAT,
reversed fentanyl-induced apnea in urethane anesthetized rats. This response
was completely abolished by microinjection of 5HT1A receptor antagonist, WAY100635 directly into the caudal NTS prior to 8-OH-DPAT administration, or by
destruction of the vagal projections to the NTS. Together, these findings suggest
that 5-HT1A receptors of the caudal NTS facilitate ventilation when an organism is
challenged by central hypoxic hypoventilation (Zhuang et al., 2012).
During prolonged hypoxic exposure, attenuated ventilatory drive termed
hypoxic ventilatory decline is associated with accumulation of GABA in the
caudal NTS (Tabata et al., 2001). Activation of 5-HT1A receptors typically
induces neuronal hyperpolarization (Fargin et al., 1989) . Thus, we speculated
that serotonin may activate 5-HT1A receptors in the NTS during hemorrhage and
thereby facilitate peripheral chemoreflex responses that would reverse hypoxic
ventilatory decline. The accumulation of GABA that mediates hypoxic ventilatory
decline is dependent on the integrity of the sinoaortic nerves. The
sympathoexcitatory effect of 8-OH-DPAT is also dependent on integrity of
sinoaortic nerves (Osei-Owusu and Scrogin, 2006). Therefore, we hypothesized
that the acidosis that develops during hemorrhage would promote activation of
serotonin neurons in the caudal raphe. We further speculated that the resulting
release of serotonin in the NTS would facilitate peripheral chemoreflex response
to hypoxia by activating 5-HT1A receptors. Therefore, in this study, we tested
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whether serotonin neurons of the caudal raphe are activated by acidosis
(hypercapnia) and whether this condition further improves peripheral chemoreflex
responses to hypoxia. We also tested the hypothesis that knockdown of 5-HT1A
receptors in the NTS would attenuate peripheral chemoreflex responses to
hypoxia under acidic conditions in unanesthetized rats.

Methods
Animals
Male Sprague-Dawley rats (275 to 300 g; Harlan, Indianapolis, IN) were
acclimated to the institutional animal facility under standard conditions (22°C
ambient temperature, 12:12-h light-dark cycle) with food and water available ad
libitum for at least 1 week prior to surgery. All experimental protocols were
approved by the Institutional Animal Care and Use Committee and conducted in
compliance with the Principles of Laboratory Animal Care, as adopted and
promulgated by the United States National Institutes of Health.
Surgical procedures
Femoral catheter implantation
In a subset of rats, blood sampling was performed during gas exposure in
order to determine the extent of blood gas and acid-base balance changes
elicited by the chemoreflex stimuli. Rats (n = 5) were anesthetized with
isoflurane (5% for induction and 1.5-2.5% for maintenance) in 100% O2 (1L/ min)
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and instrumented with a femoral arterial catheter (PE-50 fused with PE-10
tubing) to enable blood sampling. The arterial catheter was externalized at the
nape of the neck and secured with 3-0 silk suture. Following catheter
implantation, a Vascular Access Harness™ (Instech Laboratories, Inc., USA)
was attached and secured to the catheter to allow blood sampling. Rats were
given ampicillin (150 mg/kg sc) and buprenorphine (0.05 mg/kg sc) and allowed
to recover in their home cage. Forty-eight hours after surgery, the catheters
were flushed daily with dexamethasone (0.1 mg/mL) in heparinized saline (75 U)
to maintain patency (Yang et al., 2005).
AAV injections
Prior to surgery, AAV vectors were diluted in viral storage buffer [400nM
NaCl, 20 mM Tris base, (1x1012 vg/ml)] and dialyzed in 0.9% saline (Slide – a –
Lyzer, ThermoScientific) as described in Chapter 3. Rats (n = 28) were
anesthetized with ketamine/xylazine (85/13mg/kg, im) and placed in a stereotaxic
apparatus with the nose bar positioned 11 mm below a flat skull plane then AAV
vectors were injected as described previously in Chapter 3 and utilizing the same
injection parameters. Animals were then allowed to recover for four weeks prior
to chemoreflex protocol 3.
Experimental Protocols
1. Unrestrained whole body plethysmography to determine caudal raphe
serotonin cell activation (c-Fos expression) in response to hypoxic
normocapnia, hyperoxic hypercapnia or hypoxic hypercapnia.
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Naïve rats (n = 32) were habituated to a whole body plethysmograph
(Buxco Research Systems) for 10 days prior to study. During habituation, rats
were handled and placed in the chamber which was situated in a visually–
isolated, low–ambient noise room while continuously flushed with 21% O2
balanced with N2 at a rate of 2 L/min. Gas flow was regulated by a custom-made
mass flow controller for O2, N2, and CO2 (Buxco Research Systems).
Temperature within the chamber was stable across experimental groups (± 0.5°
C), but varied from 23-25° C between cohorts. Ventilatory variables were
captured and analyzed by iox2 software (EMKA Technologies). On the day of
the experiment, rats were placed in the chamber and allowed to acclimate for at
least 1 hour. Baseline ventilation variables were then recorded for 60 minutes
prior to gas change. After baseline recordings, rats were randomly assigned to
receive a 60 minute exposure to one of three conditions: hypoxic normocapnia
(10%O2/0.04% CO2), hyperoxic hypercapnia (95%O2 /5%CO2), or hypoxic
hypercapnia (10%O2/5%CO2). Changes in gas concentration required 5-10
minutes. Once the new gas concentration had stabilized, the condition was
sustained for 60 minutes during which ventilatory variables were assessed. After
60 minutes, the gas mixture was switched back to normoxic conditions and the
animal recovered in the chamber for an additional 30 minutes to allow maximal cFos protein expression to develop. Immediately after the end of the experiment,
rats were deeply anesthetized with sodium pentobarbital (100mg/kg, ip). Once
anesthetized the rat was given an injection of heparinized saline (100 U/0.1 ml)
into the apex of the left cardiac ventricle. The rat was then perfused
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transcardially with 250 mL (25 mL/min) sodium nitrate (0.1M) in 6.7 mM
phosphate buffer followed by 360 mL (18 mL/min) 4% paraformaldehyde in 0.05
M potassium phosphate buffer (KPB), pH 6.8. Subsequently, brains were
removed and post-fixed with the same solution for one hour, then blocked in the
same solution overnight at 4°C. The following day, brains were transferred to
30% sucrose and stored until sectioning could be performed. Brains were
sectioned on a freezing microtome in 40 µm sections and collected serially into 6
wells filled with cryoprotectant (30% sucrose and 30% ethylene glycol in 0.1 M
phosphate buffer) and stored at -20° until immunohistochemical analysis was
performed.
2. Unrestrained whole body plethysmography for analysis of gas effects
on acid-base balance and blood gases.
Two days after catheter implantation, rats were habituated for 4 days to a
whole body plethysmograph (Buxco Research Systems) as described above in
protocol 1, except that their catheters were connected to a tether that consisted
of a spring covered catheter connected to a fluid swivel (Instech Laboratories)
placed in the top of the chamber. On the day of the experiment, rats were
acclimated to the chamber and attachment to the tether, after which, baseline
ventilatory variables were recorded for 60 minutes during exposure to normoxic
conditions. An arterial blood sample was then withdrawn through the fluid swivel.
Two times the dead space of the catheter and tether system was withdrawn, after
which a 150 l sample was obtained. The fluid was returned to the animal and
the catheter was flushed with isotonic saline. Rats were then randomly assigned

154
to receive exposure to one of the following three conditions: hypoxic
normocapnia (10%O2/0.04% CO2), hyperoxic hypercapnia (95%O2 /5%CO2), or
hypoxic hypercapnia (10%O2/5%CO2). The condition was sustained for 60
minutes during which ventilatory data were measured. At the end of the 60
minute gas exposure, a second arterial blood sample was obtained in the same
manner as the first. Arterial blood samples were analyzed with an i-STAT 1
analyzer (i-STAT, East Windsor, NJ). At the end of each experiment, rats were
returned to their home cage and allowed to recover for 40 hours. The procedure
was then repeated until blood was sampled under each condition for each rat.
The order of the gas conditions was randomized across rats. After the last
experiment, rats were euthanized by an overdose of sodium pentobarbital (100
mg/kg, ip) and subsequent thoracotomy.
3. Assessment of 5-HT1A receptor knockdown in the caudal NTS on
chemoreflex responses.
Four weeks following viral injections, the ventilatory function of rats was
assessed in the whole body plethysmograph (Buxco Research Systems) as
described above with slight modifications. Each animal was subjected to 5
acclimation sessions of escalating duration (15, 25, 35, 45, and 60 minutes) over
5 days prior to experiments. Each rat was exposed to the 3 gas conditions
described above in protocol 2 on separate days, with a day of rest between each
of the 3 experiments. For each experiment, rats were acclimated to the chamber
and baseline ventilation variables were recorded for at least 30 minutes prior to
gas change. The gas concentration was then changed over the next 5-10
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minutes to one of the three conditions. Once the gas transition was complete,
ventilatory data were recorded for 45 minutes. The gas was then switched back
to normoxia and animals were removed and allowed to rest in their home cage
for approximately 40 hours prior to the next experiment.
Tissue homogenization
Total RNA was extracted from a subset of micropunch samples using a
homogenizing buffer that consisted of 50 mM Tris buffer (pH 7.6) with sodium
chloride (0.01M) and the addition of a proteinase inhibitor cocktail (Roche).
Protein concentration from the micropunch samples was determined by BCA
assay (Pierce) as described in Chapter 3. Immunoblotting protocols were also
performed in the same manner as described in Chapter 3.
Tissue RNA Isolation and cDNA synthesis
Total RNA was extracted, genomic DNA removed, and then synthesized
into cDNA according to protocols described in Chapter 3.
Quantitative Real-Time PCR
Messenger RNA levels of the 5-HT1A receptor were determined from
tissue obtained from the commissural NTS, mNTS, RO, hypoglossal nucleus,
and DR as described in Chapter 3. The 5-HT2A receptor was also assessed in
mNTS and commissural NTS to rule out off target, or compensatory effects of
shRNA treatment. Real-time qPCR was performed on amplified cDNA using the
CFX96 TouchTM Real-Time PCR Detection System (Bio-Rad). The following
general PCR protocol was used with various annealing/extension temperatures:
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95°C for 30 sec, 40 cycles of 95°C for 5 sec and 56-63°C for 30 sec. Melt curves
from 65°C to 95°C were included to confirm that only a single product was
formed for each primer pair. Samples were prepared and analyzed as described
in Chapter 3. Primer sequences used for amplification and annealing
temperatures for each gene are listed in Table 11. Results are presented as
relative mRNA expression normalized to relative GAPDH mRNA.
Immunohistochemistry
For c-Fos and serotonin (5-HT) immunolabel, one of every six 40-µM sections
through the brainstem was washed 6 times for 10 minutes in 0.05 M potassium
phosphate buffered saline (KBPS), incubated in 0.1% H2O2 for 15 minutes,
washed 5 times for 5 minutes, then incubated for 48 hours at 4°C with rabbit antic-Fos primary antibody (1:10,000 dilution; PC#38 from EMD Sciences) in 0.4%
Triton X-100 KPBS (KPBST). Sections were then washed 10 times for 6 minutes
and incubated in biotinylated goat anti-rabbit IgG (1:1,000 dilution in KPBST;
Vector Laboratories) for 1 hour at room temperature, washed 5 times for 10
minutes, then incubated for 1 hour in Avidin DH solution combined with
biotinylated horse-radish peroxidase (5 l each/ml prepared 30 minutes prior to
use, Vectastain Elite ABC Kit Standard, Vector Laboratories) in KPBST.
Sections were then rinsed 3 times for 5 minutes with KPBS and then washed 3
times for 5 minutes in 0.175M sodium acetate, pH 7.0. During washes nickel
sulfate-intensified 3,3’-diaminobenzadine tetrahydrochloride (NiDAB) chromagen
solution was prepared as follows: 250 mg nickel (II) sulfate hexahydrate, 2 mg
DAB, 20mg D-glucose, 1.5μL glucose oxidase (Sigma) in 10 mL 0.175M sodium
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Table 11. Primers for qPCR analysis of chemoreflex challenged AAV rats.
T
(°C)

Primer
Efficiency
(%)

GAPDH

56/61

99/96

5-HT1A

56

89

5-HT2A

56

102

Gene
Symbol

Forward Primer (5’ 3’)
Reverse Primer (5’ 3’)
GAC ATG CCG CCT GGA GAA AC
AGC CCA GGA TGC CCT TTA GT
AAG AAG AGC CTG AAC GGA
CAG AGG AAG GTG CTC TTT GG
TCA TCA TGG CAG TGT CCC TA
ATC CAG ATC GCA CAG AGC TT

Size
(bp)
94
171
172

Forward and reverse primers are shown for GAPDH, 5-HT1A (5-HT1A), and 5HT2A receptor (5-HT2A). Annealing temperature (T), primer efficiency, and
product length are also shown.
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acetate buffer. Sections were incubated in NiDAB to produce a black nuclear
label over the course of 7 minutes. The reaction was stopped by washing
sections 3 times for 5 minutes in 0.175 M sodium. Afterwards, sections were
washed 4 times for 15 minutes, and incubated with rabbit anti-serotonin primary
antibody (1:400,000 dilution in KPBST; Immunostar) for 48 hrs at 4°C. Sections
were then subjected to the same secondary and tertiary antibodies as described
above, but this time immunoreactivity was exposed with DAB in the absence of
nickel (5 minutes) to produce a brown cytoplasmic label. Omission of either
primary antibody completely abolished cellular label. After the final set of
washes, sections were mounted onto gelatin-coated slides and allowed to dry
overnight. The next day sections were dehydrated and cleared by immersion in
the following solutions: distilled water, 50% ethanol (5 minutes), 75% ethanol (5
minutes), 95% ethanol (5 minutes), 100% ethanol (10 minutes), fresh 100%
ethanol (10 minutes), xylene (10 minutes), fresh xylene (10 minutes). Slides
were then immediately coverslipped with Permount mounting media (Fisher
Scientific).
Histology
Cells that showed immunolabel for both c-Fos and serotonin were counted
in one out of every six 40 m sections (240 μM apart) throughout the anatomical
extent of each serotonin-rich caudal raphe nuclei as described previously (Kung
et al., 2010). Specifically, we examined double-labeled of neurons in the RP, RM
and its lateral extensions around the pyramids (referred to as the parapyramidal
region), RO, cells in the subependymal layer on the ventrolateral border of the
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pyramids (referred to as the subependymal region), and the RP (Steinbusch,
1981). The percent of serotonin-labeled neurons that showed c-Fos
immunoreactivity were summed for the entire raphe region (Table 12). Rostrocaudal profiles of double-labelled cells were determined for each nuclei. For
these determinations, the total number of double-labeled cells were combined
from three sections (720 μm) and compared for each gas condition. Cell counts
were pooled in this way to reduce the impact of small variations in the anatomical
location of serial sections between animals.
Cells showing c-Fos immunoreactivity were also counted in one of every
six sections (240 μM apart) throughout the commissural and medial NTS (-15.00
mm to -13.8 mm from Bregma).
Statistical Analysis
Effect of Gas Treatment on blood gases and acid-base balance was
determined by 2-way repeated measures ANOVA with Newman-Kuels post hoc
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Table 12. The percentage of serotonin-immunoreactive neurons that also express c-Fos immunoreactivity
during chemoreflex challenges
Normoxia (8)

Hypoxic
Normocapnia (6)

Hyperoxic
Hypercapnia (6)

Hypoxic
Hypercapnia (7)

Raphe Pallidus

12.9 ± 2.3

21.3 ± 3.8

22.0 ± 8.0

22.8 ± 4.5

Raphe Obscurus

1.3 ± 0.3

2.9 ± 0.6

2.6 ± 0.6

4.7 ± 0.7**,†,‡

Subependymal region

4.0 ± 0.9

8.8 ± 2.0

7.0 ± 2.8

5.9 ± 1.0

Parapyramidal region

2.5 ± 0.6

5.0 ± 0.7

4.3 ± 2.0

7.2 ± 2.0

Raphe Magnus

2.5 ± 0.8

5.7 ± 0.9

4.5 ± 0.5

6.8 ± 0.6*

Values are group means ± SEM in 40 μm sections obtained every 240 μm throughout the anatomical extent of the
indicated nucleus. A one-way ANOVA with Gas treatment as a factor revealed an effect of Gas treatment on activation of
serotonin neurons within the RO [F(3) = 6.79, P < 0.01]. Post-hoc analysis with Newman-Keuls’ method determined that
hypoxic hypercapnia increased the percent of serotonin neurons that were activated during the gas exposure compared to
all other treatment groups. A Kruskal-Wallis one-way ANOVA on Ranks also revealed an effect of Gas treatment on
activation of serotonin neurons within the RM [H(3) = 13.06, P < 0.01]. Post-hoc analysis by Dunn’s method determined
that the difference of treatment was due to the fact that hypoxic hypercapnia increased the percent of serotonin neurons
that expressed c-Fos compared to normoxia,*P < 0.05 vs Normoxia, **P < 0.01 vs Normoxia, †P < 0.05 vs Hyperoxic
hypercapnia, ‡P < 0.05 vs Hypoxic Normocapnia. The raphe pallidus, subependymal region, and parapyramidal region
did not show significant changes in double-label following gas treatments, P = 0.384, P = 0.257, and P = 0.101
respectively.
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tests. Effect of Gas Treatment on total number of cells expressing c-Fos was
determined for each raphe region by one-way ANOVA or a Kruskal-Wallis oneway ANOVA on Ranks. Effect of Gas Treatment and Distance from Bregma for
RO and RM were analyzed by 2-way ANOVA with repeated measures.
Newman-Keuls post-hoc tests were used to compare effects of gas exposure at
each location. Effect of Viral injection over Time on ventilatory variables was
assessed independently for each gas treatment by 2-Way ANOVA. Effect of
Viral injection on cumulative minute volume and area under the curve of
ventilatory rate for the entire 45 minute exposure was assessed by 2-way
repeated measures ANOVA with Bonferroni correction for the 3 gas exposures.
PCR data from rats treated with the 1ARshRNA-encoding virus were normalized
to the group average of rats injected with the ScramshRNA that were in the same
qPCR cohort. Typically, two animals of each shRNA group were run in the same
cohort. Significance was determined by unpaired Student’s t-tests. When group
data failed the Shipiro-Wilk normality test, the Mann-Whitney Rank Sum Test
was used instead. All qPCR results are expressed as the group mean ± SEM.

Results
Chemoreflex- elicited c-Fos expression in caudal raphe serotonin neurons
As expected, exposure to hypoxic normocapnic gas reduced P aCO2 and
PaO2, caused respiratory alkalosis and increased lactate accumulation.
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Hyperoxic hypercapnia increased PaCO2 and PaO2, caused a primary respiratory
acidosis and reduced lactate levels. The addition of hypercapnic gas to hypoxia
normalized PaCO2 and PaO2 and respiratory alkalosis and also lowered lactate
accumulation (Table 13).
More serotonin neurons of the RM showed c-Fos expression over the
entire nucleus following hypoxic hypercapnic gas exposure compared to
normoxia, hypoxic normocapnia, and hyperoxic hypercapnia (Table 12, P < 0.01,
P < 0.05, and P < 0.05, respectively), but not in any one specific region of the RM
(Figure 22). Similarly, only hypoxic hypercapnia increased c-Fos expression in
the RO compared to normoxia and hyperoxic hypercapnia (Figure 23, P < 0.01
and P < 0.05 respectively), but not in any particular region of the RO. No other
caudal raphe region showed elevated c-Fos expression in serotonin neurons.
Expression of c-Fos was increased in the middle and rostral portions of
the commissural NTS, as well as the caudal portions of the medial NTS by
hypoxia alone and hypoxic hypercapnia, and the response was similar between
gas treatments (Table 14 and Figure 24, P < 0.01). Hyperoxic hypercapnia only
increased c-Fos expression in the caudal portions of the medial NTS.
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Table 13. Arterial blood gases and acid-base status determined before and after a 60-minute exposure to
chemoreflex challenges
n
Hypoxia
Normocapnia
0 min

60 min
Hypoxic
Hypercapnia
0 min
60 min

paCO2
(mmHg)

paO2
(mmHg)

BE
(mmol/L)

Lactate
(mmol/L)

5

60 min
Hyperoxic
Hypercapnia
0 min

pH

7.46 ± 0.01

43. 86 ± 0.65

84.40 ± 1.03

7.00 ± 0.63

0.84 ± 0.17

7.58 ± 0.01##

29.76 ± 1.01##

37.80 ± 0.66##

6.00 ± 0.89

1.21 ± 0.11##

7.45 ± 0.01

45.74 ± 0. 60

88.60 ± 1.40

7.4 ± 0.68

0.97 ± 0.08

7.38 ± 0.01**,##

60.18 ± 2.12**,##

437.20 ± 21.73**,##

10.00 ± 0.71 0.42 ± 0.03**,##

7.45 ± 0.01

43.78± 0. 72

89.80 ± 3.46

6.2 ± 0.66

1.03 ± 0.12

7.40 ± 0.01**,†,##

49.00 ± 0.90**,‡,##

54.00 ± 1.10‡,#

7.4 ± 1.12

0.62 ± 0.07*,##

5

5

Values are group means ± SEM. Significant interactions were followed up by Newman-Keuls’ post-hoc analysis. *P <
0.05, **P<0.01 vs hypoxia normocapnia, †P < 0.05, ‡P<0.01 vs hyperoxic hypercapnia, #P < 0.05, ##P<0.01 vs baseline (0
minutes) within group.
Two-way ANOVA with repeated measures revealed an interaction between Gas treatment and Time on arterial blood pH
[F (4,8) = 171.07, P < 0.01]. Post-hoc analysis showed that hypoxic normocapnia increased pH while both hyperoxic
hypercapnia and hypoxic hypercapnia reduced pH.
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Two-way ANOVA with repeated measures revealed a significant interaction between Gas treatment and Time on p aCO2
values [F (4,8) = 273.59, P < 0.01]. Post-hoc analysis showed that hypoxic normocapnia reduced paCO2 while both
hyperoxic hypercapnia and hypoxic hypercapnia increased p aCO2.
Two-way ANOVA with repeated measures revealed an interaction between Gas treatment and Time on p aO2 values [F
(4,8) = 303.96, P < 0.01]. Post-hoc analysis showed that hypoxic normocapnia reduced paO2 while paO2 was reduced to a
similar degree when hypercapnia was combined with hypoxia. Conversely, hyperoxic hypercapnia dramatically increased
paO2 following treatment.
Two-way ANOVA with repeated measures revealed an interaction between Gas treatment and Time on lactate levels [F
(4,8) = 96.56, P < 0.01]. Post-hoc analysis showed that hypoxic normocapnia augmented lactate accumulation, whereas
hyperoxic hypercapnia and hypoxic hypercapnia both reduced lactate levels.
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Figure 22. Effect of gas challenges on c-Fos expression in serotonin
neurons of the raphe magnus. A) Representative 5-HT and c-Fos
immunoloabel in raphe magnus (RM) of rats subjected to normoxia (left) and
hypoxic hypercapnia (right). B) number of serotonin neurons within the RM that
were also expressed c-Fos in rats exposed to normoxia, hypoxic normocapnia,
hyperoxic hypercapnia, hypoxic hypercapnia. Total number of serotonin neurons
are shown at each location for comparison. Data were combined for 3 sections
(720μm) at each point along the rostro-caudal extent of the nucleus and are
expressed as groups means ± SEM. A 2-way ANOVA with repeated measures
with Gas treatment and Distance from Bregma as factors revealed only a main
effect of Distance from Bregma in the RM [F (3) = 14.65, P < 0.01].
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Figure 23. Effect of gas challenges on c-Fos expression in serotonin
neurons of the raphe obscurus. A) Representative coronal sections of
brainstem showing typical c-Fos and serotonin double immuno-label (arrows) in
the Raphe Obscurus (RO) of rats exposed to normoxia (left) and hypoxic
hypercapnia (right). B) Number of serotonin-immunoreactive neurons that also
showed c-Fos expression in brain sections from rats exposed to normoxia,
hypoxic normocapnia, hyperoxic hypercapnia or hypoxic hypercapnia and total
number of serotonin positive neurons. Data are group mean of cells identified in
3 sections taken at 240 μm intervals across the rostro-caudal plane, and shown
as a single value every 720 μms. A 2-way ANOVA with repeated measures with
Gas treatment and Distance from Bregma as factors revealed main effects of
Gas treatment [F (3,23) = 5.93, P < 0.01] and Distance [F (3,23) = 13.31, P <
0.01]. Post-hoc analysis using Newman-Keuls’ method showed that the main
effects were due to increased c-Fos immunoreactivity in the RO of rats exposed
to hypoxic hypercapnia vs normoxia (P<0.01) and hypercapnia (P<0.05).
Although not significant, there was a strong tendency for hypoxic hypercapnia to
increase c-Fos expression compared to hypoxic normocapnia (P = 0.055)
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Figure 24. Effect of gas challenges on c-Fos expression in the
commissural and mNTS. Typical c-Fos label in commissural NTS of rats
subjected to normoxia (A) hypoxic normocapnia (B), hyperoxic hypercapnia (C)
and hypoxic hypercapnia (D). E) Numbers of c-Fos positive cells in the
commissural and mNTS shown throughout rostral-caudal extent of the nucleus
for each gas condition. Data a group means ± SEM. A 2-way ANOVA with
repeated measures using Gas treatment and Distance from Bregma as factors
revealed a significant interaction between factors [F (3,183) = 4.98, P < 0.01].
Post-hoc analysis with Newman-Keuls’ showed that both hypoxic normocapnia
and hypoxic hypercapnia significantly increased c-Fos expression in the mid and
rostral portions of the commissural NTS and all three conditions resulted in
increased c-Fos expression in the mNTS compared to normoxia, *P < 0.05 and **
P < 0.01. Both hypoxic normocapnia and hypoxic hypercapnia also showed
significantly increased c-Fos expression compared to hyperoxic hypercapnia, #P
< 0.05, $P < 0.01.
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Table 14. Total number of cells that expressed c-Fos in the commissural and medial NTS during exposure to
chemoreflex challenges.
Normoxia (8)

Hypoxic
Normocapnia (6)

Hyperoxic
Hypercapnia (6)

Hypoxic
Hypercapnia (7)

Commissural NTS

79 ± 3

606 ± 32*

255 ± 14

590 ± 24*

Medial NTS

131 ± 5

556 ± 27*

369 ± 20

649 ± 17*

Total number of c-Fos positive cells in the commissural and medial NTS after exposure to normoxia, hypoxic
normocapnia, hyperoxic hypercapnia and hypoxic hypercapnia. Values are group means ± SEM. A Kruskal-Wallis oneway ANOVA on Ranks with Gas treatment as the factor revealed a main effect of Gas treatment on c-Fos expression
within the commissural NTS [H (3) = 15.99, P < 0.01]. Post-hoc analysis using Dunn’s method showed that hypoxic
hypercapnia and hypoxic normocapnia increased c-Fos expression in the commissural NTS. A Kruskal-Wallis one-way
ANOVA on Ranks also revealed a signficant effect of Gas treatment on activation of neurons within the mNTS [H (3) =
16.36, P < 0.01]. Post-hoc analysis using Dunn’s method showed increased c-Fos expression during hypoxic
normocapnia and hypoxic hypercapnia. *P < 0.05. Exposure to normoxia or hyperoxic hypercapnic gas did not produce
significant changes in c-Fos expression in either the commissural or medial NTS.
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5-HT1A receptor activation contributes to ventilatory compensation during
hypoxic hypercapnia
Body weight did not differ between groups injected with virus encoding the
ScramshRNA and 1ARshRNA (353 ± 5 and 358 ± 5 g respectively). Baseline
ventilatory variables of ventilatory rate (VR), and minute ventilation (MV) did not
differ between groups (Figure 25). In both treatment groups, hypoxic
normocapnic gas exposure elicited a dramatic increase in VR and MV which
quickly declined over the first 5 minutes of exposure and then declined more
slowly over the remainder of the recording period. Hyperoxic hypercapnic gas
exposure also produced an immediate and robust increase in VR and MV that
declined over the first 10 minutes of exposure. Ventilation stabilized after 10-15
minutes and remained at this elevated level throughout the gas exposure period.
There were no differences in ventilation between groups during either hypoxic
normocapnia or hyperoxic hypercapnia alone. During hypoxic hypercapnia, both
groups had an initial increase in ventilation that diminished over the first 10
minutes and stabilized, but there were obvious intermittent fluctuations in
ventilatory rate in the ScramshRNA-treated group that were not observed in
1ARshRNA-treated rats. But there was no group difference in ventilatory
variables at any time point during the recording period.
Examination of data from individual rats showed a clear increase in ventilatory
rate fluctuations in control rats that was not apparent in rats treated with the
1ARshRNA (Figure 26A). To determine if the fluctuations were greater
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Figure 25. Ventilatory rate (VR) and minute volume (MV) in rats treated with AAV encoding the scrambled shRNA
(ScramshRNA) or the 1ARshRNA. Shown are values determined prior to gas change (-5-0 min) and during exposure to
hypoxic normocapnia (left panel), hyperoxic hypercapnia (middle panel), and hypoxic hypercapnia (right panel). Two-way
ANOVA with repeated measures using ShRNA treatment and Time as factors revealed no significant effects or
interactions.
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Figure 26. Ventilatory rate changes of individual rats over the course of
exposure to hypoxic hypercapnia. A) Individual ventilatory rate (VR) during 45
minute exposure to hypoxic hypercapnia in all animals treated with the
ScramshRNA-encoding virus (left) or the 1ARshRNA-encoding virus (right). B)
Area under the curve of VR during entire exposure period hypoxic hypercapnia in
ScramshRNA- and 1ARshRNA-injected rats. Data are group means ± SEM.
Mann Whitney U Rank Sum test determined that 1ARshRNA-injected rats had
lower overall variability in ventilatory rate during the course of hypoxic
hypercapnia compared to ScramshRNA treated rats (U = 14, T = 105, P < 0.01).

172

To determine if intermittent fluctuations in ventilatory rate affected total
ventilation, cumulative minute ventilation at the end of gas exposure was
determined (Figure 27). There was a strong trend for decreased ventilation over
the course of gas exposure during hyperoxic hypercapnia in rats treated with the
1ARshRNA-encoding virus. But correction for repeated measures reduced
significance below the acceptable alpha level.
Inspection of the ventilatory wave form data revealed that 1ARshRNAtreated rats spent less time sniffing than ScramshRNA rats during hypoxic
hypercapnia (Figure 28A and B). There was no difference in time spent sniffing
between hypoxic normocapnia or hyperoxic hypercapnia alone. In a small
subset of rats, ventilation was recorded during normoxic conditions prior to gas
change for at least 45 minutes. Therefore, data from these animals were also
analyzed for sniffing. These data are shown for comparison but were not
included in the analysis. Qualitatively, animals showed little sniffing during
normoxia and the percent time spent sniffing was similar between groups.
Analysis of brain tissue showed a correlation between 5-HT1A mRNA
levels in the commissural NTS and the area under the curve of ventilatory rate
during exposure to hypoxic hypercapnia (R = 0.52, r2 = 0.27, P < 0.05) , but there
was no correlation with the mNTS 5-HT1A receptor expression and (R = 0.05, r2 =
0.01, P = 0.87; Figure 29A and B). The 5-HT2A receptor gene expression in the
caudal NTS was not affected by 1ARshRNA AAV injection (Figure 29C).
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Figure 27. Effect of ScramshRNA and 1ARshRNA expression in NTS on
cumulative minute ventilation (MV) during gas challenges. Cumulative
minute ventilation (MV) over the 45 minute exposure to hypoxic normocapnia (left
panel), hyperoxic hypercapnia (middle panel) and hypoxic hypercapnia (right
panel) in ScramshRNA-treated and 1ARshRNA-treated rats. Values are group
means ± SEM. Effects of AAV injection and gas exposure on cumulative MV at
45 minutes of gas exposure (i.e., last value at 45 minutes) were assessed by 2way ANOVA with repeated measures of Gas treatment and ShRNA treatment as
factors. Though a strong trend for decreased cumulative MV was observed
(P=0.048) in rats treated with the 1ARshRNA-encoding virus, Bonferroni
correction for exposure to the 2 other gas treatments reduced the significance of
the effect.
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Figure 28. Percent of time during each gas challenge spent sniffing.
Normoxia is shown for comparison, but not included in the analysis. Rats treated
with the 1ARshRNA-encoding virus showed decreased sniffing during hypoxic
hypercapnia compared to ScramshRNA-injected rats. A) Time spent sniffing
(determined as VR > 250 bpm) during normoxia, hypoxic normocapnia, hyperoxic
hypercapnia, and hypoxic hypercapnia in ScramshRNA (blue) and 1ARshRNA
(pink) injected rats. Group n for normoxia is 4 and 5 for ScramshRNA and
1ARshRNA-injected rats, and 15 and 13 for ScramshRNA and 1ARshRNAtreated rats respectively in other conditions. Bars show group means ±SEM.
Data from individual animals are shown as dot plots over the appropriate bar.
Mann-Whitney U Rank Sum test showed that ScramshRNA-treated rats spent
more time sniffing during exposure to hypoxic-hypercapnic gas compared to
1ARshRNA-injected rats [U = 44, T = 135, P < 0.05]. The shRNA treatment
during exposure to hypoxic gas alone [df = 26, t = -0.01, P = 0.996] or
hypercapnia alone [U = 77, T = 168, P = 0.357] as determined by Student’s t-test
and Mann-Whitney Rank Sum test respectively, failed to have any significant
effects. B) Individual recording of flow in a ScramshRNA-injected rat illustrating a
short bout of sniffing.
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Figure 29. Relationship of 5-HT1A mRNA expression in commissural and
medial NTS to area under the curve of ventilatory rate during exposure to
hyperoxic hypercapnia. Pearson’s correlation between the area under the
curve of ventilatory rate over the full duration of exposure to hyperoxic
hypercapnia and relative 5-HT1A receptor mRNA in the commissural NTS (cNTS)
A) and mNTS B) showed significant correlation only in the commissural NTS. C)
Relative 5-HT2A receptor mRNA levels in the commissural and medial NTS of
AAV injected rats. Values are group means ± SEM. Unpaired Student’s t-test
revealed no significant effect of shRNA treatment on 5-HT2A receptor mRNA
levels.
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Discussion
In the current study, hypoxic hypercapnia increased c-Fos expression in
caudal serotonin neurons of the RO and RM. However, both hypoxia and
hypoxic hypercapnia induced c-Fos expression in the commissural and mNTS to
the same extent. Reduction in 5-HT1A receptor gene expression reduced
intermittent bouts of sniffing behavior during hypoxic hypercapnia, but did not
otherwise affect ventilation during normoxia, hypoxic normocapnia, hyperoxic
hypercapnia or hypoxic hypercapnia. These findings indicate that in the absence
of central chemoreceptor activation, peripheral chemoreceptor activation is
sufficient to activate serotonin neurons of caudal raphe regions known to
innervate the commissural and mNTS. Moreover, activation of the peripheral
chemoreflex sensitizes serotonin cells of the caudal raphe to activation by
hypercapnia. Serotonin, released in the NTS during the combined activation of
peripheral and central chemoreflexes, acts on 5-HT1A receptors to mediate
arousal.
Our findings contradict our original hypothesis that hypercapnia per se is
sufficient to activate serotonin cells of the caudal raphe. This prediction was
based on evidence provided by da Silva et al., who recently showed that lesion of
RO neurons using a saponin toxin targeting cells that express serotonin reuptake
proteins, reduced the ventilatory response to 7% CO2 in unanesthetized rats
when oxygen levels were normal (da Silva et al., 2013). We also found that
selective lesion of serotonin neurons in the caudal raphe using 5, 7-
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dihydroxytryptamine attenuated the ventilatory and sympathetic responses to
hyperoxic hypercapnia (Kung et al., 2010). In these studies hyperoxic gas was
used to suppress peripheral chemoreceptors and determine the effect of central
chemoreceptor activation per se. However, recent findings have shown that the
sensitivity of the ventilatory response to hypercapnia is suppressed when
peripheral chemoreflex responses are inhibited (Blain et al., 2010). In our prior
study, the effect of serotonin cell lesion on ventilatory response to hypercapnia
was only apparent when CO2 levels were raised to 8%. There was no difference
in ventilatory response upon exposure to 5% CO2. Thus, the inability of 5%
hypercapnia to activate serotonin cells of the caudal raphe in the current study
may have been due to reduced sensitivity of serotonin cells as a result of
peripheral chemoreceptor suppression by hyperoxia. Thus, when peripheral
chemoreceptor activation is absent, serotonin cells of the caudal raphe may
require a greater CO2 challenge to become activated. Indeed, we found that
when peripheral chemoreceptors were activated by hypoxia, c-Fos expression in
serotonin cells was evident with 5% hypercapnia.
As expected, hypoxia also induced c-Fos expression primarily in the
commissural NTS where the majority of peripheral chemoreceptor afferents
terminate, as has been repeatedly shown by others (Gozal et al., 1999; Song et
al., 2011; Teppema et al., 1997). Hypoxic hypercapnia also produced the same
degree of NTS cell activation. Thus, despite greater activation of serotonin
neurons in the caudal raphe during hypoxic hypercapnia, there was no additional
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activation of NTS cells, contrary to our hypothesis. However, it remains to be
determined what percentage of cells activated by hypoxia are GABAergic or
glutamatergic. We originally hypothesized that serotonin facilitates peripheral
chemoreflex responses by reversing the GABAergic cell activation that mediates
hypoxic ventilatory decline. Thus, it is possible that the same number of NTS
cells are activated during hypoxia in the presence or absence of serotonin cell
activation, but that a larger percent of activated cells are glutamatergic when
serotonin cells have been activated by hypoxic hypercapnia. This remains to be
determined.
Studies in this dissertation implicate 5-HT1A receptors expressed in the
NTS as the mediator of the sympathoexcitatory effects of endogenous serotonin
and 8-OH-DPAT during the second wave of compensation that develops after
syncope with blood loss. This effect appears to be dependent upon sinoatrial
nerve signaling. During the syncopal phase of hemorrhage, loss of blood flow to
the carotid bodies increases activation of chemoreceptor afferents. Thus, we
speculated that 8-OH-DPAT may act on 5-HT1A receptors in the NTS to facilitate
chemoreflex responses to hypoxia. However, our data did not support this
conclusion. Decreased 5-HT1A receptor mRNA expression did not influence
either ventilatory frequency, tidal volume or cumulative minute volume at any
time during a 45 min exposure to hypoxic hypercapnia, despite our evidence that
this same stimulus was sufficient to activate serotonin neurons. Instead, during
hypoxic hypercapnia we did notice a difference in ventilatory pattern between
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groups. The ventilatory pattern of control rats was characterized by fluctuations
in ventilatory frequency. This was verified by statistical evidence of increased
variability in ventilatory rate over the course of hyperoxic hypercapnic gas
exposure. Assessment of ventilatory wave forms showed an increased incidence
of intermittent bouts of high frequency ventilation characteristic of sniffing
behavior. Indeed, during 5% hypercapnia, rats treated with the ScramshRNAencoding virus tended to investigate the chamber and sniff the perimeter in what
looked like an effort to find the gas inlet. In contrast, rats with successful 5-HT1A
receptor knockdown did not show such investigative behaviors. Sniffing during
chemosensory stimuli has been associated with arousal (Carnevali et al., 2013).
Thus, it appears that instead of mediating chemoreflex responses, serotonin may
act on 5-HT1A receptors in the NTS to mediate arousal to chemosensory input.
It remains to be determined if such 5-HT1A receptor-dependent arousal
facilitates sympathetic and ventilatory responses to hemorrhage. Interestingly, a
similar deficit in sniffing was reported during peripheral and central chemoreflex
challenge in unanesthetized rats with lesion of the lateral parabrachial nucleus
(Mizusawa et al., 1995). It was reported that control animals were restless and
rambled during the initial gas change while lesioned animals remained calm.
Control animals eventually calmed down with prolonged hypoxia. Thus, activity
appeared to parallel changes in ventilation attributed to hypoxic ventilatory
decline. It was proposed that such behavioral responses to chemosensory input
require transmission of chemosensory-related signals to higher cortical or
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subcortical centers that project through the parabrachial nucleus. Indeed, full
ventilatory responses to hypercapnia requires intact supercollicular structures
and is attenuated in sleep (Murphy et al., 1990). Interestingly, similar lesions of
the parabrachial nucleus have also been found to greatly attenuate the
secondary compensatory phase of compensation during hemorrhage (Blair et al.,
2001; Blair and Mickelsen, 2006). Thus, our data are consistent with the
hypothesis that arousal during the combined activation of peripheral and central
chemoreflex responses is dependent upon 5-HT1A receptors in the NTS. It
remains to be determined if the same arousal mechanism is responsible for
sympathetic and ventilatory compensation following hypotensive hemorrhage.

CHAPTER VI
GENERAL DISCUSSION
The main findings from the studies conducted in this dissertation are
highly novel in that they are the first to identify 5-HT1A receptors in the caudal
NTS as a downstream target by which endogenous serotonin and exogenous 8OH-DPAT mediate sympathoexcitatory and pressor effects in recovery from
hypotensive hemorrhage. Furthermore, 8-OH-DPAT appears to augment the
effects of endogenous serotonin release that occurs with blood loss. Given our
evidence that 5-HT1A receptors in the NTS, particularly the commissural NTS, are
critical in reducing lactic acidosis in the unanesthetized rat subjected to
hemorrhage, the data further indicate an important role for 5-HT1A receptor
agonists in improving oxygenation of peripheral tissue following hypotensive
hemorrhage.
Based on prior work, we constructed a working hypothesis of how
endogenous serotonin and 8-OH-DPAT mediate their ability to improve
peripheral oxygenation following hypotensive hemorrhage (Figure 29). Evidence
from other laboratories identified serotonin neurons in the caudal raphe as
putative central chemoreceptors that are intrinsically sensitive to changes in pH
and CO2. Although this remains a controversial topic, there is some consensus
that serotonin neurons somehow facilitate the chemoreflex response to
181
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Figure 30. Original working model. During hypotensive hemorrhage,
peripheral chemoreceptors in the carotid bodies are activated by reduced blood
flow. Activation of second-order chemosensitive neurons in the caudal NTS to
stimulate sympathetic and ventilatory drive through downstream activation of the
RVLM and PreBötC respectively. During prolonged activation of the peripheral
chemoreceptors, GABA interneurons become activated and reduce sympathetic
and ventilatory drive. As blood loss continues, metabolic acidosis develops,
which activates serotonin neurons in the caudal raphe to release serotonin in the
NTS. In turn, activation of 5-HT1A receptors on GABAergic neurons disinhibits
the peripheral chemoreflex, ultimately restoring sympathetic and ventilatory drive.
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respiratory acidosis in unanesthetized animals (Bradley et al., 2002; Guyenet et
al., 2010; Teran et al., 2014; Wang et al., 1998; Wang and Richerson, 1999;
Wang et al., 2001). Whether serotonin neurons themselves have intrinsic
chemosensitivity in vivo remains to be determined. Given their importance in
mediating the response to acidosis, we predicted that serotonin neurons in the
caudal raphe would be stimulated by the metabolic acidosis that develops with
hypotensive hemorrhage and, as a consequence, would release serotonin into
the NTS and activate 5-HT1A receptors to facilitate peripheral chemoreflex
responses. However, 5-HT1A receptors are negatively coupled to signaling
pathways that excite cells (Fargin et al., 1989). Therefore, in our model we
predicted that 5-HT1A receptors involved in the response to hemorrhage would be
expressed by inhibitory GABAergic interneurons that are activated during
prolonged hypoxia and mediate the decrease in sympathetic activity and
ventilation that accompany hypoxic ventilatory decline. As such, 5-HT1A receptor
activation was speculated to reverse the decline in ventilation that develops with
sustained peripheral chemoreceptor activation. Hypoxic ventilatory decline is
accompanied by reductions in sympathetic drive as well. Therefore, reversal of
this GABA-mediated response would be expected to increase ventilation and
sympathetic activation.
To address this hypothesis, we examined whether acidosis stimulates
serotonin neurons in the caudal raphe, and whether acidosis would further
augment peripheral chemoreflex responses to hypoxia. Contrary to our working
model, hyperoxic hypercapnia did not reliably activate serotonin neurons in the
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caudal raphe despite causing an acidosis comparable to that seen in severe
hemorrhage. Instead, we noted that hypoxic hypercapnia caused more
activation of serotonin neurons of the RO and RM than did hypercapnia alone.
Our results are incongruent with evidence that serotonin neurons are intrinsically
sensitive to changes in arterial blood pH and PaCO2. We utilized hyperoxic
conditions in the presence of hypercapnia in order to prevent the activation of
peripheral chemoreceptors which are also sensitive to pH. However, recent
evidence has shown that in unanaesthetized dogs peripheral chemoreceptor
input can sensitize the ventilatory response to central chemoreceptor activation
(Blain et al., 2010). Conversely, denervation of the carotid sinus nerve impairs
the central chemoreceptor-induced increase in ventilation. In light of the recent
evidence that hyperoxia may reduce the sensitivity of central chemoreceptors, it
is plausible that peripheral chemoreceptor activation may contribute to the
excitability of serotonin neurons in the caudal raphe and this may contribute to
the sensitization of central chemoreception. This may explain why more caudal
raphe serotonergic neurons were activated during hypoxic hypercapnia than
hyperoxic hypercapnia.
Nevertheless, our results indicate that acidosis did not appear to augment
the chemoreflex ventilatory response to hypoxia, as indicated by the lack of
consistent increase in minute ventilation over the course of the hypoxic
hypercapnic challenge. Interestingly, we instead observed increased sniffing
during hypoxic hypercapnia that appeared to be attenuated in rats subjected to 5HT1A receptor knockdown. Based on these final experiments, we deduced that
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the sympathoexcitatory effect of 5-HT1A receptors in the caudal NTS was not due
to augmentation of the peripheral chemoreceptor responses.
Instead, we now propose that activation of 5-HT1A receptors in the caudal
NTS may be an important signaling mechanism that stimulates arousal. Several
laboratories have documented sniffing as a measure of exploratory behavior as
well as an arousal response (Carnevali et al., 2013). High frequency ventilation
or sniffing behavior is dramatically increased in response to novel stimuli such as
odors and visual cues as well as in response to rewards (Freeman et al., 1983;
Waranch and Terman, 1975; Wesson et al., 2009). Therefore, increases in
arousal may be demonstrated by increases in sniffing behavior such as that seen
in our rats during exposure to hypercapnic gas mixtures. We noted sniffing
behavior during hypoxia and hyperoxic hypercapnia in both treatment groups.
However, only sniffing in response to hypoxic hypercapnia was reduced by 5HT1A receptor knockdown. These findings suggest that multiple mechanisms
contribute to sniffing behavior, but that sniffing behavior and thus arousal during
hypoxic hypercapnia requires activation of 5-HT1A receptors in the caudal NTS.
Arousal responses require connections to the higher centers of the brain.
One such pathway may be through the parabrachial nucleus (Kubo et al., 1998;
Saper, 1982). The lateral subnucleus of the parabrachial nucleus (LPBN) has
reciprocal projections with the NTS (Herbert et al., 1990). Lesion of the LPBN
impairs sniffing behavior during chemoreceptor activation (Mizusawa et al.,
1995). Interestingly, similar lesions impair the secondary compensatory
response to hypotensive hemorrhage in rats. (Blair et al., 2001; Blair and
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Mickelsen, 2006). Prior work has shown that the LPBN is activated in response
to hypotensive hemorrhage, chemoreceptor activation, and peripheral tissue
hypoxia (Chan and Sawchenko, 1994; Hirooka et al., 1997; Jaworski et al.,
2002). Thus, it is tempting to speculate that 5-HT1A receptors in the NTS transmit
arousal signals to higher-order centers through the LPBN. This could also
explain the inability of 8-OH-DPAT to raise sympathetic activity in anesthetized
models of hemorrhage in which behavioral arousal is not expressed.
Based on our findings from this project, we revised our working model to
include a pathway through LPBN to higher-order centers. It remains to be
determined how this pathway participates in sympathetic and ventilatory
activation. However, it is recognized that 5-HT1A receptors expressed in the
RVLM inhibit sympathetic activity (Bago et al., 1999). Therefore, it seems less
likely that 8-OH-DPAT (and therefore, endogenous serotonin) is able to mediate
sympathetic excitation through a pathway that incorporates RVLM.
Alternatively, it is possible that both sympathetic and ventilatory activation
mediated by serotonin during hemorrhage are due to downstream activation of
the paraventricular nucleus of the hypothalamus (PVN). The PVN is recognized
as an integration site of higher-order sensory and central inputs with autonomic
functions and provides direct excitatory projections to the intermediolateral cell
column containing pre-ganglionic sympathetic fibers as well as to the RVLM
(Badoer, 2001; Coote et al., 1998). Moreover, the PVN has direct projections to
PreBötC and phrenic nuclei in the spinal cord and electrical stimulation of these
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projections can augment ventilation, HR and BP (Duan et al., 1997; Kc et al.,
2002a).
Even more interesting, several investigators have shown that electrical or
chemical activation of the PVN results in increased BP and HR as a result of
increased sympathetic activation (Chen et al., 2003; Kenney et al., 2003; Martin
et al., 1991). Since larger venules and veins have extensive sympathetic
innervations, it is plausible that PVN-mediated increases in sympathetic drive can
augment CO and venous tone (Furness and Marshall, 1974). In fact, studies
performed by Martin et al. demonstrated that disinhibition of the PVN results in
an increase in CO, without altering TPR in a conscious rat (Martin and Haywood,
1993). Since 8-OH-DPAT administration during hemorrhagic shock and
disinhibition of the PVN both result in similar hemodynamic effects, it is tempting
to speculate that PVN-mediated increases in venous tone may be disinhibited by
5-HT1A receptor activation during hemorrhage, but the exact mechanisms require
further investigation. Moreover, the PVN is also activated in response to hypoxia,
hypercapnia, and hemorrhage (Badoer and Merolli, 1998; Kc et al., 2002b; King
et al., 2012). Thus, it is plausible that PVN-mediated increases in sympathetic
drive could augment venous tone and promote peripheral tissue perfusion during
blood loss.
The LPBN also has direct projections to the central nucleus of the
amygdala (CeA), a region also important in regulating arousal responses and
cardiovascular control (Dampney, 1994; Davis and Whalen, 2001; Saha, 2005;
Saha et al., 2005; Saper, 1982; Saper and Loewy, 1980). Electrical stimulation of
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the CeA produces increases in HR and BP in conscious animals, but produces
the opposite effect when stimulated in an anesthetized animal (Iwata et al.,
1987). Furthermore, hypotension produced by hydralazine infusions causes cFos activation of neurons within the CeA. Electron microscopy studies confirmed
that these same neurons that are activated by hypotension in the CeA, receive
innervation from the LBPN (Takeuchi et al., 2004). Therefore, activation of the
CeA may be contributing to the arousal responses seen during hypoxic
hypercapnic gas exposure. Taken together, we revised our model to incorporate
the projections from the NTS to the LPBN, CeA, and PVN which we now believe
to be components of the pathways involved in compensation from hypotensive
hemorrhage.
In our revised model (Figure 30) we speculate that some pathway that is
initiated by peripheral chemoreceptor afferents contributes to increased
excitability of serotonin neurons of the caudal raphe, such that they become
more responsive to acidosis. Thus, the combination of peripheral and central
chemoreflex stimulation increases serotonin release in the NTS. Subsequent
activation of 5-HT1A receptors stimulates excitatory projections to higher-order
centers, possibly through connections in the LPBN that contribute to a
combination of effects that include arousal via the CeA, and parallel increases in
sympathetic activity and ventilation possibly mediated by PVN. We further
predict that this promotes increased tissue perfusion by stimulating increased
venoconstriction.
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Figure 31. Revised working model. Based on our most recent conclusions
from this dissertation, we hypothesized that in our revised working model,
serotonin neurons become more sensitive to metabolic acidosis during
hemorrhage with concurrent activation of the peripheral chemoreceptors. In turn,
serotonin activates 5-HT1A receptors in the caudal NTS that project directly to the
lateral parabrachial nucleus (LPBN). The LPBN signals arousal to hemorrhage
via projections to the amygdala and promotes sympathetic and ventilatory drive
by downstream activation of the paraventricular nucleus of the hypothalamus
(PVN). Once activated, the PVN promotes sympathoexcitatory activation via
IML.
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